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‘…the health of the people employed in rubber factories, coupled
with verbal questioning of many hands, male and female, and
likewise of foreman and others connected with such works for
months and years, in several instances 20 years and upwards, has
led me to the conclusion that the occupation is productive of no
definitive disease, nor of lasting inconveniences. This is the
concurrent testimony of all the employed, as well as of the
employers.’
Dr J.T. Arlidge in a report to the Chief Inspector
of Factories in 1894 1
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Chapter 1
General introduction
Chapter 1 outlines the background and main research
objectives of the study described in this thesis. Epidemio-
logical evidence for genotoxic risk in relation to exposure
in the rubber manufacturing industry is briefly discussed
and a strategy for the evaluation of exposure to complex
mixtures is presented. Subsequently, the study design and
research methods are described.
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General introduction
Background
The rubber industry has been associated with cancer risks for more than 5 decades. When
in 1949, β-naphthylamine was found as an impurity in some of the rubber antioxidants
it was possible to establish with reasonable certainty a direct causal link between that
usage and the excess of urinary bladder cancer cases observed by Case and Hosker 2 in
the British rubber industry. Although β-naphthylamine was subsequently phased out in
the following years it became apparent that other less evident cancer risks were present
in this industry 3-6. In 1982 the International Agency for Research on Cancer (IARC)
reviewed the evidence for carcinogenic risk in the rubber industry. It concluded that
there was sufficient evidence for excess mortality from cancer of the urinary bladder,
lung, stomach and leukemia and limited evidence for excess mortality from cancer of the
skin, colon, prostate and lymphoma 7. Epidemiological evidence of cancer risk in the
rubber industry published after this initial IARC evaluation was reviewed recently by
Kogevinas et al. 8. Their aim was to examine whether health and safety measures taken
since 1982 had resulted in a decrease in previously observed cancer risks. Although the
magnitude of the observed risks varied considerably between studies, the findings still
supported an excess mortality from cancer of the lung, urinary bladder, and leukemia.
An excess risk of stomach cancer among rubber workers was no longer found, but now
an excess risk of laryngeal cancer was found to be consistent between studies that was
not seen in the initial evaluation by IARC 7. It was concluded that preventive measures
taken in the rubber industry might have decreased risks, but that this had not yet been
picked up in epidemiological studies so far. Due to the long latency time between
exposure to a carcinogen and the clinical manifestation of solid tumors, at least 10 to 20
years, the observed excess risk for urinary bladder, laryngeal and lung cancer are likely
related to exposure conditions encountered in the remote past. These exposure
circumstances would still have included among others β-naphthylamine exposure. It
remains therefore uncertain if the observed cancer risks in recent epidemiological studies
are related to exposures from the past or, from exposures that still exist today.
Although 33 cohort and 15 industry specific nested case control studies 7; 8 have been
conducted in the rubber industry since 1972, it has generally not been possible to
identify chemicals which might be responsible for the increase in malignant neoplasms in
the rubber manufacturing industry. The exceptions are urinary bladder cancer associated
with the exposure to aromatic amines, especially β-naphthylamine and benzidine and
leukemia associated with exposure to solvents in particular benzene 7. However, the
exclusive link of urinary bladder cancer to β-naphthylamine exposure was questioned by
recent data indicating an excess of urinary bladder cancer among workers with no
recorded exposure to β-naphthylamine 9. Unfortunately, an absence of detailed exposure
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data in epidemiological studies in this particular industry has prohibited the linkage of
certain chemicals to specific cancer sites. The primary reason for this deficiency is the
considerable amount of chemical additives (several hundreds) that are being used in the
rubber industry. Moreover, due to high pressures and temperatures during curing more
(unknown) chemical substances are being formed and released. This complex exposure
profile does not only differ between rubber factories but also in time due to variations in
production and control technology, process requirements for different products and
variation in work practices 7; 10.
Exposure in the rubber manufacturing industry
Some general studies of environmental contamination in the rubber manufacturing
industry have been carried out. Most of these surveys were conducted in the late
seventies and early eighties in the USA and UK and focussed on exposure to airborne
particulate matter and solvents 11-13. Later, more specific studies were conducted of
exposure to nitrosamines and several polycyclic aromatic hydrocarbons 14-16. Although
these studies yielded a wide range in average exposure levels, some general exposure
patterns could be identified. Exposure to airborne particulate matter occurs mostly in
the beginning of the production process during the handling of raw materials, weighing
and mixing, and decreases further down the production process.  Solvents are mainly
used during assembling of rubber goods and in lubricants sprayed on rubber goods
before curing. Curing itself generates rubber fumes and gases occasionally containing
benzene, polycyclic aromatic hydrocarbons and nitrosamines. During inspection,
finishing and storage of rubber goods, products still off-gas contaminants like
nitrosamines into the workplace atmosphere 7.
Little attention has been paid to dermal exposure in this particular industry. Falck et al. 17
and Kilpikari 18 already suggested in the early eighties that dermal absorption of
chemical compounds could play an important role in the rubber industry. Direct
evidence for this hypothesis was found in a study by Bos et al. 19 in an aircraft tire
retreading company where a direct relation was found between dermal exposure to
cyclohexane soluble matter (CSM) and urinary mutagenicity while no relation was found
between urinary mutagenicity and rubber particulates and fumes in air. Later,
Kromhout et al. 10 studied dermal exposure to CSM in the rubber manufacturing industry
on a large scale. Calculations suggested that the amount of cyclohexane soluble
compounds on the skin of hands and wrists was potentially higher than the inhaled
amount. Depending on the specific situation in a factory and the use of protective
devices for skin contamination, the amount available for uptake through the skin could
be up to a tenfold higher than the amount inhaled 10.
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Evaluation of exposure to complex mixtures
In the evaluation of exposure of complex mixtures of potentially carcinogenic chemicals
several approaches can be followed. If the chemical composition of the complex mixture
is well characterized and detailed toxicological as well as epidemiological data on the
mixture are available, compound specific exposure indicators of external, internal, and/or
biological effective dose would suffice. However, selection of appropriate biomarker(s),
as an index of exposure to carcinogens is difficult as complex mixtures frequently
contain more than one carcinogen and in addition the concentration of the marker in
the mixture often varies within workplaces and time. In most instances, the exact
composition of the complex mixture is unknown. In such exposure situations non-
specific exposure variables have to be used. In the evaluation of exposure to complex
mixtures of potentially carcinogenic chemicals, these estimates are usually derived from
techniques that make use of the notion that one step in carcinogenesis is damage to or
mutation in DNA. To further unravel what proportion of the total genotoxic effect is
attributable to specific components in the mixture, a step-wise evaluation has been
proposed 20. First, external exposure is characterized as completely as possible (Figure 1-1).
This provides an estimate of the level and pattern of exposure both to the mixture and if
practical to its individual constituents. The next step is to analyze the relation between
external exposure and relevant (early) biological effect markers. Identification and
quantification of early genotoxic effects consequently evolves from non-specific effect
indicators (chromosome aberrations, sister chromatide exchanges, gene mutations,
oncogene activation etc.) through specific effect indicators (DNA adducts). Ultimately
this scheme would result in the identification of specific constituent(s) responsible for
the observed cancer risk.
In the assessment of external exposure additional ‘non-specific’ exposure indicators can
be used to estimate the toxic properties of the exposure. An example of such a ‘non-
specific’ technique for the estimation of mutagenicity is the S. typhimurium
mutagenicity assay 21, which has been used in several studies to evaluate life-style and
occupational exposure to mutagens and potential carcinogens 22; 23. Although the
bioassay does not discriminate between specific mutagens, it has the advantage of
detecting the integrated genotoxic potency of these components, without the need for
analytical methods to identify each mutagenic compound separately 24.
In several studies in the rubber manufacturing industry, exposure to mutagenic
compounds was established with this assay either by measuring mutagenicity of airborne
particulates and fumes or by measuring mutagenicity in urine of workers 14; 17; 19; 25; 26.
Although, these studies showed occupational exposure to mutagens, components
responsible for the mutagenic activity were hardly identified 27.
14
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Figure 1-1 Stepwise approach for assessment of potential carcinogenic risk of complex mixtures (Based on
Perera et al.20)
Measurement of exposure or effects of contaminants and/or their metabolites in human
body fluids and tissues are likely influenced by gene-environment interactions, including
biotransformation polymorphisms. It appears that many of the carcinogen metabolizing
enzymes are inducible by xenobiotics 28. Furthermore, many of the encoding genes are
polymorphic and multiple allelic variants relevant for the phenotype exist in human
populations 29. Cytochrome P450 (CYP), glutathione S-transferase (GST) and
N-acetyltransferase (NAT) gene families play an important role in the human variability
to metabolize carcinogens. In the metabolism of aromatic and heterocyclic amines and
hydrazines of which some are used in occupational processes (e.g. rubber and dye
industry) NAT capacity plays a significant role 30. In humans, two genes, NAT1 and NAT2
(both polymorphic) are responsible for N-acetyltransferase activity.
Slow NAT2 acetylation status has been associated with increased levels of urinary
mutagenicity 31-33, DNA adducts 34-37, increased urinary bladder cancer risk 38 and several
other cancer risks 39. In contrast rapid acetylators were suggested to be at higher risk of
developing cancer of the colon 40. Although the increase in cancer risk due to specific
biotransformation polymorphisms in most cases is small they are widespread in the
general population and of importance for individuals with a particular environmental
exposure 41.
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Research objectives
The objectives of the studies described in this thesis were:
♦ To evaluate current inhalable particulate and dermal exposure levels in the rubber
manufacturing industry in The Netherlands (Sections 3.1 & 3.2)
♦ To characterize external mutagenic exposure conditions in the rubber
manufacturing industry in The Netherlands (Sections 4.2 & 4.3)
♦ To study the relation between inhalable particulate matter, dermal exposure levels,
urinary mutagenicity and DNA adducts in exfoliated urothelial cells (Sections 4.4
& 4.5)
As a decrease in the barrier function of the skin could lead to increased dermal uptake 42; 43,
workers with a damaged skin possibly reveal higher internal doses. Therefore, a
considerable effort was made to ascertain adverse skin conditions and possible workplace
related and personal factors (Sections 2.1 & 2.2). As non-chemical specific exposure
indicators were used to evaluate genotoxic exposure conditions, special attention was
paid to control for the possible influence of other sources of genotoxic exposures such
as active and passive smoking (Section 4.1).
Study description
The results presented in this thesis stem from two studies. A pilot study was conducted
in 1995 in two rubber tire companies located in The Netherlands and Sweden. The main
study was conducted in 1997 in 9 different rubber manufacturing companies. The
selected companies formed a representative cross-section of the rubber manufacturing
industry in The Netherlands (3 rubber tire (including the pilot company from The
Netherlands), 5 general rubber goods and 1 retreading company). Seven of the selected
companies already participated in an earlier industry-wide survey conducted in 1988 10.
This enabled direct assessment of trends in inhalable particulate matter and dermal
exposure levels and subsequently the effectiveness of control measures implemented over
a nine-year period.
In total 225 subjects took part in the industry-wide survey. Subjects were asked to
complete a self-administered questionnaire prior to the survey on, among others
demographics, lifestyle factors, skin symptoms and known risk factors of skin diseases.
Evaluation of current skin condition was performed on the last day of the exposure
survey by a dermatologist. During the one-week exposure survey per company ambient
and personal inhalable particulate matter and dermal exposure levels were quantified.
Subsequently, ambient measurements were used to estimate the genotoxic properties of
the samples collected in the rubber manufacturing industry. Based on these results the
study population was divided in four categories of different inhalation and/or dermal
mutagenic exposure levels. Subsequently, 116 subjects, both smokers (n=45) and non-
smokers (n=71) were randomly selected from the a-priori defined exposure groups to
16
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unravel the relative contribution of the dermal exposure route. Spot urine samples of
these selected subjects, collected during the exposure survey were analyzed for urinary
mutagenicity and cotinine levels. Additionally, subjects were phenotyped for CYP1A2
and NAT2 biotransformation polymorphism. Finally, 60 out of the 71 non-smokers, were
selected to investigate the possible relation between genotoxic exposures and DNA
adduct formation in exfoliated urothelial cells of workers in the rubber manufacturing
industry.
Chapter 2
Skin aberrations in the rubber
manufacturing industry
In chapter 2 some methodological considerations regarding
the ascertainment of hand dermatitis in an industrial
population are described and the differences in perception
of skin diseases between different (occupational) populations
are addressed (Section 2.1). In section 2.2 prevalence of
hand dermatitis among rubber workers and possible
work-related risk factors such as dermal exposure and
hand washing practices are investigated.
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Section 2.1
Ascertainment of hand dermatitis using a symptom-
based questionnaire; Applicability in an industrial
population
In this study, the applicability of a symptom-based questionnaire on hand
dermatitis was assessed in a population of rubber workers. The
questionnaire was previously validated in a study among nurses. 224
subjects employed in 9 different companies completed a questionnaire on
skin complaints. Subsequently, 202 workers attended the physical
examination of the skin by a dermatologist.
The ascertainment of skin complaints according to the questionnaire
was compared to the medical evaluation. The 2 different diagnostic tools
used for assessing dermatitis resulted in dissimilar estimates of the
prevalence of active hand dermatitis, ranging from 6.9% to 38.1% of all
workers. Using the medical evaluation as ‘gold standard’ we observed a
moderate sensitivity and specificity (respectively 71.4%; 95% CI: 47.7-
95.1 and 76.1%; 95% CI: 70.0 – 82.2), a low positive predictive value
(18.2%; 95% CI: 8.0 –28.4) and a high negative predictive value (97.3%;
95% CI: 94.7 –99.9) for the classification based on the self-administered
questionnaire. When evaluated against ‘first symptoms of dermatitis’ the
sensitivity decreased, while the specificity remained almost the same.
The deviant findings between the present and the original validation
study of the same questionnaire among nurses hamper its applicability in
populations with different occupations. Therefore, if questionnaires are to
be used, validity studies have to be carried out to evaluate differences in
perception of skin diseases between different (occupational) populations.
Contact dermatitis, 2000, 42, 202 - 206
Introduction
Skin diseases such as contact dermatitis are common occupational illnesses and are
estimated to account for 9-35% of all occupational diseases 44-47. However, because these
estimates are based on several different diagnostic methods, such as medical records,
questionnaires and physical examinations, it is difficult to draw comparisons between
occupational groups and the general population. It is generally believed that the use of
medical records leads to an underestimation of the prevalence of contact dermatitis as
only relatively few people with skin complaints seek medical assistance 48. Other studies
have used medical evaluations by trained physicians. However, the use of such a labor-
intensive diagnostic tool in large epidemiological studies is often not feasible. As a
consequence, questionnaires are most often used as a diagnostic tool for estimating the
prevalence of skin diseases or as a primary screening method. Their validity, however, has
been addressed in only a few studies, in which questionnaire-based diagnoses of hand
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dermatitis were compared to an objective assessment of hand dermatitis by trained
physicians 48-52. The results of these validation studies range from high specificity (100%)
and lower sensitivity (60%) to a high sensitivity (100%) but lower specificity (64%) 48; 52.
In this study a symptom-based questionnaire on hand dermatitis, previously validated
among nurses, and a physical examination were used to identify skin diseases in a
population of rubber workers. The aim of the study was to assess the applicability of
such a symptom-based questionnaire in an industrial population.
Materials and methods
Study population
The study was conducted from January 1997 through July 1997 among 225 subjects
employed in the rubber manufacturing industry in The Netherlands. Subjects were part of
a large exposure survey in the rubber manufacturing industry investigating the relative
contribution of dermal exposure to the total genotoxic dose. Subjects were employed in
9 companies and were selected on the basis of their production function 53. Subjects
were asked to complete a self-administered medical questionnaire prior to the exposure
survey (Monday). 224 (99.6%) Subjects successfully completed the questionnaire; of
these, 202 (90.2%) workers attended the medical evaluation at the end of the week
(Friday).
Hand dermatitis
Hand dermatitis was assessed using a symptom-based questionnaire and a medical
evaluation. Questions concerning hand dermatitis were adapted from a validated
questionnaire developed by Smit et al. 48. In total 4, different criteria were used for the
diagnosis of hand dermatitis on the basis of the questionnaire.
Hand dermatitis was defined as a positive answer to at least 1 of the following: ‘Have you
had one of these symptoms at your hands or fingers in the past 12 months: (a) ‘red
swollen hands or fingers’, (b) ‘red hands or fingers and fissures‘, (c) ‘vesicles on the hands
or at the sides of the fingers’, (d) ‘scaling hands or fingers with fissures’, (e) ‘itching
hands or fingers with fissures’. Moreover, subjects had to give a positive answer to either
of these 2 questions: ‘did one or more of these symptoms last for more than three
weeks?‘; ‘did one or more of these symptoms occur more than once ?’ (Criteria I). A more
lenient additional classification based on 1 or more symptoms but without the
requirement of long-lasting or recurrent symptoms (Criteria II) and a more stringent
classification based on the occurrence of 2 or more symptoms with the addition of long-
lasting or recurrent symptoms were also used (Criteria III). The question ‘do you have a
skin disease at this moment?’ was used to estimate the point prevalence of current skin
diseases (Criteria IV).
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The medical evaluation of current skin conditions was conducted by 2 dermatologists.
Objective skin symptoms were used for the classification: ‘active hand dermatitis’ (‘major’
dermatitis), and ‘the first symptoms of dermatitis’ (‘minor’ dermatitis). ‘Major’ dermatitis
was defined as: erythema, papules, vesicles and fissures, comprising a clear eczematous
picture. ‘Minor’ dermatitis was exhibited as erythema, slight chapping and scaling of the
skin 51; 54. No distinction was made between irritant and allergic dermatitis, as
morphologic characteristics of these skin disorders are similar. Neither the dermatologist
nor the worker was informed about the results of the questionnaire on hand dermatitis
prior to the medical evaluation.
Data analysis
The questionnaire’s applicability was studied by computing its sensitivity (% of individu-
als with the disease, who are classified as having the disease), specificity (% of individu-
als without the disease who are classified as not having the disease), positive predictive
value (PPV) (% of subjects with a positive test who have the disease) and negative
predictive value (NPV) (% of subjects with a negative test who do not have the disease).
The medical diagnosis served as ‘gold standard’ in these calculations. For the statistical
procedures regarding ‘minor’ dermatitis, subjects with ‘major’ dermatitis were excluded
from the analysis. 95% confidence intervals were calculated assuming prevalence and
validity statistics as a proportion (ρ) drawn from a normal distribution
(ρ ± 1.96 √ρ (1- ρ)/n).
Results
The prevalence of hand dermatitis as estimated by the symptom-based questionnaire and
medical evaluation is presented in Table 2.1-1. The different classifications and
diagnostic tools resulted in dissimilar estimates of the prevalence of hand dermatitis. The
prevalence of workers with hand dermatitis based on the symptom-based questionnaire
ranged from 14.9 % to 38.1% depending on the criteria used. 35 subjects (17.3%) had
skin complaints at the time of the survey. Although 70 subjects (34.6%) were diagnosed
with skin diseases of some kind, only 14 cases (6.9%) of ‘major’ hand dermatitis were
identified according to the medical evaluation.
Both sensitivity and specificity for ‘major’ hand dermatitis were moderate (respectively
71.4% and 76.1%), the positive predictive value was low (18.2%) and the negative
predictive value high (97.3%) (Table 2.1-2). Estimates of these statistics for ‘minor’
dermatitis resulted in a considerable decrease in sensitivity (39.3%) while the specificity
remained almost unaffected (82.6%). Application of the more lenient classification
(Criteria II) of hand dermatitis based on the symptom-based questionnaire resulted in a
higher sensitivity for ‘major’ and ‘minor’ dermatitis, respectively 85.7% and 57.1%.
However, the specificity decreased slightly. For the more stringent categorization
(Criteria III) the opposite was observed, as the sensitivity decreased and the specificity
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Criteria 
 
‘Major’ Dermatitis ‘Minor’ Dermatitis Dermatitis c 
  % (95% CI) % (95% CI) % (95% CI) 
I Symptom based diagnosis: ≥ 1 symptoms and recurrent or lasted more than 3 weeks 
 Sensitivity 71.4 (47.7 – 95.1) 39.3 (26.5 – 52.1) 45.7 (34.0 – 57.4) 
 Specificity 76.1 (70.0 – 82.2) 82.6 (76.1 – 89.1) 82.6 (76.1 – 89.1) 
 PPV a 18.2 (8.0 – 28.4) 48.9 (34.3 – 63.5) 58.2 (45.2 – 71.2) 
 NPV b 97.3 (94.7 – 99.9) 76.2 (69.2 – 83.2) 74.1 (67.0 – 81.2) 
II Symptom based diagnosis: ≥ 1 symptoms 
 Sensitivity 85.7 (67.4 – 100) 57.1 (44.1 – 70.1) 62.9 (51.6 – 74.2) 
 Specificity 65.4 (58.6 – 72.2) 75.0 (67.6 – 82.4) 75.0 (67.6 – 82.4) 
 PPV a 15.6 (7.5 – 23.7) 49.2 (37.0 – 61.4) 57.1 (46.0 – 68.2) 
 NPV b 98.4 (96.2 – 100) 80.5 (73.5 – 87.5) 79.2 (72.1 – 86.3) 
III Symptom based diagnosis: ≥ 2 symptoms and recurrent or lasted more than 3 weeks 
 Sensitivity 28.6 (4.9 – 52.3) 21.4 (10.7 – 32.1) 22.9 (13.1 – 32.7) 
 Specificity 86.2 (81.3 – 91.1) 89.4 (84.1 – 94.7) 89.4 (84.1 – 94.7) 
 PPV a 13.3 (1.1 – 25.5) 46.2 (27.0 – 65.4) 53.3 (35.4 – 71.1) 
 NPV b 94.2 (90.7 – 97.7) 72.8 (65.9 – 79.7) 68.6 (61.7 – 75.5) 
IV Skin complaints at time of medical evaluation 
 Sensitivity 57.1 (31.2 – 83.0) 12.5 (3.8 – 21.2) 21.4 (11.8 – 31.0) 
 Specificity 85.6 (80.6 – 90.6) 84.8 (78.7 – 90.9) 84.8 (78.7 – 90.9) 
 PPV a 22.9 (9.0 – 36.8) 25.9 (9.4 – 42.4) 42.9 (26.5 – 59.3) 
 NPV b 96.4 (93.6 – 99.2) 69.6 (62.5 – 76.7) 67.1 (60.0 – 74.2) 
 
a) Positive Predictive Value 
b) Negative Predictive Value 
c) Summation of ‘major’ and ‘minor’ dermatitis 
Table 2.1-2 Validity statistics of self-reported hand dermatitis compared to physical
examination of hand dermatitis (95% confidence intervals between parentheses).
Table 2.1-1 Prevalence of hand dermatitis as estimated by a symptom-based questionnaire and medical
evaluation (95% confidence interval between parentheses).
Criteria Type of diagnosis of hand dermatitis Prevalence 
  N % c (95% CI) 
 Questionnaire    
I  One or more symptoms and recurrent or lasted more than 3 weeksa 55 27.2 (21.1 -  33.3) 
II  One or more symptoms a 77 38.1 (31.4 – 44.8) 
III  Two or more symptoms and recurrent or lasted more than 3 weeksa 30 14.9 (10.0 – 19.8) 
IV  Complaints at time of survey b 35 17.3 (12.0 – 22.5) 
     
 Medical evaluation    
  ‘Major’ Dermatitis 14 6.9 (3.4 – 10.4) 
  ‘Minor’ Dermatitis 56 27.7 (21.5 – 33.9) 
 
a) Period prevalence  (last 12 months) 
b) Point prevalence 
c) N=202 subjects 
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increased. Remarkably, the sensitivity for ‘major’ and ‘minor’ dermatitis both dropped
when only skin complaints at time of the study were considered, although the specificity
improved slightly.
Discussion
Validation of the questionnaire revealed an overall moderate sensitivity and specificity,
indicating moderate agreement. Overestimation of the prevalence of ‘major’ hand
dermatitis based on the questionnaire was clearly illustrated by the very low positive
predictive value (18.2%; 95% CI: 8.0 –28.4). More stringent criteria for identifying
dermatitis applied at the medical evaluation probably resulted in the observed
difference. Hence, when less severe skin diseases like ‘minor’ dermatitis were included,
the positive predictive value increased, indicating that self-reported complaints were
related to these skin diseases. Overestimation of the prevalence could also have been
influenced by the different time frame the medical evaluation and questionnaire covered,
respectively a point prevalence vs. a 12-month period prevalence. However, the validity
calculated for reported complaints at the time of the study was even poorer than for the
criteria based on self-reported symptoms, indicating that the different time frames
reflected are probably not the most important factors for the observed difference.
Although overreporting of hand dermatitis was apparent in this study, only a moderate
sensitivity was observed, indicating that a number of workers (29%) did not report
pronounced symptoms of hand dermatitis as confirmed by the medical examination.
In a validation study of the same questionnaire among nurses, a high sensitivity (100%)
and negative predictive value (100%) was observed, while the specificity (64%) and
positive predictive value (38%) were relatively low 48. The difference in sensitivity found
between these 2 validation studies can likely be explained by a different perception of
skin diseases. Susitaival et al. 52 validated their questionnaire in a population sample of
Finnish farmers and found also a low sensitivity, probably, indicating that workers with a
more physical workload have got used to having skin diseases. Although medical
evaluations by trained physicians were used as a ‘gold standard’ in all of these validity
studies, the observed differences could have been influenced by inter-expert variability.
However, among dermatologists a clear consensus on the morphological signs of hand
dermatitis is present.
Questionnaires are not only used for estimating the prevalence of skin diseases but also as a
primary screening method. The high negative predictive value (97.3%; 95% CI: 94.7-99.9)
found for ‘major’ hand dermatitis in this study suggests that the questionnaire could be
used as a diagnostic tool for primary screening. However, due to the low prevalence of
hand dermatitis (6.9%), the NPV is severely influenced by the large amount of healthy
subjects. Hence, if the questionnaire had been used for this purpose, 29% of the cases of
hand dermatitis would still have remained undetected.
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The more lenient classification without the requirement of long-lasting or recurrent
symptoms is to be preferred in this case, as the sensitivity was considerably higher.
Therefore, workers reporting even the mildest symptoms of possible hand dermatitis
should be included in a medical screening. However, none of the classifications used
resulted in a good diagnostic tool for estimating the prevalence of hand dermatitis, as
the overall sensitivity and specificity remained moderate for all criteria used.
The ‘true’ prevalence (6.9%; 95% CI: 3.4 – 10.4) of ‘major’ hand dermatitis as assessed by
the dermatologist in this study, was similar to findings in previously reported studies in
the rubber manufacturing industry using the same methodology 55; 56. Reported
prevalences of hand dermatitis in the general population are nevertheless similar
(2-10%) 57-62. However, these estimates are mainly based on information gathered from
questionnaires and therefore are likely an overestimation of the true prevalence. The
apparent differences between the several diagnostic tools for identifying hand dermatitis
complicate comparisons of prevalences between occupational groups and the general
population. Furthermore, it was concluded that the applicability of a questionnaire for
identifying skin diseases, and in particular hand dermatitis, is limited, as large
differences were found in validity when applying a standardized questionnaire to
different populations. Moreover, if questionnaires are to be used, validity studies must
be carried out to evaluate perception of skin diseases in specific occupational
populations or subgroups of the general population.
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Section 2.2
Dermal exposure, hand washing and hand
dermatitis in the rubber manufacturing industry
Skin diseases, such as hand dermatitis are thought to be a common
problem in the rubber manufacturing industry as workers are exposed to a
wide range of chemicals with known irritant and sensitizing potential. We
conducted a cross-sectional survey of a representative sample of rubber
manufacturing workers (n=202), selected from 9 different rubber
companies. Prevalence of hand dermatitis (‘major’- and ‘minor’ dermatitis)
and skin injuries was assessed based on a diagnosis by a dermatologist.
The possible relations between actual skin exposure, hand washing
practices and hand dermatitis were investigated. Prevalence of ‘major’
hand dermatitis (7%) was comparable with that in the general population,
‘minor’ signs of dermatitis, however, were more common among the
surveyed population (28%) as were traumata’s of the skin (17%). Dermal
exposure to cyclohexane soluble agents during work was related to the
occurrence of ‘major’ hand dermatitis, but not to the occurrence of ‘minor’
hand dermatitis. Moderate and frequent hand washing especially with
industrial surfactants containing scrubbing particles were found to be
strongly associated with the occurrence of ‘minor’ dermatitis OR=4.27
(95% C.I. 0.90 – 20.27) and OR=6.38 (95% C.I. 1.33 – 30.17),
respectively.
Epidemiology, in press
Introduction
Skin diseases are estimated to account for 9-35% of all occupational diseases 44-46; 63, of
which allergic and irritant contact dermatitis comprise the majority of occupational
cases 64. Frequent causes of occupational allergic contact dermatitis (ACD) are rubber
chemicals, chromates, and epoxy resins. Detergents, cutting fluids, organic solvents, and
environmental factors such as humidity, occlusion and mechanical friction have been
shown to elicit irritant contact dermatitis (ICD) 64-66. Several of these stimuli are present
in the rubber manufacturing industry and as a result the rubber industry has often been
considered as a high-risk industry in relation to skin diseases 67; 68. Most of the data,
however, stem from routinely collected governmental statistics or clinical series 18; 64.
Epidemiological investigations identifying particular occupational processes are scarce,
and have focused on working conditions encountered in large rubber tire companies 55; 69; 70.
Rubber manufacturing in The Netherlands, is predominantly a small-scale industry
producing mainly custom-made technical rubber goods.
The focus of most of these industry-based epidemiological studies has been on the
occurrence of ACD due to exposure to chemical substances with great sensitizing
potential, such as thiuram-, carbamate-, paraphenylene- and mercapto-compounds 71; 72.
A recent study has indicated that not only are rubber additives an important risk factor
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for allergic reactions but so is natural rubber, as allergenic natural rubber latex (NRL)
proteins have been detected in extracts from rubber products 73. On the other hand,
scant data are available on ICD and skin trauma related to working conditions in the
rubber manufacturing industry. Furthermore, none of the epidemiological studies
controlled for potential confounders or effect modifiers such as past or present atopic
dermatitis, hand washing practices and domestic exposures.
The aim of this study was to investigate the prevalence of skin disorders and the possible
relation between dermal exposure and hand dermatitis in a cross-sectional study of
rubber manufacturing workers. Detailed information on actual skin exposure, hand
washing practices, personal characteristics and domestic exposures facilitated the
identification of specific risk factors associated with increased likelihood of work-related
skin disorders.
Subjects and methods
Study population
The study was conducted from January 1997 through July 1997 as part of a large cross-
industry survey to evaluate the possible role of dermal exposure on the total genotoxic
dose of workers in the rubber manufacturing industry in The Netherlands. Subjects were
employed in 9 companies (3 rubber tire, 5 general rubber goods and 1 retreading
company) and were randomly selected based on their production function (e.g.
compounding and mixing, pre-treating, moulding, curing, finishing, shipping,
engineering service and laboratory) 74 to cover a variety of production processes and
exposures. General characteristics of the companies and production functions studied are
presented in Table 2.2-1. Total workforce in the surveyed companies equaled 1355
subjects, of which 225 subjects were selected. 202 (90.2%) subjects took part in the
medical evaluation and exposure survey and successfully completed a self-administered
questionnaire. The self-administered questionnaire included detailed questions
concerning demographics (age, ethnicity, etc.), known risk factors of skin complaints
and diseases, atopic dermatitis, absenteeism and medical consultation due to skin
complaints. All 202 subjects were male, between 19 and 60 years of age, with a mean
age of 37.6 (sd. 9.1) years.
Hand dermatitis
Two dermatologists conducted a medical evaluation of current skin condition. Objective
skin symptoms were used for the classification: active hand dermatitis (‘major’
dermatitis), the first symptoms of dermatitis (‘minor’ dermatitis) and skin injuries
(traumata). ‘Major’ dermatitis was defined as: erythema, papules, vesicles and fissures,
comprising a clear eczematous picture. ‘Minor’ dermatitis was exhibited as erythema,
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slight chapping and scaling of the skin. Traumata of the skin comprised cuts and burns.
No distinction was made between irritant and allergic dermatitis, as morphologic
characteristics of these skin disorders are similar 54; 75.
Hand washing
Information regarding hand washing frequency and type of surfactant used during the
workday was gathered as part of the medical survey based on standardized questions.
Contents of identified surfactants were subsequently verified and categorized as mild
surfactants (normal household soaps) and industrial surfactants (soaps containing
scrubbing particles with or without the addition of an organic solvent).
Dermal occupational exposure
Personal dermal exposure to cyclohexane soluble matter (CSM) was measured with a
dermal pad sampler on three consecutive days (Tues., Wed., and Thurs.). The pad sampler
consisted of 24 layers of cotton surgical gauze with a surface of 9 cm2, worn on the volar
forearm (wrist) of the hand of preference throughout the 8-h working period 10; 76. CSM
content of the pad sampler was determined by means of the NIOSH P+CAM 217 method 77.
Natural rubber latex (NRL) allergy
Plasma of all subjects was analyzed for anti-NRL IgE by enzyme immunosorbent assay
(EIA) 78. Flat-bottom 96-wells polystyrene microtiter plates with high binding capacity
were coated overnight at 4°C with latex allergen dilution (10 µg/ml) (Hevea Brasiliensis,
ALK Benelux, Houten, The Netherlands). Sera diluted 1/10 in phosphate-buffered saline
(PBS) containing 0.5% (w/v) Tween were added to the wells, and incubated for 2h at
37°C. Bound IgE was measured with a four-step procedure, consisting of three 1h
incubations at 37°C with monoclonal mouse anti-human-IgE, biotinylated rabbit anti-
mouse immunoglobulins, avidin-peroxidase and finally an incubation for 30 minutes
with o-phenylenediamine (OPD) containing 0.015% (v/v) H2O2. The reaction was stopped
after 30 minutes by the addition of 50 µl 2N HCl and the absorption was read at 492 nm.
All sera were tested in duplicate wells on the same microtiter plate. Each plate included
a positive control serum tested in duplicate, and two reagent blanks (no-serum
controls). Sera were considered positive if the mean OD492 was 0.05 units higher than the
reagent blanks.
Calculations and statistical analyses
Mean individual dermal exposure levels were calculated from the repeated individual
measurements. The median of the aggregated exposure distribution was used as cut-off
point to classify exposure dichotomous as low/high. Use of protective gloves was
evaluated based on the actual use of gloves during the exposure survey. If gloves were
worn during more than 50% of the measurement days, subjects were classified as
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‘frequent’ glove users. Information about domestic activities and hobbies, such as
gardening, car maintenance etc., was evaluated by two of the authors (RV & DB), blind to
outcome, on known skin aggravating potency resulting in a dichotomous classification
(yes/no).
Possible relations between personal and work related determinants and hand dermatitis
were initially studied by computing crude prevalence odds ratios (OR) from univariate
logistic regression analyses. Identified risk factors were further investigated by means of
a multiple logistic regression analysis. In the regression analyses subjects with a
particular skin condition (e.g. ‘major’ and ‘minor’ dermatitis) were compared to subjects
without any adverse skin condition (n=113). In evaluating ‘major’ hand dermatitis, the
regression analyses were adjusted for reported past or present atopic dermatitis. All
statistical analyses were performed with Statistical Analysis System (SAS) V6.12 packages 79.
Results
Among the 202 subjects, 14 subjects were diagnosed with ‘major’ hand dermatitis. 28%
showed symptoms of ‘minor’ hand dermatitis and 17% were diagnosed with traumatized
skin at time of the study (Table 2.2-1). The overall clinical picture of ‘major’ hand
dermatitis was characterized by erythema and papules with vesicles and sometimes
fissures on the palms and the palmar sides of the fingers and fingertips. The clinical
manifestation of ‘minor’ dermatitis was characterized by almost exclusively erythema
with occasionally scaling and chapping of the hands. Large differences in prevalence of
skin disorders between the different companies were observed. Variation in prevalence
among different production functions was, however, smaller than between companies
(Table 2.2-1).
34.8% of the subjects with skin disorders attributed their skin condition to working
conditions encountered in the rubber manufacturing industry. 41.6% claimed relief of
skin problems while not working for several days. A clear trend was observed between
the severity of skin disorders and the proportion of subjects who claimed beneficial
effects from a few days off work; 64.3% of those with ‘major’ dermatitis, 42.9% of those
with ‘minor’ dermatitis and 29.4% of those with traumata. Only 2 subjects reported
having had an allergic reaction due to contact with rubber goods and/or chemical
additives. None of the 202 workers showed a class II or higher positive anti-NRL IgE
reaction. Although skin disorders were prevalent in this population, only in 7 instances
did the occurrence of hand dermatitis result in a subject’s absenteeism from work in the
last 12 months.
Median (31.7 µg/cm2) of the aggregated personal dermal CSM exposure distribution was
used as cut-off point to classify dermal exposure as low or high. Subjects without any
skin disorders (n=113) had a median dermal CSM exposure concentration of 31.2 µg/cm2
(Q1-Q3= 19.1- 57.7 µg/cm2), which was similar to subjects with major or minor hand
dermatitis (median=31.3 µg/cm2; Q1-Q3= 14.9- 70.5 µg/cm2). In Table 2.2-2 crude
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prevalence odds ratios and results of the multiple logistic regression analyses are
presented. Crude odds ratios did not differ much from the odds ratios derived from the
multiple logistic regression analyses, except for dermal CSM exposure and hand washing.
High dermal exposure levels measured at the wrist was associated with ‘major’ hand
dermatitis (OR=2.15, 95% C.I. 0.58 – 7.95). Other determinants under consideration
suggested an overall protective effect in relation with ‘major’ hand dermatitis, especially
for domestic activities with potentially skin aggravating potency (OR=0.33, 95% C.I.
0.10 -1.10). In contrast, ‘minor’ hand dermatitis was positively associated with the
studied determinants except for glove use (OR=0.58 95% C.I. 0.27 – 1.23). Moderate and
frequent hand washing during the workday showed a strong positive effect OR 3.09 (95%
C.I. 1.16 – 8.21) and OR 2.27 (95% C.I. 0.92 – 5.56) after adjustment. The use of
industrial surfactants seemed to augment the occurrence of ‘minor’ hand dermatitis (OR
1.92, 95% C.I. 0.91 – 4.02). Domestic activities with potentially skin aggravating
potency were found to be one of the major risk factors for the occurrence of ‘minor’
dermatitis (OR 4.33, 95% C.I. 1.72 – 10.92). Little association was observed between age
and ‘major’ or ‘minor’ dermatitis (data not shown).
Table 2.2-2 Associations between hand dermatitis and personal and work related determinants. Presented
as prevalence odds ratios (OR) with 95% Confidence Intervals from multiple logistic regression
analyses.
Controls (N=113) ‘Major’ Dermatitis a (N=14) ‘Minor’ Dermatitis (N=56) 
N b N Crude 
OR c 
OR  (95% C.I.) N Crude 
OR 
OR  (95% C.I.) 
High dermal Exposure d 56 8 1.36 2.15 (0.58 - 7.95) 26 0.88 0.82 (0.40 - 1.69) 
5 – 9 33 3 0.72 0.53 (0.11 - 2.66) 18 1.68 3.09 (1.16 - 8.21) Hand washing e 
> 10 40 6 1.20 1.18 (0.30 - 4.62) 25 1.92 2.27 (0.92 - 5.56) 
Industrial surfactant use 60 7 0.88 0.64 (0.19 - 2.21) 35 1.47 1.92 (0.91 - 4.02) 
Glove use 51 5 0.68 0.61 (0.18 - 2.11) 19 0.62 0.58 (0.27 - 1.23) 
Domestic activities f 71 6 0.44 0.33 (0.10 - 1.10) 46 3.40 4.33 (1.72 - 10.92) 
       
a) Regression analyses adjusted for atopic dermatitis (OR=6.6, p=0.07) 
b) Number of subjects with particular determinant 
c) Odds ratio derived from the univariate logistic regression analyses 
d) Tested against low dermal exposure to cyclohexane soluble matter 
e) Tested against low hand washing frequency (# 0 – 4) 
f) Domestic activities with potentially skin aggravating potency 
The relation between hand washing frequency, surfactant use and ‘minor’ hand dermatitis
was further investigated in a stratified analysis according to the type of surfactant used.
A clear dose-response relation was found between the frequency of industrial surfactant
use and the prevalence of ‘minor’ dermatitis (Table 2.2-3). This trend between hand
washing frequency and ‘minor’ dermatitis was not observed among the subjects using
only mild surfactants during the workday.
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Table 2.2-3 Relation between ‘minor’ hand dermatitis and hand washing frequency stratified
for industrial and mild surfactant use a. Presented as prevalence odds ratios (OR)
with 95% Confidence Intervals.
Hand washing 
frequency 
All detergents 
(N=167) 
Industrial surfactant 
(N= 76) b 
Mild surfactant  
(N=71) c 
5 – 9 3.09 (1.16 - 8.21) 4.27 (0.90 – 20.27) 2.38 (0.52 - 10.95) 
> 10 2.27 (0.92 - 5.56) 6.38 (1.35 – 30.17) 1.17 (0.28 - 4.80) 
 
 
a) Analyses adjusted for personal dermal exposure, glove use and domestic exposures (model table 2) 
b) Exclusive use of  industrial surfactants 
c) Exclusive use of mild surfactants 
 
Discussion
As the study was not primarily designed to study the occurrence of skin disorders in this
particular industry, selection bias is not likely to have occurred. As the relative sample
size per production function and company was not equal, however, the prevalence of
skin disorders could have been biased by the relative over-representation of a particular
production function or company. Adjusted prevalences were similar when compared with
crude prevalences for ‘major’- and ‘minor’ dermatitis and traumata of the skin
(respectively 7.2% vs. 6.9%, 29.0% vs. 27.7% and 17.8% vs. 16.8%). Therefore, the
observed prevalence of skin disorders and associated risk factors is representative for the
rubber manufacturing industry in The Netherlands. Although some authors 80; 81 have
argued for the use of prevalence ratios, the standard effect measure in prevalence studies
is the prevalence odds ratio 82; 83 since, in a stable population, this provides an estimate
of the ratio of the products of disease incidence and average disease duration in the two
populations being compared. Thus, if an exposure does not affect disease duration, then
the prevalence odds ratio directly estimates the incidence rate ratio 84.
Prevalence of ‘major’ hand dermatitis (7%) was similar to previous reports from the
rubber manufacturing industry 55; 56; 62. Although 27% of the subjects with ‘major’ hand
dermatitis attributed their skin condition to the working conditions encountered in the
rubber industry, the reported prevalences of hand dermatitis in the general population
are nevertheless comparable (2-10%) 59. Minor signs of dermatitis, however, were more
common in the rubber workers (28%). Although symptoms were mild, irritated, damaged
skin is a precursor to eczema 54. The overall absence of self-reported allergic reactions
due to contact with rubber goods or chemical additives suggests that irritant contact
dermatitis is the predominant form of hand dermatitis observed in this industry.
Nevertheless, as morphologic characteristics of allergic and irritant contact dermatitis
are similar 54; 75, only application of diagnostic patch tests could have ruled out with
certainty the presence of allergic contact factors.
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The presented results could have been prone to selection bias in the form of a healthy
worker effect owing to the cross-sectional character of the survey. As not many people
seek employment elsewhere because of skin disorders (except in the case of proven ACD)
this phenomenon is not very likely to have occurred 85.
A large difference in prevalences of all skin disorders between companies and production
functions was observed. As variation in prevalences between production functions was
lower than between companies, company specific production characteristics and/or
working conditions (including hand washing) probably play an important role in the
occurrence of skin disorders. Nevertheless, no consistent picture was observed between
rubber tire, general rubber goods and retreading companies. Investigation of possible
underlying risk factors for ‘major’ hand dermatitis showed an overall protective effect
with the exception of dermal CSM exposure. Damage to the skin can be repaired, at least
in part, when the interval between individual damaging processes is sufficiently long and
when the damage is not too extensive 86. This rehabilitation was demonstrated in our
study as 42% of all subjects with diagnosed skin disorders claimed relief of their
complaints while not working for several days. Thus, it is likely that subjects with
diagnosed ‘major’ hand dermatitis consciously try to avoid skin damaging activities
leading to the observed reversed relations with e.g. industrial surfactant use and
domestic activities. Since symptoms for ‘minor’ dermatitis are mild, they are seldom
considered as an adverse health effect by the subjects themselves 75. Consequently,
subjects do not change their working habits and domestic activities accordingly.
Hand washing practices (frequency and soap use) were found to be an important risk
factor for ‘minor’ hand dermatitis. Even though the mechanisms of skin irritation due to
surfactants are not fully understood, it is well documented that repetitive hand washing
can lead to irritant contact dermatitis 87; 88. The use of industrial surfactants, containing
scrubbing particles and often organic solvents, elicited the observed relation, due to the
fact that the chronically irritated skin is more vulnerable to other chemical exposures
and is less able to withstand mechanical stress 89. Industrial surfactants were available in
all companies and although differences in average use per day between companies were
observed (range 0.9 – 7.1) this did not account fully for the observed differences in
prevalence of ‘minor’ dermatitis between these companies. Therefore, additional
unidentified company related risk factors may be associated with the occurrence of
contact dermatitis in this industry.
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Chapter 3
Inhalable dust and dermal exposure
in the rubber manufacturing industry
In chapter 3 personal inhalable and dermal exposure
levels in the rubber manufacturing industry in
The Netherlands are evaluated. Long-term trends in
exposure to inhalable particulate and dermal contamination
and effectiveness of implemented control measures
in the last decade are discussed in section 3.1. In section
3.2 relevant exposure pathways involved in the process
of dermal contamination are considered based on a
conceptual model for dermal exposure assessment.
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Section 3.1
Trends in exposure to inhalable particulate and
dermal contamination in the rubber manufacturing
industry; Effectiveness of control measures
implemented over a nine-year period
Exposure to inhalable particulates and dermal exposure to cyclohexane
soluble matter (CSM) were evaluated in seven rubber manufacturing
companies in 1988 and 1997. The identified exposure trends were used to
study the effectiveness of control measures implemented over a nine-year
period.
Sampling and analytical methodologies were identical for both surveys.
Inhalable particulate exposure was measured with a PAS6 sampling head.
Dermal exposure was assessed by means of a dermal pad sampler worn at
the lower wrist of the hand of preference. Changes in working
organization and control measures taken after 1988 were identified based
on discussions with management representatives and two walk-through
surveys performed in 1994 and 1997. Exposure data were aggregated for
comparison between years both at company and production function level.
The mixed effect statistical procedure was used to evaluate the influence
of control measures and seniority on current exposure levels.
Comparison of the exposure levels between 1988 and 1997 revealed a
reduction rate of 5.7% and 6.7% per year for inhalable particulate and
dermal exposure, respectively. Companies and production functions with
the highest exposure levels in 1988 and workers with seniority (more
experience) showed a steeper decline in exposure levels. Fifty-seven
control measures, mostly designed to control the levels of inhalable
exposure were identified. Elimination of sources significantly reduced the
inhalable particulate and dermal exposure by two-thirds of the level of
1988. Reduction of emission did not show a significant overall decrease in
exposure concentrations. Control measures designed to control the levels
of contaminants showed a significant reduction for both inhalable and
dermal exposure, respectively 34 and 49% of the exposure level of 1988.
These result indicate that efforts taken to improve work conditions in
the rubber manufacturing industry in The Netherlands over this decade
have been successful in reducing both inhalable particulate and dermal
contamination.
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Introduction
Epidemiological studies among workers employed in the rubber manufacturing industry
have indicated a significant excess cancer risk in a variety of sites 7; 8. Although, several
associations between exposures and observed cancer risks have been hypothesized, it has
in general not been possible to identify specific agents for the majority of observed
cancer risks.
Roel Vermeulen
Jeroen de Hartog
Paul Swuste
Hans Kromhout
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General reviews of environmental contamination, conducted in the late seventies and
early eighties in the USA and UK, focused on inhalable particulate exposure to rubber
dust and fumes and solvents 11-13. Later on, more specific surveys were conducted for
exposure to nitrosamines and several polycyclic aromatic hydrocarbons 14-16. These
industry-wide cross-sectional surveys described the exposure levels throughout the
industry and the influence of control measures on the inhalable particulate exposure
levels. Little attention has been paid to dermal exposure in this particular industry,
although dermal exposure was found to be an important contributor to the total
genotoxic dose 19.  Only one large-scale exposure survey systematically studied dermal
exposure to cyclohexane soluble matter (CSM) in the rubber industry 90. This study
showed that the amount of CSM on the skin of hands and wrists was higher than the
amount inhaled. Depending on the specific situation in a factory and the use of
protective devices for skin contamination, the amount available for uptake through the
skin could be up to a tenfold higher than through inhalation 10.
In 1988 a large project for workplace improvement in the rubber manufacturing industry
in The Netherlands was carried out. Based on empirical modeling of the inhalable
particulate and dermal exposure, exposure affecting factors were identified for which
working conditions could be improved 10. These results were consequently used in a
covenant for improvement of working conditions in the Dutch rubber manufacturing
industry entered into by the Ministry of Social affairs and the social partners 91. Five
years after the initial survey the implemented control measures were evaluated. The
greatest effort had been taken in reducing and eliminating dust hazards. However, almost
no attempts were made to control exposure to curing fumes and exposure to dermal
contaminants 92. Whether these control measures were effective or not could not be
further substantiated as no quantitative exposure data were available.
This study was performed to evaluate current exposure to inhalable particulates and
dermal exposure to cyclohexane soluble matter (CSM) in seven out of ten companies that
were originally surveyed. The paper describes exposure trends in inhalable particulate
and dermal exposure and the effectiveness of control measures taken in the last decade.
All measures and changes in the production process a-priori assumed to result in reduced
exposure levels (inhalable particulate and dermal CSM contamination) were regarded as
control measures. The effectiveness of the control measures was studied with a simple
conditional hierarchical linear mixed effect model allowing estimation of fixed and
random effects simultaneously.
Material and methods
Exposure information collected in two industry wide surveys in the rubber
manufacturing industry in The Netherlands was used in this study. The initial survey was
completed in 1988 10; 90; 93 and the second survey in 1997.
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Study population
Companies involved in the initial exposure survey formed a representative cross-section
of the rubber manufacturing industry in The Netherlands 10. The companies (two rubber
tire, two retreading and six general rubber goods companies) were approached to
participate in the second survey of which seven agreed to do so. Of the three companies
that did not take part in the second survey; two companies had merged and
subsequently moved to another location and one company refused to co-operate as a
result of a major re-organization. The general characteristics of the plants studied are
presented in Table 3.1-1.
 Table 3.1-1 General characteristics of the surveyed companies.
No. of workers b Factory  
(SBI-code) a 1988 1997 
Production 
A (3111)  270 195 Bicycle and moped tires 
B (3111)  135 150 Belting, hose 
C (3112)  40 25 Mould and extruding articles, rubber foils  
D (3112)  35 35 Mould and extruding articles, roller covering, metal to 
rubber bonded articles 
E (3112)  50 40 Mould articles 
F (3112)  40 50 Mould and extruding articles, metal to rubber bonded articles 
G (3112)  180 150 Mould and extruding articles, metal to rubber bonded articles 
All 750 645  
    
 
a) Dutch Standard Industrial Classification: 3111 rubber tyre; 3112 general rubber goods 
b) Number of workers directly involved in production  
 
A random sample of the total workforce in each company was selected, stratified by
production function and job in both surveys. Subjects present in both surveys and who
still worked in the same production function were identified as more experienced
workers (seniority).
Exposure measurements
In 1988 measurements were carried out on random days during the course of a one week
period (Tues.- Fri.), resulting in two to three repeated inhalable particulate and dermal
exposure measurements per subject. A slightly different exposure strategy was employed
in 1997 where three repeated personal exposure measurements per subject were
collected on three consecutive days within one week (Tues., Wed., and Thurs.).
Measurements were taken in the same period of the year (± 1 week) to minimize the
effect of differences in meteorological conditions.
Sampling and analytical methodologies were kept the same for both surveys as
previously described by Kromhout et al. 10. Personal inhalable particulates were measured
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with a PAS6 sampling head mounted near the breathing zone of the worker 94; 95. Personal
dermal exposure was measured by means of a dermal pad sampler. The pad sampler
consisted of 24 layers of cotton (3x3 cm) and was worn on the lower part of the wrist of
the hand of preference 10; 76. Cyclohexane soluble matter (CSM) on the pad sampler was
determined by means of the NIOSH P+CAM 217 method 77. The pad was placed into
cyclohexane and sonificated for 30 minutes after sampling. The suspension was
consequently filtered through a glassintertube G4 (Schott, Germany) and collected in a
pre-weighed 10 ml vial. After evaporation of cyclohexane under nitrogen and
subsequently 2h drying at 40°C the residue was weighed by means of a microbalance.
Evaluation of control measures
Changes in working organization and control measures taken after 1988 and a-priori
assumed to result in reduced inhalable particulate and dermal exposure levels were
inventoried in 1994 and 1997. On both occasions changes were discussed with
management representatives and a walk-through survey in each company was carried
out, using company-specific reports of the initial survey as a basis. Control measures
were categorized by two different classification schemes; one related to the production
process, and another one related to the type of control measures 92. For the production
process the design analysis was used, dividing a production process into its key
activities: production function, production principle and production form. Production
function is analogous to the unit of operation and divides the production process into
its core activities (for example weighing, curing, etc.). The general principle by which
the production function is achieved is described by the production principle (for
example manual or mechanical driven operations). The production form relates to the
actual design of the installation or machine (materials, tools and machines used) 53. The
type of control measures was divided into source-oriented and exposure-oriented control
measures, using the division of elimination and reduction of emission (source-oriented)
and control of level of exposure and personal protective equipment (exposure-oriented).
Statistics
Exposure data were aggregated for comparisons between years at both company and
production function level. Exposure concentrations were successively averaged for each
worker (arithmetic mean of repeated individual measurements), for each production
function within each company (median of individual means) and eventually for each
production function or company (median of production function or company medians)
(Figure 3.1-1).
Within- and between-worker components of exposure variance were estimated from the
log-transformed exposure concentrations employing a one-way nested random-effects
ANOVA model. Variance components were estimated for each company production
function combination.
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1988 1997 
2-3 measurements 
random
  
(ninh= 486 ; nderm= 579) 
3 measurements 
(Tues., Wed., Thurs.)  
(ninh= 417 ; nderm= 446) 
Subjects 
(ninh= 202 ; nderm= 239) 
Subjects 
(ninh= 154 ; nderm= 154) 
Production function / 
company
 
(n=39)
 
Production function / 
company
 
(n=39)
 
Production function 
(n=9) 
Company 
(n=7) 
Figure 3.1-1 Aggregation of exposure data for comparison between years at both company and production
function level. Exposure concentrations were successively averaged for each worker (arithmetic
mean of repeated individual measurements), for each production function within each company
(median of individual means) and eventually for each production function or company (median
of production function or company medians). Number of measurements and subjects available in
each survey between parenthesis for both inhalable particulate (inh) and dermal exposure (derm).
The mixed effect procedure of SAS systems for Windows (version 6.12) 96 was used to
evaluate the effectiveness of the control measures and to quantify the influence of
seniority on current exposure levels. As workers were nested within a production
function and company a conditional hierarchical linear model was used 97. The model
used to study the fixed and random effects is described by the following expression:
Ygh(ij)= µgh + αg(h) + β1 +…. + βn+ δ + χgh(I) + εgh(ij)
Ygh(ij)  is the logarithm of the exposure concentration measured at the j
th day
(j=1,2…ngh(I)) of the i
th worker (i=1,2…kgh) in the g
th production function (g=1 to 8) of
the hth company (h=1 to 7); µgh is the true underlying mean of log-transformed exposure
averaged over all companies and production functions; αg(h)  is the fixed effect of  the g
th
production function in the hth company; β1,…, βn is the fixed effects of the control
measures taken [fixed effect per control measure, for example β1 is local exhaust ventila-
tion, β2 is automation (control measure indicator 0/1)]; δ is the fixed effect of seniority
(seniority indicator 0/1); χgh(I) is the random effect of the ith worker; εgh(ij) is the random
within-worker variation.
To estimate the fixed effect of the separate or categorized control measures dummy
variables were used in the above model for each measure taken ( β1,…  βn). As the 1988
survey served as a ‘base-line’ the control measures were only assigned, if appropriate, to
the individual observations of the 1997 survey. As the pad sampler was directly attached
to the lower wrist, the use of gloves and towels in both the 1988 and 1997 surveys could
possibly have affected dermal exposure measurements. Therefore, the use of dermal
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protection was included in the mixed effect model. Workers were assigned a unique
id-code for each of the surveys.  Seniority was assigned to the observations in 1997
when a subject had participated in the previous survey.
Variance components derived from the mixed effect models were estimated by the
Restricted Maximum Likelihood (REML) method. It is assumed thatχgh(I) and εgh(ij) are
normally distributed with zero mean and variance s2B,gh and s
2
W,gh (χgh(I)  ~ N(0, s2B,gh);
εgh(ij)  ~ N(0, s
2
W,gh)) and that s
2
B,gh and s
2
W,gh are mutually independent.
Explained variance of the used models was estimated using the mixed effect model
without the fixed effect variables for the implemented control measures and seniority
but with inclusion of a dummy variable for sampling period as random effect as the
reference. Explanation of the period variance component by the studied fixed effects is
consequently treated as explained variance of the observed changes in inhalable
particulate and dermal exposure.
Results
Rubber manufacturing in The Netherlands has always been a relative small industry with
a main activity in custom-made technical rubber goods. In 1988 employment totaled
about 7000 workers, which decreased over the years to about 4000 workers in 1997. In
contrast to the overall industry statistics the companies in the presented survey showed
reasonable stable employment figures (Table 3.1-1). The bicycle and moped tire company
formed an exception as it had moved a large part of its production to low income
countries resulting in a 28% reduction of the workforce over the nine-year period. Of the
750 production workers, 240 subjects (32%) were monitored in 1988 while in 1997,
24% (154 subjects) of the workforce in the companies were studied.
In total 57 control measures for inhalable particulate and dermal exposure were
identified (Table 3.1-2). Most of these control measures were implemented in the
production functions ‘compounding and mixing’, ‘moulding’ and ‘curing’ and were mainly
directed towards the control of exposure. Furthermore, measures were mainly taken at
the production form level (79%), followed by control measures that interfered with the
production function (16%). Control measures at the production principle level, mainly
related to the distance between worker and source, were only applied in three instances.
The use of personal protective devices as a control measure was evaluated based on the
information gathered at time of measurements (Table 3.1-3). In both surveys
approximately 5% of the workers wore some kind of respiratory protective device during
the exposure measurements. Even at production function level the use of respiratory
protection did not differ much, except for the engineering services where the use of
welding masks had increased. The same overall view was observed for the use of dermal
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protective devices, which were worn during approximately 45% of the dermal exposure
measurements. The only noteworthy difference was the decreased usage of towels as
dermal protection particularly in the curing departments.
Table 3.1-2 Control measures taken since 1988 for inhalable particulate and dermal exposure by production
function categorized by two classification schemes, respectively related to the key activities and
to type of control measures. Number of companies with particular control measure between
parentheses.
Type of control measures
Production
function
Key activities Elimination of sources Reduction of emission Control of exposure
Production function Closing department (2) a Stock blender (1) c
Masterbatches (1) b
Compounding
/ mixing
Production form Liquid anti-tacking(1) b Empty bag compactor (2)b
Dust free chemicals (7) b
Improved LEV (6) b
Production function No anti-tacking usage (1)b Cold feed extruder (1) cPre-treating
Production form Plasma degreasing (1) c
Anti-tacking foil (1) c
Improved LEV (2) b
General ventilation (1) b
Production function Cold feed extruder (1) c
Production principle Automation (2) c Mechanizing transport
routes (1) c
Moulding
Production form Liquid anti-tacking(1) b Improved LEV (6) b
General ventilation (1) b
Enclosure talc drum (1) b
Production function Cold feed extruder (2) cCuring
Production form Improved LEV (7) b
General ventilation (3) b
Finishing Production form Removing anti-tacking (1)b General ventilation (2) b
Engineering
service
Production form Improved LEV (1) b
Vacuum cleaning (1) b
a)
 
Control measures a-priori assumed relevant for exposure to particulates and dermal contamination
b)
 
Control measures a-priori assumed relevant for exposure to particulates
c)
 
Control measures a-priori assumed relevant for exposure to dermal contamination
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Table 3.1-3 Use of personal protective devices during the 1988 and 1997 exposure survey.
 Respiratory protective devices a Dermal protective devices b 
Production function %88 %97 %88 %97 
Compounding / mixing 28.8 26.3 57.3 72.9 
Pre-treating 1.8 8.6 (2.9) c 50.0 29.3 (0.8) d 
Moulding 10.7 3.1 (1.0) c 35.4 27.1 
Curing 0 0.9 59.7 (18.0) d 72.1 (4.1) d 
Finishing 0 0 16.9 16.7 
Engineering service 2.4 0 (15.4) 37.5 16.3 
Laboratory 0 0 40.0 55.6 
Shipping 4.3 0 8.0 3.7 
Total 5.0 (0.8) c 4.8 (1.8) c 43.0 (5.3) d 40.0 (1.2) d 
 
    
 
a) Percentage of face pieces used for respiratory protection 
b) Percentage of gloves used as dermal protection  
c) Percentage of other devices used for respiratory protection in parentheses 
d) Percentage of towels used as dermal protection in parentheses  
 
For comparison of the inhalable particulate exposure levels between the two surveys 903
repeated measurements were used (n88=486, n97=417). Exposure concentrations were
averaged by worker (k88=202, k97=154) and consequently grouped in 39 production
function / company combinations per surveyed period. The median inhalable particulate
exposure ranged from 0.56 to 1.85 mg/m3 when aggregated per company in 1988. In
1997 the exposure range had diminished to 0.49 to 0.90 mg/m3. All companies, except
one showed a decrease in exposure levels ranging from 0.07 to 0.95 mg/m3 over the
nine-year period (Table 3.1-4).
Table 3.1-4 Median exposure to inhalable particulates per company for the 1988 and 1997 exposure
surveys.
Measurements Subjects      
Company 
N88 a N97 b K88 a K97 b N c Median88 
(mg/m3) 
Median97 
(mg/m3) 
Difference 
(mg/m3) 
Percentage 
difference 
A 102 85 42 32 5 0.75 0.56 -0.19 25.3 
B 107 82 49 34 6 0.56 0.49 -0.07 12.5 
C 58 47 23 16 6 1.85 0.90 -0.95 51.4 
D 48 43 20 15 6 1.15 0.66 -0.49 42.6 
E 32 49 14 18 5 0.84 0.49 -0.35 41.6 
F 50 53 20 18 5 1.02 0.75 -0.27 26.5 
G 89 58 34 21 6 0.66 0.85 +0.19 28.8 
Total 486 417 202 154 39 1.00 0.59 -0.41 41.0 
          
 
a) Number of observations available for computation from the 1988 survey 
b) Number of observations available for computation from the 1997 survey 
c) Number of production functions within a particular company available in both surveys 
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At production function level the exposure range diminished from 0.50 to 3.71 mg/m3 in
1988 to 0.22 to 1.47 mg/m3 in 1997. This resulted in an overall decrease in inhalable
particulate exposure levels ranging from 0.02 mg/m3 at the ‘curing’ department to
2.24 mg/m3 at the ‘compounding and mixing’ department (Table 3.1-5).
Table 3.1-5 Median exposure to inhalable particulates per production function for
the 1988 and 1997 exposure surveys.
Production function N a Median88 
(mg/m3) 
Median97 
(mg/m3) 
Difference 
(mg/m3) 
Percentage  
difference 
Compounding / mixing 6 3.71 1.47 -2.24 60.4 
Pre-treating 5 1.00 0.85 -0.15 15.0 
Moulding 6 1.71 0.50 -1.21 70.8 
Curing 7 0.58 0.56 -0.02 3.4 
Finishing 5 0.69 0.54 -0.15 21.7 
Engineering 7 1.02 0.94 -0.08 7.8 
Laboratory 1 0.50 0.22 -0.28 56.0 
Shipping 2 1.13 0.56 -0.57 50.4 
      
 
a) Number of companies within a particular production function available in both surveys 
 
 
In total 1025 (n88=579, n97=446) dermal exposure measurements gathered from 393
workers (k88=239, k97=154) workers were used in the comparison of the two surveys.
Median dermal exposure to CSM ranged from 41 to 128 µg/cm2 per 8h in 1988 to 38 to
77 µg/cm2 per 8h in 1997 across companies. Five out of seven companies showed a
decrease in dermal exposure levels ranging from 18 to 72 µg/cm2 per 8h. The two
remaining companies showed a small increase of respectively 3 and 14 µg/cm2 per 8h,
respectively (Table 3.1-6). Across production functions a small increase in exposure
range was observed between 1988 and 1997, respectively 32 - 161 µg/cm2 per 8h and
22 - 184 µg/cm2 per 8h (Table 3.1-7). While a decrease in dermal exposure levels was
found for the production functions ‘compounding and mixing’, ‘pre-treating’, ‘moulding’,
‘curing’ and ‘finishing’ varying from 24 to 109 µg/cm2 per 8h, an increase was found for
‘engineering’, ‘laboratory’ and ‘shipping’ ranging from 5 to 46 µg/cm2 per 8h.
The reduction in mean inhalable particulate and dermal exposure levels had a
considerable effect on the variability in exposure concentrations of workers grouped by
company and production function combination. For inhalable particulate exposure a
decrease in both the between- and within-worker variance was observed. While for
dermal exposure an increase in both variance components was observed (Table 3.1-8).
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Table 3.1-6 Median dermal exposure levels to cyclohexane soluble matter per company for the 1988 and
1997 exposure surveys.
Measurements Subjects      
Company 
N88 a 
 
N97 b N88 N97 N c Median88  
(µg/cm2.8h) 
Median97 
(µg/cm2.8h) 
Difference 
(µg/cm2.8h) 
Percentage 
difference 
A 133 91 55 32 5 82 64 -18 22.0 
B 99 96 42 34 6 110 53 -57 51.8 
C 58 45 24 16 6 110 38 -72 65.5 
D 62 45 24 15 6 128 56 -72 56.3 
E 48 53 21 18 5 41 44 +3 7.3 
F 67 54 26 18 5 63 77 +14 22.2 
G 112 62 47 21 6 105 40 -65 64.4 
Total 579 446 239 154 39 101 54 -47 46.5 
          
 
a) Number of observations available for computation from the 1988 survey 
b) Number of observations available for computation from the 1997 survey 
c) Number of production functions within a particular company available in both surveys 
Table 3.1-7 Median dermal exposure levels to cyclohexane soluble matter per
production function for the 1988 and 1997 exposure surveys.
Production function N a Median88 
(µg/cm2.8h) 
Median97 
(µg/cm2.8h)
 
 
Difference 
(µg/cm2.8h)  
Percentage 
difference  
Compounding / mixing 6 161 52 -109 67.7 
Pre-treating 5 60 22 -38 63.3 
Moulding 6 137 73 -64 46.7 
Curing 7 68 44 -24 35.3 
Finishing 5 64 37 -27 42.2 
Engineering 7 138 184 +46 33.3 
Laboratory 1 32 76 +44 137.5 
Shipping 2 70 65 +5 7.1 
      
 
a) Number of companies within a particular production function available in both surveys  
 
Table 3.1-8 Between- and within-worker variability of exposure to particulates and dermal
exposure for the two exposure surveys.
  1988 exposure survey 1997 exposure survey 
  
S2bw  a S2ww b S2bw  S2ww  
Inhalable particulate exposure c 0.14 (0-12.06) 0.30 (0.02 – 6.66) 0.08 (0 – 5.45) 0.14 (0 – 2.31) 
Dermal exposure c 0.10 (0 – 3.89) 0.54 (0.01 – 5.01) 0.14 (0 – 2.99)  0.77 (0 – 7.70) 
     
 
a) S2bw= Between-worker variance 
b) S2ww= Within-worker variance 
c) Median of variance components grouped by company and production function combination, range of 
variance components in parentheses 
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Table 3.1-9 Influence of control measures and seniority as fixed effects on inhalable particulate
and dermal exposure levels  (960 observations, random effects shown below table a):
#p<0.10, * p<0.05, ** p<0.01, ***p<0.001.
 Inhalable particulate exposure Dermal exposure 
 N b Relative  
exposure 
95% CI N b Relative  
exposure 
95% CI 
Model 1 c 
 
     
Type of control measures       
 Elimination 36 0.33** (0.15 - 0.71) 38 0.34**  (0.17 – 0.67) 
 Reduction 97 0.86 (0.53 - 1.40) 105 0.89 (0.58 – 1.37) 
 Control 233 0.66* (0.47 - 0.93) 249 0.51***  (0.38 – 0.69) 
       
Seniority 134 0.71# (0.50 – 1.02) 147 1.01 (0.74 – 1.37) 
 
      
Model 2 d       
Control measures       
 General ventilation 63 0.93 (0.54 – 1.65) 62 0.74 (0.43 – 1.27) 
 Local exhaust ventilation 194 0.89 (0.62 – 1.26) 206 0.68* (0.48 – 0.96) 
 Anti-tacking 40 0.57# (0.29 – 1.11) 44 0.34*** (0.19 – 0.63) 
 Dust free chemicals 25 0.78 (0.36  - 2.39) 27 0.66 (0.29 – 1.53) 
 Closing department 8 0.28# (0.07 – 1.18) 8 0.28* (0.08 – 0.99) 
 Empty bag compactor 10 0.36# (0.11 – 1.14) 10 0.26* (0.09 – 0.75) 
 Automation 47 0.22*** (0.12 – 0.39) 55 0.83 (1.39 – 0.49) 
 Cold  feed extruder 27 1.82 (0.84 – 3.90) 27 0.54# (0.27 – 1.08) 
 Other 22 0.52 (0.20 – 1.41) 24 0.56  (0.24 – 1.27) 
        
Seniority 134 0.72# 0.50 – 1.03 147 0.98 (0.72 – 1.34) 
 
      
 
a) Results of the random effect part of the applied mixed effect models: Model 1 inhalable particulate 
exposure, S2bw=0.83, S2ww=0.50; Model 2 inhalable particulate exposure, S2bw=0.78, S2ww=0.50; 
Model 1 dermal exposure, S2bw=0.45, S2ww=0.87; Model 2 dermal exposure, S2bw=0.44, S2ww=0.87 
b) Number of observations with a particular control measure present 
c) Model explained, respectively 83 and 29% of the observed reduction in inhalable particulate and dermal 
exposure 
d) Model explained, respectively 80% and 40% of the observed reduction in inhalable particulate and 
dermal exposure 
In Table 3.1-9 the influence of control measures on inhalable particulate and dermal
exposure levels are shown. Model 1, based on the classification of type of control
measures, explained respectively 83% and 29% of the observed reduction in inhalable
particulate and dermal exposure. Another model (model 2), in which all control
measures were included as dummy variables explained slightly less of the reduction in
inhalable particulate exposure (80%) but explained more of the observed decline in
dermal exposure levels (40%).
The estimated coefficient (β) for the control measures derived from the mixed effect
model yields a factor for the relative exposure (RE) in a situation with a particular
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measure present. Elimination of a source was found to be the most effective control
measure efficiently reducing both inhalable particulate and dermal exposure levels by
67 and 66%, respectively. Measures to control the level of exposure reduced the
inhalable particulate and dermal exposure levels by 34 and 49%, respectively. Reduction
of the emission did not reveal a statistical significant decrease in exposure levels.
Investigation of specific control measures (model 2) showed a significant reduction in
inhalable particulate exposure levels as a result of automation of the production process
(RE=0.22, p<0.0001), closing of department (RE=0.28, p<0.10), installing empty bag
compactors (RE=0.36, p<0.10) and the reduced used of anti-tacking agents (RE=0.57,
p<0.10). Dermal exposure to CSM was successfully reduced by installment of empty bag
compactors (RE=0.26, p<0.05), closing of department (RE=0.28, p<0.05), reduced use of
anti-tacking agents (RE=0.34, p<0.0001), installment of local exhaust ventilation
(RE=0.68, p<0.05) and use of cold feed extruders instead of warm up mills
(RE=0.54,p<0.10).
Inclusion of an interaction term for control measures and company production function
combination showed statistically significant effects for elimination of the source and
control of exposure, automation, empty bag compactors and the reduced use of anti-
tacking agents in relation to inhalable particulate exposure. For dermal exposure,
statistically significant interaction terms for control measures and company production
function combination were found for elimination of the source and control of exposure,
local exhaust ventilation and reduced use of anti-tacking agents (results not shown).
In the mixed effect model, used to study the influence of control measures on dermal
contamination, the use of dermal protection equipment (e.g. gloves) was included in the
model as these devices could have affected dermal exposure measurements. Overall the
use of gloves and towels showed a significant decrease in dermal exposure levels
(RE=0.80, p<0.10) for both the 1988 and 1997 survey. However, inclusion of an
interaction term for dermal protective equipment and company production function
combination was found to be statistically significant. Investigation of the underlying
estimates revealed both decrement and increment of dermal exposure levels in
combination with the use of dermal protective equipment.
Besides the influence of control measures on current exposure levels in the rubber
manufacturing industry the possible influence of seniority was studied. Of the 154
subjects participating in the 1997 survey, 49 workers had also participated in 1988.
Investigation of the age of these workers at the time of the 1997 survey, showed a
significant increased age of approximately 9 years between workers with or without
assigned seniority (t-test, p<0.0001). Assigned seniority was found borderline
statistically significant negatively associated with the level of inhalable particulate
exposure (p=0.06), indicating that workers with more work experience were more
successful in reducing their inhalable particulate exposure than their colleagues with
less familiarity with the production process. Examination of the actual tasks performed
by these subjects in both surveys revealed that subjects with seniority had reduced the
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number of tasks which were statistically associated with high inhalable exposure levels
in the 1988 survey 10 with about 8%. The association between seniority and reduced
exposure levels was, however, not confirmed for dermal exposure to CSM.
Discussion
It is generally believed that exposures to airborne contaminants have decreased over the
last decades. This long believed paradigm in occupational hygiene was recently
confirmed by Symanski et al. 98; 99 in a large comprehensive evaluation of long-term
trends in occupational exposures. Estimates of reduction rates for airborne exposures
showed typically downwards trends at rates between 4% to 14% a year, with a median
value of 8% for datasets with a significant downward trend.
Unfortunately, not only the levels of exposure differ over the years but also the
methodologies used to quantifying the exposures, hampering the analyses of time trends
in occupational exposures. Moreover, information about changes in the work
environment and process conditions is often lacking. As a result observed time trends are
most likely affected by factors other than the actual decrease in exposure levels 98.
This paper describes exposure conditions in the rubber manufacturing industry in The
Netherlands encountered in the last decade. The study consisted of two cross-sector
surveys performed in 1988 and 1997. Companies, analytical and sampling methodologies
were kept identical in both surveys. This enabled direct comparison of the exposure
situations in both years. Only one minor difference in sampling strategy between the two
surveys was present. In the 1988 exposure survey, all measurements were performed on
random days while the exposure survey in 1997 was carried out on fixed days of the
week. However, as no significant day-effect was observed in the 1988 data 10, this will
probably have had little to no effect on the comparison of the observed exposure levels.
As exposures in the rubber manufacturing industry are classified as exposure
circumstances that are carcinogenic to humans 7 the ALARA principle in exposure
management should be employed. Therefore, the obligatory effort to reduce the
exposure to levels that are as low as reasonable achievable automatically implies that
every reduction in exposure levels is relevant at all times. Furthermore as no relevant
occupational exposure limits exist for the particular inhalable and dermal exposure
conditions under study, at least in The Netherlands, exposure levels are only compared
between the two surveys and not relative to an OEL.
Comparison of the exposure levels between 1988 and 1997 revealed a significant drop of
41% in inhalable particulate exposure levels over all companies and production
functions. Assuming a constant relative decrease of exposure over the years in between
the exposure surveys the rate of reduction is approximately 6% per year. This observed
decline rate is comparable to the rates found in the study of Symanski et al. 98, although
a decline rate of 6% is on the lower side of the decline rate ranges, especially when one
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takes into account that the data were collected in Western Europe, in manufacturing, for
aerosol contaminants and after 1972. These were all identified as factors that caused a
more rapid decline in particulate exposure 99. Whether the lower decline rate is a
consequence of specific circumstances within the rubber manufacturing industry in The
Netherlands, or the described decline rates in the comprehensive evaluation are an
overestimation of the true reduction rates is unknown. As Symanski et al. 99 indicated,
changing sampling strategies from worst-case to a more random approach would indeed
yield an overestimation of the decline rate 100; 101. Remarkably, an almost identical drop
of 47% in dermal exposure levels was found over the nine-year follow-up period,
resulting in a decline rate of approximately 7% per year. As no other data are available
on time trends in dermal exposures, at least to our knowledge, no comparison with the
literature can be made. The results are extremely interesting as it is often hypothesized
that because of declining airborne exposure levels the dermal exposure route is
becoming increasingly important 102; 103. The presented results of this study do not
support this hypothesis.
Companies with the highest inhalable exposure levels in 1988 were found to be most
effective in reducing the exposure levels. As a result the range of inhalable particulate
exposure levels between companies was significantly reduced compared with the initial
survey. The same phenomenon was observed when inhalable exposure levels were
aggregated at production function level. The largest reductions in exposure levels were
observed in front processing. As a result the large differences in airborne particulates
formerly observed between workers in front and back processing are apparently
something from the past 12. Consequently the reduction in inhalable exposure levels
resulted in a significant drop in the between- and within-worker variance component
when grouped by company and production function. This indicates that especially
workers with formerly high inhalable particulate exposure levels were able to effectively
reduce their personal exposure to airborne contaminants. This drop in the between- and
within-worker variance component was not observed for dermal exposure, instead an
increase was observed. These result imply that although an overall reduction in dermal
exposure levels was achieved exposure conditions were not steadily controlled which
would have resulted in a decrease in the variance components.
Fifty-six per cent of the control measures taken since the initial survey in 1988 focused
on the control of exposure, whereas engineering controls interfering with the emission
of contaminants were less common. Control measures designed to eliminate the source of
contamination were especially sparse (12%). An investigation by the Labor Inspectorate
in The Netherlands revealed that 76% of the control measures taken in industry were
designed to control the level of exposure; the remaining measures were taken at the
source of emission (e.g. elimination and reduction) 104. The figures derived from the
present survey indicate that within the rubber manufacturing industry relatively more
effort has been paid to reduce or eliminate sources of emission than on average in
industry (respectively 44 and 24%, respectively).
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However, almost 80% of the control measures were taken at the production form level.
These control measures are predominantly the ‘add-on’ type of measures or ‘retrofit’
solutions (e.g. changes or alterations to existing equipment), which are believed to have
very limited effect in controlling the exposure to particulates, mainly due to inadequate
construction and maintenance schemes 53. Furthermore, virtually all control measures
taken were directed towards the exposure to inhalable particulates. Control measures
especially designed to reduce dermal contamination were scarce (7 out of 57). The
absence of dermal occupational exposure limits 102; 105 and the limited evidence of the
relevance of dermal uptake in the rubber manufacturing industry 10; 19 apparently did not
encourage the industry to take adequate control measures in this period. Nevertheless, a
reduction of approximately 47% in dermal exposure concentrations was achieved.
Evaluation of the effectiveness of implemented control measures showed that all control
measures resulted in a decline in both inhalable particulate and dermal exposure levels.
Exceptions to this rule were automation, which only reduced the inhalable exposure, and
the introduction of cold feed extruders, which only reduced dermal contamination but
increased inhalable exposure levels. Automation separates workers from the source and
as a result reduces the emission of contaminants in the direct surroundings of the
worker. However, manual handling of the materials and products still occur at the start
and end of the production process. Empirical modeling of the chemical exposures in the
1988 survey revealed that tasks with frequent contact with warm compound resulted in
high dermal exposure 10. The introduction of cold feed extruders instead of heating mills
followed by extrusion would therefore diminish the contact with warm rubber and as a
result cause a decline in dermal contamination. However, the pre-mixed rubber
compounds used for the cold feed extruders are treated with anti-tacking agents, which
are in turn associated with higher inhalable particulate exposures.
Elimination of the source was found to be the most effective type of control measure,
with closing down the mixing department as the most prominent underlying control,
resulting in a 72% drop in inhalable particulate and dermal exposure levels. Conversely,
on a more global scale the reduction in exposure levels by elimination of departments is
questionable, as it is merely a transfer of high exposure situations to another facility or
country. Whether the concentration of mixing activities will result in a decrease in
exposure levels and workers exposed remains to be seen.
Introduction of dust free chemicals was believed to be an important measure to reduce
inhalable particulate concentrations in the mixing departments. Although a relative
exposure of less than one was observed for this particular control measure no statistical
significant reduction in exposure levels was observed. Kromhout et al. 10 postulated that
the absence of large differences in exposure levels between front and back processing
workers in the 1988 survey was due to the replacement of chemicals in the form of
powders by chemicals in other forms. Although, this replacement continued after 1988
the main effect of introducing non-powder forms of chemicals had probably occurred
before the initial survey. A third important measure taken was the phasing-out of
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powdered anti-tacking agents by either anti-tacking foils or liquid anti-tacking agents.
That this control measure also effectively reduced the dermal exposure levels to
cyclohexane soluble matter is remarkable. However, anti-tacking agents like talc, zinc
stearate and chalk have been shown to contribute to higher CSM levels in exposure
samples containing vast amounts of these anti-tacking agents 106. The reduced use of
these agents could therefore have reduced the dermal exposure level to CSM.
Identification of significant interaction terms between several control measures and
company production function combinations indicate that the effectiveness of a certain
control measure depends on the actual situation and design of the workplace. Therefore,
results regarding the effectiveness of certain control measures can give guidance but can
not be used as a rule of thumb.
Seniority has been shown to influence exposure levels both in the upward and downward
direction 107; 108. In this study seniority showed a possible association with reduced
inhalabe particulate exposure levels but no association was found between work
experience and dermal exposure. The criteria used for seniority in this study was not
based on actual information about the work history but were assigned to subjects
present in both surveys and still working in the same production function. Therefore,
misclassification of workers who did not participate in the 1988 survey but who were
selected in the 1997 survey could have occurred. However, as most companies were
relatively small a fair amount of the total population that worked in those companies
was sampled in both 1988 and 1997. As a result misclassification due to the fact that
subjects were initially not selected seems unlikely. Furthermore, a nine-year difference
in mean age was observed between subjects with and without seniority, while for the
total population no differences in mean age between the two surveys was found. This
indicates that indeed these subjects were the eldest workers in the company with at least
nine years of workpractice. The observation that seniority at the same time did not show
a significant association with declining dermal exposure levels indicates that workers
were able to consciously reduce their inhalable exposure but not their dermal
contamination.
The remarkable similar drop in inhalable particulate and dermal exposure levels
concurrently with comparable results regarding the effectiveness of control measures
indicates a relation between inhalable and dermal contamination levels in the rubber
manufacturing industry. Dermal exposure can occur through direct contact with sources
or contaminated surfaces and deposition of particulates on the skin 109. Therefore,
reduction of inhalable exposure concentrations will directly reduce dermal exposure
levels as a result of reduced deposition of contaminants on the skin. However, direct
contact with warm rubber products and contaminated surfaces is thought to be the
primary route in the rubber industry 10.  Nevertheless, it is plausible that a reduction in
inhalable particulate exposure will result in a decline in surface contamination, which
will indirectly reduce the contamination of the skin as a result of contact with less
contaminated surfaces.
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The industrial agreement, signed by the Ministry of State and the social partners 91
emphasized the necessity of a source-oriented approach to control occupational hazards.
For some particular hazards the convenant ordered specific control measures and
solutions such as replacement of dusty chemicals. Based on this convenant and the result
of the study for improvement of working conditions in the rubber manufacturing
industry, many companies have implemented control measures to reduce occupational
hazards. Modeling the effectiveness of these control measures showed that these
measures explained almost entirely the observed drop in inhalable exposure levels but
only partly the drop in dermal exposure levels. To a certain extent this could be
explained by the fact that seniority explained about 14% of the reduction in inhalable
exposure levels while it did not affect the decline in dermal exposure. Other factors such
as type of rubber used, process conditions and individual work practices could not be
evaluated but may also have influenced the decline in dermal contamination.
In conclusion, the result of this study indicate that efforts taken to improve work
conditions in the rubber manufacturing industry in The Netherlands over the last decade
have been successful in reducing both inhalable particulate and dermal exposure.
Whether the observed decline in exposure levels reduces the observed genotoxic risks in
this particular industry remains to be seen.
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Section 3.2
Identification of dermal exposure pathways in the
rubber manufacturing industry
Current existing dermal exposure assessment strategies are predominantly
based on regulatory protocols. In order to develop effective and efficient
strategies more data driven approaches are needed. In a recently
developed conceptual model for dermal exposure, compartments, barriers
and mass transport processes relevant for dermal exposure were
described. We systematically applied this conceptual model to the rubber
manufacturing industry to assess dermal exposure to cyclohexane soluble
matter (CSM) and used quantitative data to design an exposure
assessment strategy.
Identification of the spatial distribution of the dermal contamination
showed high CSM surface concentrations for the upper body. Moreover,
because of the high correlation between dermal exposure at the wrist and
calculated total body exposure (r=0.89, p<0.01) an exposure assessment
strategy based on only one pad sampler was employed to estimate CSM
surface concentrations in the skin contaminant layer.
Qualitative and quantitative evaluation of the relevant compartments
and related mass transport processes demonstrated the importance of
deposition of airborne contaminants and direct transfer of contaminants
from sources and surfaces to the skin contaminant layer. Interestingly, the
importance of the different exposure pathways varied considerably
between production functions.
The use of a model driven exposure assessment strategy in the rubber
manufacturing industry revealed relevant skin regions, compartments and
mass transport processes and enabled development of an effective and
efficient strategy for dermal exposure assessment and hazard control in
this particular occupational setting.
Annals of Occupational Hygiene, 2000, 44, 533 - 541
Introduction
Well-designed exposure assessment strategies comprise the selection of both appropriate
sampling techniques and sampling strategies. For inhalable exposure such strategies have
been developed over the years and are now commonly used in occupational and
epidemiological studies to evaluate the exposure by inhalation 110-112. For dermal
exposure to chemicals such standardized exposure assessment strategies are lacking.
Partly, this is because of insufficient attention given to dermal absorption in
environmental and occupational hygiene 113 but more importantly because of the alleged
problems concerning quantification and interpretation of dermal exposure data.
Nevertheless, several authors have proposed dermal exposure sampling strategies which
address issues as sampling method, representativeness and sample duration 102; 114; 115. They
concluded that the assessment of dermal exposure should in any case be based on a
Roel Vermeulen
Jantien Heideman
Rob P. Bos
Hans Kromhout
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sampling strategy that takes into account the distribution of the contaminant on the
body, the temporal variation of the exposure, the duration of exposure as well as the
degree of skin protection afforded by clothing 113. Furthermore, the sampling strategy
design should be based on a recognition that exposures are likely to vary widely over
time and between workers 102; 110.
In a recently developed conceptual model for dermal exposure, compartments, barriers
and mass transport processes relevant for dermal exposure were described 109. This simple
model focussed on transport of contaminant mass from the source of the hazardous
substance to the surface of the skin. It was argued that systematic application of such a
structured model for selecting relevant dermal exposure parameters could form a basis
for a dermal exposure assessment strategy. This, together with quantitative information
regarding spatial distribution across the body and dermal exposure pathways could
enable a more effective and efficient exposure assessment strategy as well as more
efficient hazard control.
We studied dermal exposure to cyclohexane soluble matter (CSM) in the rubber
manufacturing industry using this conceptual model. In the first survey, the conceptual
model was used to identify compartments and exposure pathways involved in the process
of skin contamination. As these parameters almost certainly vary for the different
exposed body areas, parameters were assessed separately for different anatomical
locations. In a second survey, exposure pathways that resulted in skin contamination of
the lower wrist were further investigated and quantified.
Material and methods
Identification and quantification of exposure pathways and body distribution of
cyclohexane soluble matter (CSM) exposure in the rubber manufacturing industry was
studied in two surveys. The first survey focussed on subjective assessment of the major
exposure pathways and quantification of CSM exposure distribution across the body. The
second survey focussed on the quantification of compartment mass and consequently the
identification of the exposure pathways relevant to the exposure at the lower part of the
wrist of the hand of preference.
Study population
The first survey was conducted in a mixing department of a rubber tire company
including both production workers (n=5) and technical engineers (n=4). The second
survey was part of a large industry-wide exposure survey of the rubber manufacturing
industry in The Netherlands. In total 225 subjects employed in nine different companies
were selected based on their production function 75.
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Identification of exposure pathways
In the first survey, workers were observed three times a day for 15 minutes while
executing their specific tasks. Based on the observations of workers’ tasks the
compartments (air, surface contaminant layer, outer and inner clothing contaminant
layer) and mass transport processes (emission, deposition, transfer, redistribution)
leading to transport of contaminant mass to the surface of the skin was qualitatively
assessed for six skin regions: neck / jaw, shoulder, upper arm, wrist, groin and ankle
(Figure 3.2-1).
Ankle 
Groin 
Shoulder 
Upper arm 
Neck / Jaw 
Wrist 
Figure 3.2-1 Body location of individual pad samplers (figure adapted from Rooij van et al. 118).
In the second survey, CSM (surface) concentration in the relevant compartments (air,
surface and skin) was quantified. Potential contact surfaces were identified based on
interviews and observations of the workers while executing their specific tasks using the
following criteria:
♦ Wipe location should be a potential dermal contact site;
♦ Site is regularly and frequently involved in the handling of chemicals and/or
rubber products;
♦ Wipe location is sufficiently large to accommodate a wipe of 100 cm2.
Surface contaminant layer
Surface CSM contamination was determined by obtaining wipe samples of potential
contact surfaces. Samples were taken by a modification of the OSHA wipe sampling
procedures 116. In the modified procedure, a surface area of 10x10 cm of a potential
contact surface was chosen as sampling region. The region was wiped three times
consecutively with Clean cylceTM wet VDU wipes (Inmac, Wargave, UK) containing 70%
water and 30% isopropyl alcohol. A consistent sampling area was maintained by use of a
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template. The same wipe pattern, applied with maximum operator pressure, was adhered
throughout the experiment. Wipe pattern consisted of wiping once around the edge of
the sampling region in an anti-clockwise direction and then wiping across the sampling
area five times in parallel followed by nine consecutive circles. Repeated samples (n=3)
were pooled and stored at –20°C before CSM analysis.
Air compartment
The air compartment was divided into two interlinked compartments e.g. near-field and
far-field 117. Airborne exposure measurements at fixed locations were used to quantify
the far-field CSM exposure. Personal inhalable exposure measurements were used to
estimate near-field CSM exposure. Ambient total suspended matter (TSPM) exposure was
measured on random days by means of a high-volume sampler 94. On average two samples
were collected per department within a company, which were consequently pooled for
CSM analysis. Personal inhalable exposure was measured on three consecutive days by
means of a PAS6 sampling head mounted near the breathing zone of the worker 94; 95.
Filters were stored at –20°C until CSM analysis.
Skin contaminant layer
Total dermal body exposure to CSM was measured by placing six exposure pad samplers
on different spots of the skin of a worker: neck/jaw, shoulder, upper arm, wrist, groin
and ankle (Figure 3.2-1) 118. In the second survey, repeated personal dermal exposure to
CSM was measured by means of a dermal pad sampler worn at the lower part of the wrist
of the hand of preference on the same days as the personal inhalable exposure
measurements. In both surveys, pad samplers consisted of 24 layers of cotton (3x3 cm)
and were worn throughout the workday 10; 76. Immediate after sampling pad samplers
were removed and stored at –20°C until CSM analysis.
Cyclohexane soluble matter analysis
Cyclohexane soluble matter was determined by means of the NIOSH PCAM 217 method 77; 95.
Dermal, surface, ambient and personal airborne particulate samples were placed in
cyclohexane, respectively 10, 15, 15, and 3ml and sonificated for 20 minutes. Eight ml
(3ml for the personal airborne particulate samples) of the suspension was filtered
through a glassintertube G4 (Schott, Germany) and collected in a pre-weighed 10 ml
vial. After evaporation of cylcohexane under nitrogen and subsequently 2h drying at
40°C the residue was weighed by means of a microbalance. All samples were conditioned
at least 24h before weighing in a conditioned weighing room at a temperature of 20 ±2°C
and 50 ±5% relative humidity.
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Calculations and statistics
In both surveys dermal exposure surface concentrations (µg/cm2) were transformed to an
8-h time weighted average exposure concentration (µg/cm2/8h). In the first survey,
total dermal body contamination (mg/8h) was calculated by multiplying the CSM TWA
surface concentration of the individual pad sampler with the anatomical dimensions
described by Popendorf and Leffingwell 119. In the calculation it is assumed that each of
the six pad samplers represent a skin region with a certain surface area (Table 3.2-1).
Table 3.2-1 Assumed percentage of total body area represented
by each pad sampler.
Skin site Skin region % of total body area a 
Neck/Jaw Head 6.8 
 Neck  
Shoulder Shoulder 22.8 
 Back   
 Chest  
Upper arm Upper arms 9.7 
Wrist Forearms 12.3 
 Hands  
Groin Hips  27.1 
 Thighs  
Ankle Calves 19.9 
 Feet  
   
 
a) According to van Rooij et al. 118 
 
In the second survey mean personal inhalable and dermal CSM TWA exposures were
determined by calculating the averages of the repeated exposure measurements per
person. Surface contamination was calculated by averaging the CSM contamination levels
of relevant contact surfaces for each subject. In these calculations, every surface wipe
sample was weighted equally regardless of the frequency and duration of contact with
the particular surface. Mean ambient CSM concentrations were calculated based on the
pooled TSPM samples according to the work areas the subject was employed in.
Pearson correlation coefficients were used to investigate the relation between dermal
exposure at individual skin regions and total dermal body exposure and to study the
correlation between CSM contamination levels in different compartments acknowledged
in the conceptual model described by Schneider et al. 109. In these analyses natural
logarithms of the exposure values were used.
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Results
Identification of exposure pathways and body distribution (survey 1)
Relevant compartments and mass transport processes for skin contamination based on
the task observations are presented in Table 3.2-2. Identified compartments and
transport processes were found to be almost identical for production workers and
technical engineers, with the exception of the contribution of the inner clothing
compartment to the skin contamination of the neck/jaw skin region of the technical
engineers because of the frequent use of coveralls with hood. Moreover, a clear
distinction in relevant compartments and processes could be made by comparing covered
with uncovered skin areas. For the covered skin regions (shoulder, upper arm, groin and
ankle) only the inner clothing compartment was found relevant. As for the uncovered
neck/jaw region, deposition of contaminants from the air, redistribution and transfer of
contaminants from hands (skin contaminant layer) and outer clothing compartment were
found to be relevant. For the wrists, direct contact with surfaces and consequently the
transfer of contaminants from the surface to the skin contaminant layer was identified as
the most relevant compartment and mass transport process, followed by direct contact
with the source, deposition of contaminants from the air and transfer of contaminants
from the inside of the gloves to the skin.
Table 3.2-2 Identification of compartments and mass transport processes involved in skin
contamination of production workers and technical engineers of a mixing
department in a rubber tire company. Compartments and corresponding
processes are given in descending order of estimated importance per skin site.
 Production workers Technical engineers 
Skin site Compartment Process Compartment Process 
     
Neck/Jaw Air 
Skin 
Outer clothing 
Deposition  
Redistribution 
Transfer 
Air 
Skin 
Outer clothing 
Inner clothing 
Deposition  
Redistribution 
Transfer 
Transfer  
     
Shoulder Inner clothing Transfer  Inner clothing Transfer  
     
Upper arm Inner clothing Transfer  Inner clothing Transfer  
     
Wrist Surface 
Source 
Air  
Inner clothing 
Transfer 
Emission 
Deposition 
Transfer 
Surface 
Source 
Air  
Inner clothing 
Transfer 
Emission 
Deposition 
Transfer 
     
Groin Inner clothing Transfer Inner clothing Transfer 
     
Ankle Inner clothing Transfer Inner clothing Transfer 
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Mean cyclohexane soluble matter (CSM) surface concentrations varied considerably across
the body surface (range 12.6 – 113.5 µg/cm2/8h) (Table 3.2-3). Highest surface
concentrations were found at the wrist of both production workers and technical
engineers, respectively 113.5 and 108.7 µg/cm2/8h. Overall lower CSM surface
concentrations were found for the lower body compared to the upper body. Calculated
total body contamination (mg/8h) showed similar variation across the body with
relative high contribution of the shoulder and wrist skin region and only minor
contribution of the ankle and neck/jaw skin region for both production workers and
technical engineers. The groin area of the production workers had also a moderate
contribution to the total body exposure, which was less pronounced for the technical
engineers.
Table 3.2-3 Cyclohexane soluble matter surface concentration (µg/cm2/8h) and calculated
total exposure (mg/8h) per skin site and for the total body by production
function.
 CSM surface concentration 
(µg/cm2/8h) 
Total exposure 
(mg/8h) 
 
Skin region N AM GM GSD AM GM GSD % a 
Production workers  
Neck/Jaw 5 41.6 35.1 1.80 54 45 1.80 5.0 
Shoulder 5 77.4 48.1 2.70 335 208 2.70 31.0 
Upper arm 5 68.9 37.5 2.91 127 69 2.91 11.8 
Wrist 5 113.5 76.9 3.23 265 180 3.23 24.6 
Groin 5 42.2 34.3 2.14 217 176 2.14 20.1 
Ankle 5 21.4 19.3 1.65 81 73 1.65 7.5 
         
Total     1079 928 1.82 100 
         
Engineering service  
Neck/Jaw 4 35.1 31.8 1.65 45 41 1.65 6.2 
Shoulder 4 57.4 41.6 2.78 249 180 2.78 34.1 
Upper arms 4 22.6 19.1 1.99 42 35 1.99 5.7 
Wrist 4 108.7 65.2 3.82 254 152 3.82 34.7 
Groin 4 18.2 16.4 1.67 93 85 1.67 12.7 
Ankle 4 12.6 12.2 1.31 48 46 1.31 6.6 
         
Total     731 624 2.10 100 
         
 
a) Percentage of total body exposure 
Total CSM mass at the wrist showed a high correlation with total CSM body exposure
(r=0.89, p<0.01) (Table 3.2-4). This relation was found both for production workers
(r=0.87, p<0.10) and technical engineers (r=0.95, p<0.05). The skin regions shoulder
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and upper arm were also significantly correlated with total body exposure, respectively
r=0.71 (p<0.05) and r=0.69 (p<0.05). However, correlation coefficients for the two
production functions were lower and non-significant. Correlation between contaminant
mass at individual sites were overall low except between the shoulder and upper arm
(r=0.83, p<0.01), between the groin and ankle (r=0.63, p<0.10) and interestingly, the
wrist was overall moderate correlated with both upper and lower body areas (range 0.33
to 0.59) but not with the neck/jaw skin area (r=0.06).
Table 3.2-4 Pearson correlation coefficients (r) between total
cyclohexane soluble matter mass (mg/8h) at individual skin
regions and total body contamination: # p<0.10 * p<0.05,
** p<0.01.
Skin region All 
(n=9) 
Production workers 
(n=5) 
Technical engineers 
(n=4) 
Neck / Jaw 0.06 -0.36 0.53 
Shoulder 0.71* 0.58 0.89 
Upper  arm 0.69* 0.80 0.49 
Wrist 0.89** 0.87# 0.95* 
Groin 0.47 0.30 0.53 
Ankle 0.50 0.53 0.27 
    
 
Quantification of exposure pathways (survey 2)
For subjects employed as technical engineer (n=19) no reconstruction of the exposure
pathways could be made as the work practice was too diverse to enable identification of
relevant contact surfaces. Forty-one observations were omitted from the analysis,
because of missing data for one of the compartments. Most (91.5%) of the remaining
subjects were employed in either the production function mixing, pre-treating,
moulding, curing or finishing.
Results of the correlation analysis between CSM (surface) concentrations in the different
compartments are presented in Figure 3.2-2 for each production function and the total
workforce. Between the far- and near-field air compartment and surface contamination
layer a moderate to good correlation was observed for the total workforce and the
production functions mixing, moulding and curing. Pre-treating showed a moderate
negative correlation between far-field exposure and the surface contamination layer. No
correlation was found between the far- and near-field air compartments and the surface
contamination layer for the production function finishing.
Correlation analysis between the skin contaminant layer and air and surface compart-
ments for the total workforce revealed significant but low correlation coefficients.
Correlation patterns observed for the three exposure pathways differed among the
individual production functions. Mixing and pre-treating showed significant moderate
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correlation coefficients between the air compartment and skin contaminant layer.
However, for pre-treating this relation was only observed between the near-field air
compartment and the skin contaminant layer. Curing revealed a moderate significant
correlation between the surface contaminant layer and skin contaminant layer. No
significant correlation coefficients were found between the compartments for the
production functions moulding and finishing.
Discussion
Relevance of dermal exposure in occupational hygiene and health is widely recognized
and several techniques for the direct and indirect assessment of dermal contamination
have been developed 102; 113. Furthermore, concepts for deriving quantitative dermal
occupational exposure limits have been developed and elaborated for a few chemicals 105; 120.
However, exposure assessment strategies are almost non-existent and in most cases the
applied strategies are based on legally required regulatory procedures 121 and not on
actual information of the exposure scenario.
In a recent developed conceptual model for dermal exposure, essential variables for
dermal and surface contamination were described 109. Consistent use of such a model
ensures that the most relevant variables are taken into consideration in any given
situation. Therefore, the model has the potential to be used as a starting point for the
development of a sampling strategy. Inherent qualitative and quantitative assessment of
dermal exposure pathways could consequently be used to design a more efficient and
effective measurement strategy for a specific occupational setting.
Workers in the rubber manufacturing industry are exposed to a wide range of different
potentially hazardous chemicals and reaction products that are known to constitute
genotoxic activity 14; 19; 122. It is generally believed that most of the genotoxic activity is
attributable to the organic fraction of the complex mixture. Therefore, the use of an
organic solvent soluble matter (e.g. benzene soluble matter, cyclohexane soluble matter)
is often used as marker for exposure to these complex mixtures 123. Since 1987
cyclohexane soluble matter (CSM) has been used in the regulation of dust and fume
exposure in rubber factories in the United Kingdom 106. Consequently, CSM exposure has
been used in the rubber manufacturing industry to quantify both inhalable and dermal
exposure to rubber dusts and fumes 10.
In the first survey, qualitative assessment of the most relevant compartments and mass
transport processes in a mixing department of a rubber tire company showed a clear
distinction between covered and uncovered skin areas. For the skin areas covered by
clothing, the inner clothing compartment was the only directly important compartment
for the skin contamination layer. Whereas for the uncovered skin, both deposition of
contaminants and direct contact with surfaces and sources were thought to be of
importance for both production workers and technical engineers. During mixing of
rubber compounds high dust levels are generated as a result of weighing and emptying
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bags of chemicals. Furthermore, because of the general low level of automation manual
contact with raw chemicals and rubber compounds occurs frequently. These factors have
previously been identified as important dermal exposure determinants 10 and are in
concordance with the task observations made with the aid of the conceptual model.
However, the task observations did not enable a relative ranking of exposed individuals,
as it is was impossible to estimate dermal exposure accurately solely on observed tasks.
Therefore, it seems more promising to a-priori identify exposure-affecting factors, which
can consequently be more objectively assessed.
Spatial distribution of dermal contamination was investigated by means of dermal
exposure pad samplers placed on six anatomical regions of the body. An underlying
assumption in this assessment is that the exposure is uniformly distributed within the
discreet anatomical region. Whether this criterion was met in this particular setting
could not be further substantiated, as application of visualization techniques was not
feasible because no fluorescent tracers could be added to the raw materials 124.
Production workers and technical engineers showed high dermal contamination levels for
the upper body areas especially the wrist and shoulder skin region. The uncovered skin
area neck/jaw had only a minor contribution to the total body contamination (5.0 - 6.2%)
because of the low CSM surface concentration and the relative small contribution to the
total body area (6.8%). In contrast, the uncovered skin area of the wrist was found to be
highly exposed. Therefore, direct contact with surfaces and sources is probably the most
important exposure pathway assuming a similar effect of deposition to uncovered skin
for both the wrist and neck/jaw skin region.
Total body exposure showed high statistically significant correlation coefficients with
the upper body skin regions, especially with the wrist. Exposure classification based
solely on the dermal exposure surface concentration measured at the lower wrist would
therefore not result in a different exposure classification than based on calculated total
body exposure utilizing all six pad samplers. However, it has been shown that differences
in permeability of the skin could exist between anatomical regions 125. Therefore the
above described relation between CSM contamination at the lower wrist and total body
contamination does not necessarily have to be relevant for total dermal uptake.
Interestingly, the wrist area was the only skin area showing moderate correlation with
both the upper- and lower body areas with exception of the jaw/neck area.
In the second survey CSM mass in the far- and near field air compartment, surface
contamination layer and skin contamination layer were assessed in a cross-industry
survey in the rubber manufacturing industry. CSM contamination in the clothing
compartment was not taken into account, as clothing did normally not cover the lowest
part of the wrist and hands. However the use of gloves could have influenced the
interrelations between the several compartments and the skin contaminant layer.
However, stratified analysis of the correlation patterns by glove use revealed overall
comparable results (results not shown).
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Correlation patterns between compartments for the total workforce revealed overall
moderate correlation coefficients illustrating the importance of both deposition of
particles on the skin and transfer of contaminants from surfaces to the skin contamina-
tion layer by direct contact. It is noteworthy that the moderate to high correlation
between surface contamination and the CSM concentration in the air, indicates the
importance of deposition of air contaminants on surfaces at the workplace, which in
return could contribute to dermal contamination. Correlation patterns for the major
production functions within the industry revealed different underlying exposure path-
ways. Mass transport of contaminants from the air compartment to the skin contamina-
tion layer by deposition was found relevant for the production functions ‘mixing’ and
‘pre-treating’. However, for ‘pre-treating’ this relation was only found between near-field
air exposure and the skin contaminant layer suggesting localized sources of CSM con-
tamination. Transfer of CSM mass from contaminated surfaces to the skin compartment
layer was found relevant for the production function ‘curing’ only. Although, contact
transfer was previously identified as the most important exposure pathway in the rubber
industry the correlation analyses revealed only low to moderate correlation coefficients.
Contaminant mass in the surface contaminant layer was assessed by averaging the CSM
contamination levels of relevant contact surfaces for each subject regardless of the
frequency and duration of contact with the particular surface. Depending on the number
of relevant contact surfaces and variability in duration and frequency of contact consid-
erable exposure misclassification might have occurred obscuring the possible relation
between the surface and skin contaminant layer.
The production functions ‘moulding’ and ‘finishing’ revealed no specific exposure
pathway. Kromhout et al. 10 identified several exposure affecting factors related to high
dermal exposure levels within the rubber manufacturing industry. For the production
function mixing the identified factors were predominantly associated with both high
dust and dermal exposure levels, supporting the importance of the deposition exposure
pathway found in this survey. Identified dermal exposure affecting factors for the
production function curing were all related to the handling of warm rubber 10 confirming
the importance of direct transfer of contaminants. Contribution of mass transport due to
splashing, spilling and ejection of particles and contact with contaminated handheld
tools could not be adequately evaluated by the used approach. These mass transport
processes could, however, have had a significant contribution to dermal contamination
for people working with raw chemicals (mixing), solvents (pre-treating) and handheld
tools (technical engineers).
Application of a structured model to assess dermal exposure was found useful for the
identification of relevant compartments and mass transport processes. However, in order
to be an effective tool for qualitative assessment of dermal exposure a more objective
tool has to be developed which focuses on the exposure affecting factors and not on
visual contamination moments.
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Identification of spatial distribution of dermal exposure and the relation with calculated
total body exposure enabled a more effective and efficient sampling strategy. Hence, in
this particular occupational setting the number of pad samplers used per worker could
be reduced from six to only one sampler, reducing the total number of pads to be
analyzed dramatically for a population of 225 workers. Furthermore, identification of
the relation between mass in several compartments was found useful in understanding
the importance of different exposure pathways for different production functions and
facilitates implementation of control measures to minimize dermal exposure levels
within the rubber manufacturing industry.
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Chapter 4
Genotoxic exposure conditions in the
rubber manufacturing industry
In chapter 4 genotoxic exposure conditions encountered
in the present-day rubber manufacturing industry are
described. In section 4.1 the possible confounding effect
of weekly patterns in smoking habits on urinary mutage-
nicity is addressed. Mutagenic exposure conditions and
related exposure determinants are described in sections
4.2 and 4.3. Consequently, possible relations between
external mutagenic exposure, urinary mutagenicity and
urothelial DNA adducts are described in sections 4.4 and
4.5. Potential influence of skin aberrations on dermal
absorption and possible effect modification by CYP1A2
and NAT2 biotransformation polymorphisms on biological
exposure and effect markers is addressed as well.
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Section 4.1
Weekly patterns in smoking habits and influence on
urinary cotinine and mutagenicity levels;
Confounding effect of non-smoking policies in the
workplace
Lifestyle factors such as smoking have been shown to influence urinary
mutagenicity. Therefore, these factors have to be considered carefully
when evaluating occupational genotoxic exposures. We investigated day-
to-day variability in active and passive tobacco smoke exposure by
studying urinary cotinine levels and determined their influence on
observed urinary mutagenicity. Urinary cotinine was assessed for 105
subjects employed in the rubber manufacturing industry in The
Netherlands on Sunday, Wednesday and Thursday. Urinary mutagenicity
was measured by the S. typhimurium strain YG1041 with metabolic
activation for the Sunday and a pooled weekday urine sample. A sharp
decrease in urinary cotinine concentration was observed during the week
compared to Sunday urine sample for smokers (39%, p<0.01) and non-
smokers (23%). Different smoking habits on Sunday resulted in higher
regression-coefficients for categorical proxies for smoking habits and
urinary mutagenicity levels. However, regression-coefficients for urinary
cotinine and urinary mutagenicity were similar for the Sunday and
weekday urine samples, (β=0.29 and β=0.28, respectively). Consequently,
these estimates were used to adjust urinary mutagenicity for tobacco
smoke intake. Cotinine adjusted urinary mutagenicity levels were
comparable between smokers and non-smokers and a similar increase in
urinary mutagenicity of respectively 39% and 34% was observed for both
smokers and non-smokers due to occupational genotoxic exposures or
other changes in lifestyle factors.
These results indicate that the introduction of non-smoking policies in
the workplace has reduced exposure to mainstream and environmental
tobacco smoke resulting in temporal variation in lifestyle related
mutagenicity. Therefore, adequate adjustment for daily tobacco smoke
exposure is a necessity when using the urinary mutagenicity assay to
evaluate possible genotoxic exposures in the workplace.
Cancer Epidemiology Biomarkers & Prevention, in press
Introduction
Urinary mutagenicity is often used as a biomarker of exposure to study the genotoxic
effect of occupational exposures 126-129. Because of the non-selective character of the
urinary mutagenicity assay, the assay has been found particularly useful in occupational
settings with exposure to complex mixtures 130-134. However, the non-selective character
of the assay makes it prone to confounding factors such as smoking and diet 135-138.
Therefore, these factors have to be considered carefully, especially when genotoxic
Roel Vermeulen
Hillion Wegh
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exposures are low 135. Because of the influence of lifestyle factors on urinary mutagenic-
ity, large variations in background mutagenicity levels can be expected between sub-
jects. Therefore, when comparing occupationally exposed and non-exposed groups large
samples are needed to ensure random distribution of confounding lifestyle factors.
Another approach that has been used to control for variation in mutagenicity due to
lifestyle factors is the use of the subject as their own internal control. In this approach,
the increment in urinary mutagenicity between urine samples collected before and after
suspected mutagenic exposure is studied 19. The underlying assumption in this approach
is that confounding lifestyle factors do not significantly change within subjects over
time. However, differences exist in activity patterns during the weekend and weekdays
like more frequent visits to restaurants and bars and increased numbers of active smokers
in the personal environment. These factors have been shown to influence the exposure to
mainstream smoke (MS) and environmental tobacco smoke (ETS) 139; 140.
The aim of the present investigation was to study the day-to-day variability in active
and passive smoking by studying urinary cotinine levels and to determine their influence
on observed urinary mutagenicity. Urinary mutagenicity was measured by the
S. typhimurium strain YG1041 with metabolic activation. S9-mix from aroclor induced
rat livers was used as metabolic activation system to detect indirect mutagenic com-
pounds or metabolites in urine.
Material and methods
Subjects
After completion of a survey, subjects (n=116), were randomly selected, based on their
reported smoking habits and external genotoxic exposure profile from a group of 224
male subjects participating on voluntary bases in a large exposure survey among 9
companies in the rubber manufacturing industry in The Netherlands 75. Subjects were
employed full-time. All companies but one had a strict non-smoking policy at the
workplace allowing, smoking only during breaks in designated areas in the company.
Spot urine samples were collected on Sunday, Wednesday and Thursday at approximately
the same time of day (around 4 PM), stored in polyethylene containers, and kept at
-20°C until use. Information regarding smoking status (yes/no) and average number of
cigarettes smoked per day (0, 1-10, >10) was obtained by self-administered
questionnaire completed before the survey and by assessing urinary cotinine levels.
Cotinine analysis
Cotinine in urine was quantified by high performance liquid chromatography according
to the method of Barlow et al. 141, using the modifications described by Parviainen and
Barlow 142. Urine samples with undetectable cotinine levels (limit of detection, 25 nmol/l)
were arbitrarily assigned a value of one-half the detection limit. Creatinine levels were
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used to estimate urinary dilution, using a colometric test, based on the Jaffé reaction
between creatinine and sodium picrate. Cotinine levels were expressed in µg/g
creatinine.
Analysis of mutagenic activity
Urine samples collected on Wednesday and Thursday were pooled for each subject before
mutagenicity analysis. A volume, corresponding to 0.5 mmol of creatinine of the
Wednesday and Thursday urine sample was pooled resulting in a volume corresponding to
1 mmol of creatinine. Urine aliquots corresponding to 1.0 mmol of creatinine from
Sunday urine sample and a pooled week urine sample were neutralized to pH 7.0 and
extracted with XAD-2 resin (6-cm3 bed volume). After the urine was passed through the
resin, the column was washed with distilled water and the adsorbed material was eluted
with 10 ml of acetone. After evaporation at 40°C under nitrogen, the residue was
dissolved in 2.5 ml of DMSO 19. Urine extracts were assayed for mutagenic activity with
the S. typhimurium bacteria strain YG1041 with S9-mix of aroclor induced rat liver 21; 143.
Mutagenic activity was calculated based on the dose- response curves acquired at
different dose levels. The slope of the linear component was used as an estimate of the
mutagenic potency 144. Urinary mutagenic activity levels were expressed in revertants/g
creatinine.
Statistical methods
Urinary cotinine and mutagenicity levels for both smokers and non-smokers were
lognormally distributed. Therefore, the natural logarithm of the cotinine concentration
and mutagenic activity was used in all statistical procedures. Intra- and interindividual
variance components of urinary cotinine based on the Wednesday and Thursday urine
samples were estimated using a one-way nested random-effects ANOVA model. The
influence of smoking habits and urinary cotinine levels on the mutagenic activity in
urine was studied in separate linear regression models. Mean urinary cotinine
concentration was calculated for the pooled weekday urine sample based on the cotinine
levels of the Wednesday and Thursday urine sample. All statistical analyses were
performed using SAS version 6.12 software 79.
Results
Of the 116 subjects, 105 subjects (90.5%) had complete data concerning smoking habits,
urinary cotinine (Sunday, Wednesday and Thursday urine samples) and mutagenic
activity levels (Sunday urine sample and a pooled weekday urine sample). No systematic
differences in smoking habits, urinary cotinine and mutagenic activity levels were
observed for subjects with incomplete data (n=11) or those with complete data (n=105).
Consequently, the results presented in this study are based on these 105 subjects.
Subjects were all male with a mean age of 37.9 (sd. 9.0) year.
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A large statistical significant difference (t-test, p<0.0001) in mean urinary cotinine
concentration between smokers and non-smokers was observed for Sunday and weekday
urine samples (Table 4.1-1, Figure 4.1-1). Furthermore, a clear dose-response
relationship was found between the average number of cigarettes smoked per day and
urinary cotinine levels for smokers on Sunday. However, this dose-response relationship
was not found for the weekday samples, in which almost no difference in mean urinary
cotinine levels was observed for the different categories of average number of cigarettes
smoked per day.
Table 4.1-1 Mean urinary cotinine concentration (µg/g creatinine) and intra- and interindividual
cotinine variability by smoking status and average number of cigarettes smoked per
day.
 Sunday Weekday samples (Wednesday, Thursday) 
 N a GM b GSD c K d GM GSD
 
GSDintra e GSDinter f λ g 
Non-smokers  67 4.4 4.33 134 3.4 3.95 2.30 2.98 0.60 
Smokers 38 1096.7 2.06 76 665.4 1.91 1.35 1.78 0.27 
 1-10/day 17 933.9 2.06 34 683.2 2.10 1.40 1.95 0.25 
 >10/day 21 1249.1 2.04 42 651.3 1.77 1.30 1.67 0.26 
           
 
a) Number of subjects 
b) Geometric mean 
c) Geometric standard deviation 
d) Number of samples 
e) Estimated geometric standard deviation of intraindividual distribution of the log-transformed cotinine 
concentrations 
f) Estimated standard deviation of interindividual distribution of the log-transformed cotinine concentrations 
g) Variance ratio of the intra- and interindividual variance components 
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Figure 4.1-1 Geometric mean (GM) and 95% upper confidence limit of urinary cotinine concentration
(µg/g creatinine) by smoking status and sampling day.
Analyses of the inter- and intraindividual variability in urinary cotinine levels of
Wednesday and Thursday samples revealed an overall higher interindividual variability.
Hence, the ratio (λ) of the intra- and interindividual variability for all smoking
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categories was well below 1 indicating that the observed cotinine levels were predomi-
nantly influenced by the individual. It is noteworthy that this phenomenon was more
pronounced for smokers than for non-smokers.
Smoking status (yes/no), categories of average number of cigarettes smoked per day,
and urinary cotinine levels were clearly associated with urinary mutagenicity, with only
minor differences in the explained proportion of the total variance for the different
proxies used for smoking habits in these models (Table 4.1-2). However, an overall larger
proportion of the total variability in urinary mutagenicity was explained by the proxies
of smoking habits for weekday urine samples than for Sunday urine samples.  Observed
regression-coefficients for smoking status and categories of average number of cigarettes
smoked per day were higher for Sunday urine samples than for pooled weekday urine
samples, with the exception of light smoking (1-10 cigarettes/day). Regression-
coefficients observed for the relation between urinary cotinine levels and urinary
mutagenicity for the Sunday and pooled weekday urine samples were practically
identical, (β=0.29 and β=0.28, respectively).
Table 4.1-2 Relation between smoking status, average number of cigarettes smoked
per day and the natural logarithm of urinary cotinine levels and urinary
mutagenicity levels on Sunday and weekdays.
 Urinary mutagenicity  
 Sunday   Weekdays  
  β(SE) a R2 b β(SE) R2 
Model 1 Smoking c  1.63 (0.29) d 0.23 1.51 (0.23) d 0.29 
Model 2 1 – 10 c 1.24 (0.39) d 0.25 1.31 (0.31) d 0.30 
 >10 c 1.94 (0.36) d  1.67 (0.28) d  
Model 3 Urinary cotinine 
ln(µg/g creat.) 
0.29 (0.05) d 0.26 0.28 (0.04) d 0.31 
      
 
a) SE, standard error 
b) Explained proportion of total variance  
c) Tested against non-smoking; expβ yields an estimate of the multiplicative effect of the 
corresponding factor on urinary mutagenicity  
d) p-value < 0.01 
In Table 4.1-3 mean urinary mutagenicity levels of the Sunday and pooled weekday
samples are presented. Smokers had, on average, a fivefold higher urinary mutagenicity
level than non-smokers. Furthermore, both smokers and non-smokers showed elevated
levels of urinary mutagenicity when Sunday and pooled weekday urine samples were
compared, with an increase of 28% for non-smokers and 14% for smokers. However,
cotinine adjusted urinary mutagenicity levels (based on the observed relationship
between urinary cotinine and urinary mutagenicity), revealed an almost identical
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increment in urinary mutagenicity for non-smokers and smokers (34% and 39%, respec-
tively). Hence, the observed levels of cotinine adjusted urinary mutagenicity were almost
similar for smokers and non-smokers.
Table 4.1-3 Mean urinary mutagenicity unadjusted and adjusted for urinary cotinine concentrations
by smoking status.
Sunday urinary mutagenicity
(Rev / g creatinine )
Week urinary mutagenicity
(Rev / g creatinine )
Increase in
mutagenicity
 Mean a ± GSD Mean ± GSD % b
Unadjusted
Non-smokers 6752 ± 4.98 8641 ± 3.36 28%
Smokers 34436 ± 2.95 39148 ± 2.63 14%
Cotinine adjusted c
Non-smokers 4416 ± 4.92 5913 ± 3.37 34%
Smokers 4664 ± 2.70 6470 ± 2.49 39%
a)
 
Geometric mean ± geometric standard deviation
b)
 
Percentage of difference between urinary mutagenicity levels on Sunday and Weekdays
c)
 
Non-smokers: Ln (Cotinine adjusted Sunday urinary mutagenicity) = ln (Sunday urinary mutagenicity) –
0.29 x ln (Sunday urinary cotinine concentration); Smokers: Ln (Cotinine adjusted Week urinary
mutagenicity) = ln (Week urinary mutagenicity) – 0.28 x ln (Week urinary cotinine concentration)
Discussion
Smoking is almost invariably the most important confounder or effect modifier in studies
focussing on occupational and environmental genotoxic exposures. In order to control
for tobacco smoke intake several exposure indices have been used, including for
example, the number of cigarettes smoked and several biochemical tests for plasma or
saliva thiocyanate, expired carbon monoxide, and carboxyhemoglobin 145; 146. These
exposure proxies have been found unsuitable because of lack in sensitivity and
specificity 147. Cotinine, one of the major metabolites of nicotine, has been considered as
the most accurate biochemical indicator of exposure to MS and ETS 147; 148. Accordingly,
urinary cotinine has been used in several studies to quantify the influence of tobacco
smoke on urinary mutagenicity 134; 135; 149. However, other lifestyle factors such as diet
have been shown to influence urinary mutagenicity as well 135. Because, no biochemical
indicators are available to control for all lifestyle factors, another approach has been
advocated. In this approach the studied subjects are used as their own internal control.
The underlying assumption in this approach is that mutagenic exposure from other
sources (lifestyle related mutagenicity) does not vary temporarily 19. However, due to
the introduction of strict non-smoking policies at indoor workplaces in The Netherlands
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in the 1990’s, this underlying assumption could possibly be refuted with regard to MS
and ETS exposure. All companies but one in the present study had strict non-smoking
policies allowing smoking only at designated times and areas of the company.
We investigated the cotinine levels in urine collected on Sunday, Wednesday and Thurs-
day and observed a statistically significant decrease (t-test; p<0.01) for smokers in both
unadjusted and creatinine adjusted urinary cotinine levels during the week when com-
pared to Sunday. Non-smokers showed a similar downward trend, but the decrease did
not reach statistical significance. Nevertheless, both downward trends in urinary cotinine
levels suggest a decrease in both active and passive intake of tobacco smoke during the
week compared to the weekend. Interestingly, heavy smokers (>10 cigarettes/day) showed
a larger decrease in cotinine concentrations than light smokers (1-10 cigarettes/day),
resulting in comparable cotinine concentrations during the week. Heavy smokers were
probably more affected by non-smoking policies in the workplace, resulting in a tobacco
smoke intake comparable to that of light smokers during weekdays.
The low ratio of the intraindividual: interindividual variability among active and passive
smokers indicated a high degree of interindividual variability in cotinine concentration.
Other investigators have found similar results, which presumably represents intersubject
differences in nicotine metabolism and inhalation patterns 150; 151. However, because of the
half-life of approximately 20h for cotinine, urinary cotinine levels of Wednesday and
Thursday could potentially have been autocorrelated and thereby have resulted in an
underestimation of the intraindividual variability 152.
Regression analysis between several qualitative estimates of MS exposure and urinary
mutagenicity showed a clear relation between active smoking and urinary mutagenicity.
However, the observed association between urinary cotinine and urinary mutagenicity
also implicates a relationship between passive smoking and urinary mutagenicity.
Stratified analyses for smokers and non-smokers revealed no significant difference in the
observed regression coefficients (data not shown). Therefore, the overall observed
relationship between urinary cotinine and urinary mutagenicity was used to adjust for
MS and ETS exposure.
In the presented study, urinary mutagenicity on Sunday was used as an estimate of
mutagenic exposure due to lifestyle factors, whereas urinary mutagenicity on weekdays
was used as a measure of mutagenic exposure due to lifestyle factors and occupational
exposure. The difference between these two measures would therefore yield an estimate
of the mutagenic activity due to occupational genotoxic exposure. Adjustment of
urinary mutagenicity levels for urinary cotinine concentrations revealed comparable
background mutagenicity levels due to lifestyle factors other than tobacco smoke for
smokers and non-smokers, indicating adequate adjustment for tobacco smoke intake.
Increase in mutagenicity due to workplace exposure or other changes in lifestyle factors,
such as diet were similar for smokers and non-smokers after adjustment for MS and ETS
exposure. Without adjustment for MS and ETS exposure, a different conclusion would
have been reached. It is worth noting that adjusted urinary mutagenicity levels for
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smokers, although statistically non-significant, were still slightly elevated compared
with those for non-smokers. This could have been caused either by inadequate
adjustment of urinary mutagenicity for cotinine levels or by smoking induced enzyme
systems leading to higher urinary mutagenicity levels due to mutagenic exposures from
other sources 153-155.
These results indicate that the introduction of non-smoking policies in the workplace
has reduced exposure to tobacco smoke by active and passive smoking resulting in a
temporal variation in lifestyle related mutagenicity. Therefore, adequate adjustment for
daily tobacco smoke exposure is a necessity when using the urinary mutagenicity assay
to evaluate possible genotoxic exposures in the workplace.
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Section 4.2
Mutagenic profile of rubber dust and fume
exposure in two rubber tire companies
The aim of this study was to evaluate curring mutagenic activity of
ambient rubber dust and fume exposure in the mixing and curing
department of two rubber tire companies situated in The Netherlands and
Sweden. S. typhimurium strains YG1021, YG1024 and YG1041 were used to
study the possible presence of mutagenic nitroarenes and aromatic
amines. A large difference in mutagenic activity was found between the
two companies. While the rubber tire company situated in The Netherlands
revealed overall high mutagenic activity of rubber dust and fumes in the
mixing and curing departments, respectively 430 and 279 rev/m3
(YG1041), the Swedish company showed almost no mutagenic activity,
respectively 18 and 54 rev/m3 (YG1041). Further identification of the
mutagenic profile showed that mutagenic activity was exclusively observed
in S. typhimurium strains with elevated levels of O-acetyltransferase
activity (YG1041 and YG1024) in the presence of a metabolic active liver
S9-fraction, possibly indicating the presence of indirect mutagenic
aromatic amines.
These results show that although production processes and lay-out
within rubber tire companies are comparable, differences in rubber
chemicals used and overall level of control measures (e.g., good
housekeeping, cleanliness) are likely to result in substantial differences in
mutagenic exposure levels between companies.
Mutation Research 2000, 468, 165 - 171
Introduction
Examination of recent epidemiological evidence has shown an excess cancer risk among
workers in the rubber industry with most consistent results for urinary bladder,
laryngeal, and lung cancer and leukemia 8. Unfortunately, these recent epidemiological
studies did not provide information associating specific job-related exposures with
observed cancer risks, mostly due to the absence of detailed exposure assessment.
Different process conditions and the large number of rubber chemicals (more than 200)
involved in the production of rubber goods mainly caused the absence of detailed
exposure information, as the chemical complexity of the exposure precludes detailed
chemical analysis of individual genotoxic components. Therefore, non-selective short-
term bioassays have been applied in several studies in the rubber manufacturing industry
to study the exposure to mutagenic compounds, either by measuring mutagenicity of
airborne particulates or in urine of workers 14; 17; 19; 25; 26. Although, these studies showed
occupational exposure to mutagens, components responsible for the mutagenic activity
were hardly identified 27.
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Since the 1950’s, health and safety measures have been widely applied in the rubber
industry by substituting some chemical agents and controlling exposure to others 53.
Two recent industry wide exposure surveys showed that these measures have led to a
significant reduction in rubber dust and fume exposure in The Netherlands and the UK 74; 156.
However, whether the reduction in exposure levels has resulted in a decrease in
mutagenic activity could not be further substantiated in these studies.
In order to investigate current occupational exposure to mutagens present in rubber
dust and fumes, two rubber tire companies were subjects of study. The S. typhimurium
strain YG1041 with elevated nitroreductase and O-acetyltransferase activity 143; 157 was
used to screen the airborne particulate matter. Consequently, S. typhimurium strains
YG1021 and YG1024 were used to discriminate between the possible presence of
mutagenic nitroarenes and aromatic amines in ambient rubber dust and fumes.
Material and methods
Location
Two rubber tire companies, one situated in The Netherlands (company A) and one in
Sweden (company B), were included in the present survey. Company A produced both
passenger and agricultural tires. Company B produced special tires for agricultural,
industrial and forestry equipment. Both rubber tire companies had a comparable layout
of the production process, although the Swedish company had a higher production
volume and degree of automation than the rubber tire company situated in The
Netherlands.
Air monitoring
Ambient air sampling was conducted in the mixing and curing departments where
worker’s activities were concentrated. Ambient total suspended particulate matter (TSPM)
exposure was determined using a high-volume sampler at a flow rate of 0.9 m3/min 94 in
combination with Whatman GF/A glass fiber filters with a diameter of 12.5 cm. Flow rate
was measured before and after sampling and the accepted range was set between 0.8 and
1.0 m3/min. All samples were conditioned at least 24h before weighing and analyzed
gravimetrically in a conditioned weighing room at a temperature of 20 ±2°C and 50 ±5%
relative humidity. After measurements, filters were stored at -20 °C.
In company A 24h TSPM samples were collected during 3 consecutive days (Tuesday
through Thursday) at two locations within the mixing and curing department. In
company B repeated 8h TSPM samples were taken within 1 week at eight different
locations within the mixing (five locations) and curing (three locations) department.
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Filter extraction
Samples were extracted consecutively with cyclohexane (Merck, Darmstadt, Germany),
dichloromethane (Merck) and methanol (Merck). A fourth part of the filter was placed in
an extraction vial with 15 ml of cyclohexane and sonificated for 30 minutes. A total of
8 ml of the suspension was filtered through a glass intertube G4 (Schott, Germany) and
collected in a pre-weighed 10-ml vial. After evaporation of the organic solvent under
nitrogen and subsequently 2h drying at 40°C, the organic soluble residue was weighed
by means of a microbalance. After evaporation of the organic solvent from the extraction
vial at 20°C under nitrogen, the filter was consequently extracted with dichloromethane
and methanol according to the previously described procedure for cyclohexane and
collected in the same 10-ml vial. Mass of the dry residue after cyclohexane extraction
was used to calculate cyclohexane soluble matter (CSM) exposure. Consequently, the
mass of the combined dry extracts was used to estimate total soluble matter (TSM)
exposure. For further identification of the mutagenic profile of the ambient air samples
of company A, another fourth of the filter material was extracted. In this case,
suspensions were collected separately after extraction with cyclohexane,
dichloromethane, and methanol, respectively. All dry extracts were stored at –20°C until
further analysis.
Mutagenicity testing
Collected ambient airborne particulate samples were tested for mutagenic activity with
the S. typhimurium YG1041 strain. Additionally, combined and separate filter extracts of
the company situated in The Netherlands (Company A) were tested for their mutagenic
activity in S. typhimurium strains YG1021 and YG1024. Rubber dust and fume samples of
the Swedish company (Company B) were additionally assayed with the conventional
S. typhimurium strain TA98.
Dry extracts were dissolved in 2 ml of dimethylsulfoxide (DMSO) (Merck) and assayed at
five different dose levels in triplicate for mutagenic activity in the S. typhimurium
mutagenicity assay with S9-mix derived from aroclor induced rat livers 21. In Table 4.2-1,
the spontaneous mutagenicity, mutagenicity of the organic solvent (DMSO) and the
mutagenicity of the positive controls (2-aminofluorene and 2-nitrofluorene, Janssen,
Geel, Belgium) are presented.
For determination of mutagenic activity, the arithmetic mean of the in triplicate tested
dose level was calculated. Dose-response curves acquired at different dose levels were
constructed and the slope of the linear component was used as an estimate of the
mutagenic potency 144. Samples were considered mutagenic if explained variation in
revertants exceeded 90% (r>0.95) and the observed number of revertants was higher
than the limit of detection (LOD) for at least two dose levels. LOD was calculated at 3
standard deviations above the mean blank (DMSO, n=10). Samples that were not
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mutagenic were arbitrarily assigned 2/3 of the LOD for the highest tested dose level and
consequently the mutagenic potency was estimated. Mutagenicity was expressed as
number of revertants per cubic meter (rev/m3).
Table 4.2-1 Mutagenicity of references (rev/plate).
 
TA98 YG1041 YG1024 YG1021 
 Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
Spontaneous 29 ± 7 164 ± 21 41 ± 13 51 ± 8 
DMSO 33 ± 5 96 ± 21 70 ± 8 42 ± 13 
2-AF a (1 µg / plate) 3394 ± 182 c 1382 ± 47.6 - - 
2-NF b (1 µg / plate) - - 181 ± 21 1735 ± 222 
     
 
a) 2-aminofluorene 
b) 2-nitrofluorene 
c) Concentration 2- AF 10 µg/plate 
 
Statistical analyses
Exposure indices and mutagenic activity were lognormally distributed. Therefore, the
natural logarithm of the exposure indices and mutagenic activity were used to test
differences in sample means (student’s t-test). All statistical analyses were performed
using SAS version 6.12 software 79.
Results
Air concentrations of TSPM, TSM and CSM are presented in Table 4.2-2. Statistically
significant higher exposure concentrations were found in company A compared to
company B for all exposure measures (TSPM, TSM and CSM) for both the mixing and
curing departments (t-test, p<0.05). These concentration differences were larger for TSM
and CSM exposure than for TSPM exposure due to a lower percentage of extractable mass
of the airborne particulate matter of company B.
TSPM exposures in the mixing and curing department within the two companies were
almost similar, whereas for TSM and CSM exposure, except for CSM exposure in company
B, statistically significant higher exposure levels were observed in the curing department
compared to the mixing department (t-test, p<0.05).
Mutagenic activity measured with S. typhimurium strain YG1041 was detected in 17 of
the 28 airborne particulate samples (61%). Filter extracts revealing no mutagenic
activity were all collected in the mixing (n=9) and curing (n=2) department of company
B, which consequently revealed overall statistically significant lower mutagenic exposure
levels than company A for both the mixing and curing departments (t-test, p<0.05)
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(Table 4.2-2). Mutagenic activity of filter extracts of company B could only be detected
with the bacteria strain TA98 in 2 out of 23 TSPM samples with a mean mutagenic
activity of 5 rev/m3. Both positive samples stemmed from the curing department. These
samples exhibited a mean mutagenic activity of 92 rev/m3 using the strain YG1041.
Remarkably, the observed range in exposure measures was small because of low
variability in both particulate exposure levels and genotoxic potency within the mixing
and curing departments of the two companies.
Table 4.2-3 Mutagenic activity (rev/m3) towards S. typhimurium strains YG1041,
YG1024 and YG1021 in the mixing and curing department of
company A.
 
N YG1041 
GM a (Range) b 
YG1024 
GM (Range) 
YG1021 
GM (Range) 
Mixing 3 430 (308 - 735) 853 (721 – 989) NM c 
Curing 2 279 (224 - 346) 940 (684 – 1292) NM 
     
 
a) Geometric mean 
b) Minimum and maximum value 
c) Non mutagenic 
Combined and separate filter extracts of ambient rubber dust and fume samples of
company A were additionally assayed with the S. typhimurium strains YG1021 and
YG1024. Mutagenic activity was only detected in the OAT-overproducing strain YG1024.
S. typhimurium strain YG1021, overproducing nitroreductase exhibited no mutagenic
activity (Table 4.2-3). Overall, higher mutagenic exposure concentrations were found in
the mixing department compared to the curing department based on the S. typhimurium
strain YG1041, respectively, 430 and 279 rev/m3. Although the amount of TSM was lower
in the mixing department, the mutagenic potency was considerably higher than in the
curing department, respectively, 3.5 and 1.1 rev/µg extracted mass. For the strain
YG1024 similar exposure levels in the mixing and curing department were found,
respectively 853 and 940 rev/m3. Analyses of the separate organic solvent fractions
showed similar patterns regarding differences in mutagenic response to the different
S. typhimurium strains used (Figure 4.2-1). Furthermore, these analyses showed that
almost all mutagenic activity of filter extracts from the mixing and curing department
was allocated in the cyclohexane soluble fraction (approximately 35%) and
dichloromethane soluble fraction (approximately 60%). Remarkably, the sum of muta-
genic activity of the separate fractions was about a factor 1.5 to 2 higher than the
mutagenic activity found in the combined filter extracts.
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Figure 4.2-1 Mutagenic activity towards S. typhimurium YG1041, YG1024 and
YG1021 for total organic and separate organic solvent fractions in
the mixing and curing departments of company A.
Discussion
Several studies conducted in the 1980’s have shown that workers in the rubber manufac-
turing industry are exposed to a complex mixture of chemical substances, many of which
are potential genotoxic compounds 14; 158. In quite a few of these studies, the S. typhimurium
mutagenicity assay was used to study mutagenic activity of raw chemicals and ambient
rubber dust and fume exposure. In addition, workers urine samples revealed an overall
increase in mutagenic activity 17; 19; 25; 159-162. Although several different base substitution
and frameshift S. typhimurium strains (TA98, TA100, TA1537, TA1538) with or without
metabolic activation were used, test conditions using S. typhimurium TA98 in the
presence of metabolizing enzyme preparations resulted overall in the highest mutagenic
activity 17; 25.
We used nitroarenes and aromatic amines sensitive derivatives of the conventional
frameshift-type strain TA98 to study the current mutagenic activity of rubber dust and
fume exposures in the mixing and curing department of two rubber tire companies.
S. typhimurium strain YG1041, which overproduces both nitroreductase and
acetyltransferase, with the addition of S9-mix was used to screen all collected ambient
particulate samples. Additional assays with strains YG1021, which overproduces
nitroreductase and YG1024, which overproduces O-acetyltransferase were carried out to
elucidate the enzyme systems involved in the detected mutagenic activity. Furthermore,
S. typhimurium TA98 was used to estimate the efficiency of the more sensitive
S. typhimurium YG1041 strain in this particular occupational setting.
A large difference in mean mutagenic activity was found between the company situated
in the Netherlands (company A) and Sweden (company B). The observed difference in
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mutagenic activity could be attributed to differences in rubber dust and fume exposure,
total solubility of TSPM and mutagenic potency of the exposure which were all found to
be higher for company A compared to company B. Observed dust levels differed by a
factor of three probably due to a higher degree of control measures implemented in the
Swedish company (more automation throughout the whole production process). Above
that differences in used chemicals and rubber compounds resulted in an additional
difference in solubility of the dust samples (approximately with a factor of 1.5).
Interestingly, only for the mixing department, a clear difference in mutagenic activity
was observed while for the curing department, this difference was almost negligible.
Analyses of the filter extracts of company B with S. typhimurium TA98 revealed very low
mutagenic activity in only two filter extracts (9%), whereas mutagenic activity was
detected in 12 of the 23 samples (52%) when using the YG1041 tester strain. Based on
the observed mutagenic activity, it was estimated that the strain YG1041 was about 5 - 30
times more sensitive in detecting mutagenic activity in the collected TSPM samples than
the conventional strain TA98.
Analyses of filter extracts of company A with S. typhimurium YG1021, YG1024 and
YG1041 revealed mutagenic activity in YG1024 and YG1041, but not in YG1021. These
results indicate the presence of mutagenic N-hydroxyarylamines and/or aromatic
amines, since detection of the mutagenicity of these chemicals depends on
O-acetyltransferase activity but not on nitroreductase activity 143. The absence of
mutagenic activity in the strain YG1021, used for the greater efficacy in detecting some
mutagenic nitroarenes, like nitropyrene are an indication that these chemicals are of
minor importance in the rubber tire industry. However, since nitroarenes are direct
acting mutagens, the addition of S9-mix could have resulted in partial metabolic
deactivation as was observed in a recent study of Fracasso et al. 14.
The high mutagenic activity in S. typhimurium strains YG1041 and YG1024 together with
the absence of mutagenic activity in YG1021 hints towards a substantial contribution of
indirect acting mutagens and underline the importance of aromatic amine exposure in
this particular industry. These findings are in concordance with recent epidemiological
evidence that have shown an excess cancer risk among workers in the rubber industry
with most consistent results, among others, for urinary bladder and lung cancer 8.
Aromatic amines have been identified as a possible causal group of chemical agents for
these specific cancer sites 163; 164. Furthermore, fractionation of mutagenic activity
showed that most of the mutagenic activity of the samples was due to a-polar/neutral
compounds much of which are possibly aromatic compounds. Summed mutagenic
activity of the different organic fractions revealed a higher mutagenic activity than the
total soluble fraction, which could have been caused by separation of toxic components
from the mutagenic components.
The results of this study indicate that although production processes and lay-out within
rubber tire companies are comparable, differences in rubber chemicals used and overall
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level of control measures (e.g., good housekeeping, cleanliness) are likely to result in
substantial differences in mutagenic exposure levels. Furthermore, the possible impor-
tance of aromatic amine exposure in the rubber tire industry is suggested.
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Section 4.3
Mutagenic exposure in the rubber manufacturing
industry; An industry-wide survey
Mutagenic exposure conditions in several rubber manufacturing companies
(n=9) in The Netherlands were studied. Mutagenicity of total suspended
particulate matter in air (TSPM) and of wipe samples from possible
contact surfaces were measured in the Ames mutagenicity assay with
S. typhimurium YG1041 in the presence of a metabolic activation system.
Large differences in median mutagenicity of TSPM samples were observed
between companies (range 49-1056 rev/m3) and to a lesser extent
between production functions (range 129 - 402 rev/m3). The production
function curing revealed overall the highest TSPM mutagenicity levels.
Forty-one percent of the surface wipe samples revealed mutagenic activity
ranging from 26 – 665 rev/cm2. Mixing had the largest proportion of
positive samples resulting in a median surface mutagenic contamination
of 39 rev/cm2. Surface mutagenic contamination, averaged per
department/company combination, showed only a weak correlation with
TSPM mutagenicity (r=0.28, p=0.05). Company, production function and
total soluble matter (e.g. mass collected upon extraction with organic
solvents with different polarity) explained 79% and 81% of the variability
in mutagenicity of TSPM and surface contamination levels, respectively.
‘Company’ was identified as the most important exposure determinant for
mutagenic activity in TSPM and surface wipe samples. This indicates the
importance of company specific determinants like production volume and
rubber chemicals used for the encountered mutagenic exposure
conditions. Detection of substantial mutagenic activity on possible contact
surfaces supports furthermore the potential importance of the dermal
route in the uptake of genotoxic compounds of workers in the rubber
manufacturing industry.
Mutation Research, in press
Introduction
Epidemiological studies among workers in the rubber industry have shown an excess
cancer risk with most consistent results for urinary bladder, laryngeal and lung cancer
and leukemia 8. Unfortunately, these epidemiological studies did not provide information
associating specific job-related exposures with the observed cancer risks. Most of these
studies used job titles and work areas as proxy of exposure, due to the general absence
of detailed exposure assessment.
A number of reports on exposure measurements among rubber manufacturing workers
have been published. Traditionally, these surveys focussed on exposure to airborne
particulate matter and solvents 10-13. More recently, compound(s) specific studies were
conducted of exposure to nitrosamines and polycyclic aromatic hydrocarbons 14-16.
However, it has in general not been possible to identify specific chemicals responsible for
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the increase in malignant neoplasms in the rubber manufacturing industry, therefore
estimation of the integrated genotoxic potency of the exposure, without the need for
analytical methods to identify each genotoxic compound separately, could possibly yield
valuable exposure information.
In several studies in the rubber manufacturing industry, exposure to genotoxic com-
pounds has been described by measuring mutagenic activity of airborne particulates and
fumes and mutagenicity in urine of workers 14; 17; 19; 25; 26. These studies were typically
performed in only one company and focussed on the mixing and curing department as
these production functions were thought to represent worst case situations. Therefore,
little is known about the range and variation in genotoxic exposure levels between
companies and production functions.
Several studies have addressed the possible relevance of dermal exposure in the rubber
manufacturing industry 10; 17; 18. Direct evidence for the importance of the dermal
exposure route was found in a study by Bos et al. 19 in an aircraft tire retreading
company. In this study a relation was found between dermal exposure to cyclohexane
soluble matter (CSM) and urinary mutagenicity. Recently, a dermal exposure pathway
analysis, carried out in the same companies as the present study, showed that personal
dermal CSM exposure was related to the level of CSM contamination of possible contact
surfaces 165. Therefore, additional assessment of mutagenic activity of these contaminated
surfaces could give insight in the potential role of the dermal route for uptake of
genotoxic compounds.
This paper describes the result of an industry-wide survey of mutagenic exposure
conditions in the rubber manufacturing industry in The Netherlands. Mutagenicity of
total suspended particulate matter (TSPM) and surface contamination was measured in
the Ames mutagenicity assay with S. typhimurium YG1041 in the presence of a metabolic
activation system. The influence of company, production function and several exposure
indices on the variance in mutagenic activity was subsequently studied.
Material and methods
Location
The actual field study was conducted from January 1997 through July 1997 in 9 rubber
manufacturing companies in The Netherlands (3 rubber tire, 5 general rubber goods and
1 retreading company). All production functions (e.g. compounding and mixing, pre-
treating, moulding, curing, finishing, shipping, engineering service and laboratory) were
included in the survey. General characteristics of the companies and production
functions studied are presented elsewhere 166; 167. Information on rubber chemicals used
was collected in companies with a compounding and mixing department (n=5) based on
chemical inventory registries and a walk through survey. All samples and additional
information were collected during the course of one week per company.
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Air monitoring
8h total suspended particulate matter (TSPM) exposure was measured on random days
with a high-volume sampler at a flow rate of 0.9 m3/min in combination with Whatman
GF/A glass fiber filters with a diameter of 12.5 cm 94. Flow rate was measured before and
after sampling and the accepted range was set between 0.8 and 1.0 m3/min. Samples
were discarded if the measured flow rate did not meet the a-priori accepted range. All
samples were conditioned (e.g. constant temperature and relative humidity) at least 24h
before weighing and analyzed gravimetrically in a conditioned weighing room at a
temperature of 20 ±2°C and 50 ±5% relative humidity. Subsequently, mass of particulate
matter was used to calculate TSPM exposure (mg/m3). On average 1.8 repeated TSPM
samples were collected per sample site for each department within a company, which
were then pooled for further analyses.
Surface contamination
Surface contamination was determined by obtaining wipe samples of potential contact
surfaces. Potential contact surfaces were identified based on interviews and observations
of the workers while executing their specific tasks using the following criteria: wipe
location should be a potential dermal contact site; site is regularly and frequently
involved in the handling of chemicals and/or rubber products; wipe location is
sufficiently large to accommodate a wipe of 100 cm2 (rubber compounds and products
(n=12), machines and tools (n=57), control panels (n=4), workbenches (n=31)). Samples
were taken by a modification of the OSHA wipe sampling procedure 116; 165. In the
modified procedure, a surface area of 100 cm2 of a potential contact surface was chosen
as sampling area. Each area was wiped 3 times consecutively with Clean cylceTM wet VDU
wipes (Inmac, Wargave, UK) containing 70% water and 30% isopropyl alcohol. A
consistent sampling area was maintained by use of a template. The same wipe pattern,
applied with maximum operator pressure, was adhered throughout the study. Repeated
samples of the same surface were pooled and stored at –20°C before analysis.
Extraction procedure
Samples (filters and VDU wipes) were extracted consecutively with cyclohexane,
dichloromethane and methanol (Merck, Darmstadt, Germany) as described previously 168.
In short, samples were placed in an extraction vial with 15 ml of cyclohexane and
sonificated for 20 minutes. A total of 8 ml of the suspension was filtered through a glass
intertube G4 (Schott, Germany) and collected in a pre-weighed 10 ml vial. After
evaporation of the organic solvent under nitrogen and subsequently 2h drying at 40°C,
the organic soluble residue (cyclohexane soluble matter, CSM) was weighed by means of
a microbalance. After evaporation of the organic solvent from the extraction vial at 20°C
under nitrogen, the filter or VDU wipe was consecutively extracted with dichloromethane
and methanol according to the same procedure as described for cyclohexane and
collected in the same 10 ml vial. Mass of the dry residue after cyclohexane extraction
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was used to calculate CSM and mass of the combined dry extracts was used to estimate
total soluble matter (TSM) of the TSPM and surface wipe samples. Dry extracts were
stored at –20°C until further analysis.
Mutagenicity testing
Extracts of TSPM and surface contamination samples were tested for mutagenic activity
with S. typhimurium YG1041 in the Ames mutagenicity assay 21. The S. typhimurium
strain YG1041, with elevated nitroreductase and O-acetyltransferase activity, is
extremely sensitive for the presence of mutagenic nitroarenes and/or aromatic amines.
Dry extracts were dissolved in 2.5 ml of dimethylsulfoxide (DMSO) (Merck) and assayed
at five different dose levels in triplicate for mutagenic activity in the presence of S9-mix
derived from aroclor 1254 induced rat livers (mutagenicity of references: spontaneous
144 ± 19 rev/plate; positive control (2-aminopyrene, 0.1 µg/plate) 2584 ± 232 rev/plate).
For determination of the mutagenic activity, the arithmetic mean of the in triplicate
tested dose level was calculated. Data acquired at different dose levels were used to
construct a dose-response curve and the slope of the linear component was used as an
estimate of the mutagenic potency 144. Samples were considered mutagenic if explained
variation in revertants exceeded 90% (r>0.95) and the observed number of revertants
was higher than the limit of detection (LOD) for at least two dose levels. LOD was
calculated at 3 standard deviations above the mean blank (DMSO, n=10). Mutagenicity of
TSPM and surface wipe samples was expressed as number of revertants per cubic meter
(rev/m3) and as revertants per square centimeter (rev/cm2), respectively. Samples that
were not mutagenic were arbitrarily assigned 2/3 of the mutagenic activity of the sample
with the lowest detectable mutagenicity level (19 rev/m3 and 17 rev/cm2 for TSPM and
surface contamination samples, respectively).
Statistical analyses
Pearson correlation coefficients were used to investigate the relation between exposure
indices (TSPM, TSM, CSM), mutagenic surface contamination and mutagenicity of TSPM
samples. To calculate the Pearson correlation coefficient between TSPM mutagenic
activity and surface mutagenicity levels, the mutagenic activity of the TSPM and surface
wipe samples were averaged per department/company combination (n=48) and
subsequently compared. Associations between company, production function, exposure
indices and mutagenic exposure conditions were further studied with linear regression
models using continuous variables (TSPM, TSM and CSM exposure) and dummy variables
(company and production function). All statistical analyses were performed using SAS
version 6.12 software 79.
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Results
In total 145 repeated TSPM samples were collected at 83 different sampling sites within 9
rubber companies. Total suspended particulate matter exposure and mutagenicity of
TSPM and contaminated surfaces are presented in Table 4.3-1 and 4.3-2 stratified for each
sampling site by company and production function, respectively. Overall a low median
TSPM concentration (0.17 mg/m3) was observed. Mutagenic activity measured with
S. typhimurium YG1041 with metabolic activation was detected in 76 of the 83 pooled
TSPM samples (95%). A large difference in median mutagenic TSPM exposure was
observed between companies (range 49 – 1056 rev/m3), with the highest median
mutagenic TSPM exposures found in companies 3 and 4, which both produced large
quantities of technical rubber goods. No systematic difference in median mutagenic TSPM
exposure was, however, observed between rubber tire, technical rubber goods and
retreading companies. Median mutagenic TSPM exposure varied only by a factor of 3
between production functions (range 129 – 402 rev/m3). The production function curing
revealed overall the highest mutagenic exposure levels (median 402 rev/m3) followed by
the production functions finishing and moulding (median 262 and 252 rev/m3,
respectively).
Forty-one percent of the 104 collected surface wipe samples had detectable mutagenic
activity levels with a range of 26 to 665 rev/cm2 for the Ames-positive samples. Wipe
samples with no detectable mutagenic activity were found for all companies and in all
production functions. Therefore, variation in mutagenic surface contamination levels was
large within production functions and companies. Variability in median mutagenic
surface contamination levels between companies was again larger than between
production functions although less pronounced as for mutagenic TSPM exposure.
Interestingly, the production function mixing revealed the largest proportion of positive
samples and consequently the highest median mutagenic surface contamination level (median
39 rev/cm2).
Table 4.3-3 Pearson correlation coefficients (and p-values) between several exposure
indices (TSPM, CSM and TSM) and mutagenicity of total suspended
particulate matter (n=83).
Exposure index Mutagenicity TSPM 
(rev/m3) 
TSM 
(µg/m3) 
CSM 
(µg/m3) 
     
Total suspended particulate matter  (mg/m3) 
(TSPM) 
0.07 
(0.56) 
0.07 
(0.55) 
0.05 
(0.62) 
Cyclohexane soluble matter (µg/m3) 
(CSM) 
0.71 
(0.0001) 
0.96 
(0.0001) 
 
Total soluble matter (µg/m3) 
(TSM) 
0.75 
(0.0001) 
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No correlation was observed between TSPM exposure and the mutagenicity of TSPM
samples (r=0.07, p=0.56) (Table 4.3-3). Extractable mass (TSM and CSM) showed an
overall good correlation with the observed TSPM mutagenicity, r=0.75 and r=0.71,
respectively. Both exposure indices were also strongly correlated with each other
(r=0.96, p=0.0001). Correlation between TSPM and surface mutagenicity, aggregated per
department/company combination, showed only a weak correlation (r=0.28, p=0.05).
Table 4.3-4 Univariate and multivariate regression models for mutagenicity of total
suspended particulate matter and mutagenic surface contamination.
 Univariate 
regression model 
Multivariate 
regression model 
 p-value a r2 b p-value c r2 d 
Mutagenicity of total suspended particulate matter (rev/m3)   
 Production function 0.04 0.17 0.15 0.79 
 Company 0.0001 0.59 0.0001  
 TSPM (mg/m3) 0.56 0.01 0.83  
 TSM (µg/m3) 0.0001 0.56 0.0001  
 
CSM (µg/m3) 0.0001 0.50 ---  
Mutagenicity of surface contamination (rev/cm2)   
 Production function 0.16 0.10 0.0001 0.81 e 
 Company 0.01 0.18 0.0001  
 Production function x company 0.0001 0.79 0.0001  
 TSM (µg/cm2) 0.27 0.01 0.011  
 CSM (µg/cm2) 0.51 0.01 ---  
      
 
a) P-value derived from the univariate regression analysis 
b) Explained proportion of variance per individual determinant 
c) P-value derived from the multivariate regression analysis 
d) Total proportion of variance explained by all factors in a multivariate regression model 
(Exclusion of CSM exposure due to collinearity with TSM exposure) 
e) With inclusion of the interaction term between production function and company in the 
multivariate regression model (without interaction term r2=0.31). 
Variability in mutagenicity of TSPM samples was to a great extent explained by company
(r2=0.59), TSM exposure (r2=0.56) and CSM exposure (r2=0.50) (Table 4.3-4). Combination
of all determinants in one multivariate regression model, excluding CSM exposure due to
collinearity with TSM exposure, explained 79% of the total variance in TSPM
mutagenicity levels. Surface mutagenic contamination was associated with company,
production function and surface TSM exposure, however, the explained variance was
considerably lower at, 18%, 10% and 1%, respectively. The interaction term between
company and production function was statistically significant for surface mutagenicity
levels (p=0.0001). This indicates that surface mutagenic contamination levels were
determined by specific conditions in each production function in each company.
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Combination of company, production function, TSM exposure and the interaction term in
one multivariate regression model explained 81% of the total variance in surface muta-
genicity levels (Table 4.3-4).
Discussion
Exposure to mutagenic compounds in the rubber manufacturing industry may occur by
inhalation, ingestion, or dermal absorption 17-19. Skin contact with contaminated surfaces
and deposition of rubber particles on the skin have been identified as important
exposure determinants of dermal CSM exposure in the rubber manufacturing industry 10; 165.
Therefore, assessment of mutagenic activity of possible contact surfaces and rubber dust
and fume exposure could yield an estimate of potential exposure to mutagenic
compounds through the dermal and inhalation route. The validity of surface wipe
samples as an indicator of dermal exposure depends greatly on the level of
contamination and the frequency and duration of skin contact with the contaminated
surfaces. In a previous study a relation was observed between dermal CSM exposure and
CSM contamination of the same contact surfaces as were tested for mutagenicity in this
study. Therefore it was assumed that the detected mutagenicity in the surface wipe
samples was indicative for dermal exposure to mutagenic compounds.
We studied the mutagenic exposure conditions in several rubber companies in The
Netherlands (n=9) by measuring mutagenicity of TSPM and surface contamination
samples. A large variation in mutagenic activity of TSPM and surface contamination
samples was observed between companies and to a lesser extent between production
functions. Modeling of the mutagenic activity of TSPM and surface contamination
samples confirmed the importance of a company effect on the observed mutagenic
exposure levels. The existence of substantial differences in mutagenic exposure levels
between companies was also observed in a previous study, in which a significant
difference in mutagenic rubber dust and fume exposure was found between two
apparently comparable rubber tire companies 168. The influence of production function
on TSPM and surface contamination mutagenicity levels was less pronounced. However, a
significant interaction term was observed between company and production function in
relation to mutagenic surface contamination (p=0.0001), indicating that surface
mutagenicity levels were determined by specific conditions in each production function
within each company. The fact that mutagenic exposure levels are largely determined by
company specific conditions and not so much by production function points towards the
importance of company specific exposure determinants such as rubber chemicals used,
production volume and overall level of control measures. Company 3 & 4 had the highest
production volume of technical rubber goods and consisted mainly out of one large
curing area. As the production function curing showed overall the highest mutagenic
exposure levels it is not surprising that these two companies revealed the highest TSPM
mutagenicity levels. The same was observed for the rubber tire companies included in
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this study where the rubber tire company with the largest mixing and production
volume capacity (company 8) showed also the highest mutagenic TSPM exposure levels.
If production volume is indeed an important determinant than the detected mutagenic
compounds must be commonly used or generated. Only a few rubber chemicals were used
in all companies of which 2,2-dibenzothiazyl disulphide (MBTS) and 2-(morpholinothio)
benzothiazole (MBS) have been found to constitute some potency in short-term
genotoxicity tests 169. However, natural and synthetic rubber, fillers and process oils,
with known and partly unknown constituents are also generally used.
TSPM and surface mutagenicity levels were only weakly correlated. The production
function ‘curing’ revealed the highest TSPM mutagenicity levels, but less than half of the
surface wipe samples was considered mutagenic. Inhalable exposure in the curing
departments consist mainly out of rubber fumes and gases, which are not likely to
deposit on contact surfaces. Mutagenicity in wipe samples originating from the curing
departments were mostly detected in wipe samples from recently (warm) cured rubber
tires or from surfaces that were in frequent contact with these products (data not
shown). For the production function ‘mixing’almost the opposite was observed with
relatively low levels of TSPM mutagenicity but with the largest percentage of positive
surface wipe samples. Most likely the mutagenic contamination on the tested surfaces
was caused by other exposure pathways than deposition of particles like for instance
spills and splashes and ejection of large particles.
The mutagenic activity of TSPM was significantly correlated with total soluble matter
(r=0.75, p<0.0001). Interestingly, cyclohexane soluble matter revealed only a marginally
lower correlation with TSPM mutagenicity levels (r=0.71, p<0.0001). CSM is used in the
regulation of rubber dust and fume exposure in the United Kingdom since 1987, and
serves as a surrogate for the complex mixture of rubber curing fumes 123. The results of
this study suggest that because CSM exposure had an overall better correlation with
TSPM mutagenicity levels than the mass of the particulate matter itself, assessment of
CSM exposure in the rubber industry might be a better indicator for biological activity
than measurement of particulate mass.
In conclusion, mutagenic activity in TSPM and surface wipe samples was found for all
production functions and companies and was certainly not restricted to the mixing and
curing departments of the surveyed companies. Although specific exposure determinants
remained unclear, company related factors seemed to be of great importance.
Furthermore, detection of substantial mutagenic activity on possible contact surfaces in
the rubber manufacturing industry is of importance for the estimation of genotoxic
exposure due to multiple exposure routes in this particular industry. These results
support the evidence presented in earlier reports suggesting the potential importance of
the dermal route in the uptake of genotoxic compounds for workers in the rubber
manufacturing industry 10; 17-19.
Genotoxic exposure and biological effects in the rubber manufacturing industry
94
Acknowledgements
S. typhimurium strain YG1041 was kindly obtained from Dr. T. Nohmi and Dr. M. Watanabe
of the division of Mutagenesis, National Institute of Genetics and Mutagenesis (Tokyo,
Japan). The authors are grateful to J. de Hartog, H. Wegh, J. Pertijs, T. de Groot and
A. Mom for assisting in the data collection and subsequent analyses.
Chapter 4 Genotoxic exposure conditions in the rubber manufacturing industry
95
Section 4.4
Skin aberrations and slow-acetylation phenotype
among rubber workers result in increased urinary
mutagen levels associated with inhalable
particulate and dermal exposure
Airborne particulate and dermal mutagenic exposure levels and mutagens
in urine of rubber workers (n=105) in 9 rubber manufacturing companies
in The Netherlands were studied to determine the relevance of the
inhalable and dermal exposure route. In addition, the potential influence
of skin aberrations and biotransformation polymorphisms (NAT2 and
CYP1A2) on urinary mutagenicity levels was addressed. Mutagenic activity
of the total suspended particulate matter, surface contamination and
Sunday and weekday urine samples was assessed with S. typhimurium
YG1041 in the presence of a metabolic activation system. Furthermore,
personal inhalable particulate, inhalable CSM and dermal CSM exposure
was quantified. A significant increase of 1605 rev./g. creat. in urinary
mutagenicity during the workweek relative to Sunday was observed for the
total population (t-test, p=0.08) and was most pronounced among
technical engineers (+4196 rev./g. creat.; t-test, p=0.08) and subjects
with potential high TSPM and surface mutagenic exposure levels (+3206
rev./g. creat. ;t-test, p=0.12). Subsequent multivariate regression
analyses revealed significant associations between the mutagenic activity
of contact surfaces, inhalable particulate exposure, skin aberrations and
slow acetylation phenotype and weekday urinary mutagenicity. Similar
trends were observed with Sunday urinary mutagenicity levels except for
slow-acetylation phenotype that only modulated the weekday urinary
mutagenicity levels. Surface mutagenic exposure levels were estimated to
increase weekday urinary mutagenicity with about 67%, while inhalable
particulate exposure increased weekday urinary mutagenicity levels with
about 23%. These results suggest that the dermal exposure route
contributes more to urinary mutagens of rubber workers than the
inhalable route. Especially since subjects with skin aberrations revealed an
additional increase in weekday urinary mutagenicity of about 40%. In
addition, levels of mutagens in urine were modulated by NAT2-dependent
enzyme activity with slow acetylators having higher levels of mutagens in
their urine. Prevalence rates of these unfavorable skin and
biotransformation conditions are, however, high in this population, 40%
and 60%, respectively. Therefore, increase in urinary mutagenicity due to
these factors is of real importance.
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Introduction
Mutagens have been found in raw rubber chemicals, airborne rubber dust and fume
samples and in urine of exposed rubber workers 25. Although, elevated urinary
mutagenicity levels were detected, direct relations with external exposure levels were
seldom identified 17; 19; 159; 170. Only in a study by Bos et al. 19 a direct relationship was
found among workers in an aircraft tire retreading company for urinary mutagenicity
and dermal exposure to cyclohexane soluble matter (CSM). The suggestion that dermal
exposure could be an important exposure route in the rubber industry was later
strengthened by the observation that the amount available for uptake through the skin
could be up to a tenfold higher than through inhalation, depending on the specific
situation in a rubber company and use of personal protective devices 10.
Recently, skin contact with contaminated surfaces and deposition of rubber particles on
the skin were identified as important exposure determinants of dermal CSM exposure in
the rubber manufacturing industry 10; 165. Moreover, substantial mutagenic activity was
detected on these contact surfaces making dermal exposure to mutagenic compounds
more than likely 171. No information is, however, available on the actual dermal
absorption of these compounds and therefore the relevance of the dermal exposure route
in relation to the inhalable route remains unclear.
Dermal absorption of chemicals can be drastically increased when the skin barrier
function is impaired 172-174. Skin diseases, such as hand dermatitis and traumata of the
skin are a common problem in the rubber manufacturing industry with prevalence rates
for skin diseases up to 56% among rubber workers 167. The high prevalence of skin
impairments in this industry could therefore significantly add to the relative
contribution of the dermal route.
We studied the presence of mutagens in urine of rubber workers, which were selected
from a large cross-industry survey in The Netherlands 74; 167. Subsequently, the possible
relationship between inhalable and dermal exposure, mutagenicity of total suspended
particulate matter (TSPM) and mutagenicity of contaminated surfaces and urinary
mutagens was investigated. Special attention was given to the possible influence of
CYP1A2 and NAT2 phenotype on urinary mutagenicity as in a recent study the
importance of exposures to aromatic amines in this particular industry was suggested 168.
Both biotransformation phenotypes modulate the primary metabolic pathways of
carcinogenic aromatic amines in humans 163.
Material and methods
Study population
Selection of the study population is described in detail elsewhere 74; 75. In short, 225
subjects, employed in 9 rubber manufacturing companies (3 rubber tire, 5 general
Chapter 4 Genotoxic exposure conditions in the rubber manufacturing industry
Section 4.4
97
rubber goods and 1 retreading company), were randomly selected based on their produc-
tion function (e.g. compounding and mixing, pre-treating, moulding, curing, finishing,
shipping, engineering service and laboratory). Sample and data collection was carried
out within one week per company and comprised a medical survey, ambient and personal
exposure measurements and collection of biological samples. Informed consent was
obtained after the study was explained to the subjects.
After completion of the field phase of the survey and preliminary analysis, 100 subjects
were selected from the original population based on their reported smoking status (yes/no)
and ambient mutagenic exposure profile. The study population was divided into 4
a-priori exposure groups using median levels of total suspended particulate matter
(TSPM) mutagenicity and surface mutagenic contamination levels. The exposure groups
are characterized as follows:
[a] low TSPM mutagenicity and low surface mutagenic exposure levels (LL);
[b] high TSPM mutagenicity and low surface mutagenic exposure levels (HL);
[c] low TSPM mutagenicity and high surface mutagenic exposure levels (LH);
[d] high TSPM mutagenicity and high surface mutagenic exposure levels (HH).
No subjects matched the a-priori categorization of low TSPM mutagenicity and high
surface mutagenic exposure levels (LH) leaving only three exposure groups (LL, HL, HH).
From each of these exposure groups 20 non-smokers were selected. Additionally, 20
smokers were selected from both the LL and HH exposure group. For subjects employed
as technical engineer (n=16) the work practice was too diverse to enable identification
of relevant TSPM and surface wipe samples. However, technical engineers are potentially
high exposed workers and were therefore included in the present survey as a separate
category. All subjects were male (n=116) and were full-time employed.
Skin aberrations
Skin aberrations at time of the exposure survey were assessed by two dermatologists 75.
Objective skin symptoms were used for the classification: active hand dermatitis (‘major’
dermatitis), the first symptoms of dermatitis (‘minor’ dermatitis) and skin injuries
(traumata) 51; 54.
Ambient exposure measures
Ambient exposure measurements were collected as described previously 165; 168. Briefly,
TSPM exposure was measured on random selected days (Tue. – Thurs.) by means of a
high-volume sampler 94. On average 1.8 samples were collected per department within a
company; samples within a department were subsequently pooled for mutagenicity
analysis. Surface contamination was estimated by obtaining wipe samples of potential
contact surfaces. Samples were taken by a modification of the OSHA wipe sampling
procedure 116; 165. In the modified procedure, a surface area of 100 cm2 of a potential
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contact surface was chosen as sampling region. The region was wiped 3 times consecu-
tively with Clean cylceTM wet VDU wipes (Inmac, Wargave, UK) containing 70% water and
30% isopropyl alcohol.
Personal exposure measures
Personal inhalable particulate exposure was measured on three consecutive days (Tue. –
Thurs.) by means of a PAS6 sampling head mounted near the breathing zone of the
worker 94; 95. Personal dermal exposure to cyclohexane soluble matter (CSM) was
measured by means of a dermal pad sampler worn at the lower part of the wrist of the
hand of preference on the same days as the personal inhalable exposure measurements
were taken 10; 76. CSM contents of inhalable and dermal exposure samples were determined
by means of the NIOSH PCAM 217 method 77; 95. In short, samples were placed in
cyclohexane (Merck, Darmstadt, Germany) and sonificated for 20 minutes. Suspension
was filtered through a glassintertube G4 (Schott, Germany) and collected in a pre-
weighed 10 ml-vial. After evaporation of cyclohexane under nitrogen and subsequently
2h drying at 40°C the residue was weighed by means of a microbalance 74.
Mutagenicity assays
TSPM and surface contamination samples were extracted consecutively with cyclohexane
(Merck), dichloromethane (Merck) and methanol (Merck) as described previously 168.
After evaporation of organic solvents under nitrogen at 40°C, the residue was dissolved
in 2.5 ml of dimethylsulfoxide (DMSO) (Merck) 19.
Spot urine samples were collected on Sunday, Wednesday and Thursday approximately at
the same time of the day (± 4 PM). A volume, corresponding with 0.5 mmol of creatinine
of the Wednesday and Thursday urine sample was pooled for each subject prior to
mutagenicity analysis. Urine volumes of 1.0 mmol of creatinine of the Sunday and
pooled weekday urine samples were neutralized to pH 7.0 and extracted with XAD-2
resin (6-cm3 bed volume) and eluted with 10 ml of acetone. After evaporation of acetone
under nitrogen at 40°C, the residue was dissolved in 2.5 ml of DMSO 19.
TSPM (n=83), surface contamination (n=104) and urine (n=232) extracts were assayed for
mutagenic activity with S. typhimurium YG1041 with S9-mix of aroclor 1254 induced rat
liver 21; 143. Mutagenic activity was calculated based on the dose-response curve acquired
at different dose levels. The slope of the linear component was used as an estimate of the
mutagenic potency 144. Mutagenicity of TSPM and surface contamination was expressed as
revertants/m3 and as revertants/cm2, respectively. Urinary mutagenic activity was
expressed as revertants/g creatinine.
Cotinine analysis
Mainstream tobacco smoke (MS) and environmental tobacco smoke (ETS) intake was
evaluated by assessing cotinine levels in both the Sunday and weekday urine samples 175.
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Urinary cotinine was quantified by high performance liquid chromatography according
to the method of Barlow et al. 141 with modifications by Parviainen et al. 142. Urinary
cotinine levels were expressed as µg/g creatinine.
NAT2 and CYP1A2 biotransformation phenotype
An aliquot of the Wednesday urine spot sample was taken and analyzed for caffeine and
metabolites, according to the procedure described by Grant et al.176. Designation of the
acetylator (NAT2) phenotype was based on the ratio between 5-acetylamino-6-
formylamino-3-methyluracil (AFMU) and 1-methylxanthine (1X). Results showed a clear
bimodality of N-acetylation capacity with a ratio cut point at 1.7 resulting in 61.5%
slow and 38.5% fast acetylators. N-oxidation phenotype (CYP1A2) was determined by the
ratio of urinary paraxanthine (17X) and caffeine (137X) as described by Lang and
Kadlubar 177. As the ratio was symmetrically distributed, the median (5.5) was used as
cut point to assign slow and rapid N-oxidation phenotypes.
Calculations & statistics
Mean personal inhalable particulate, inhalable CSM and dermal CSM exposure was
estimated using the James-Stein estimator (Bg) 
178; 179 to maximize accuracy and precision
of the exposure estimates 180. In this computation a weighted mean (Θgi), based on the
between- and within-worker variability, of the individual (zgi) and group mean (zg)
exposure is calculated (Eq. 1). Subjects were grouped by production function (n=8) and
subsequently group means were calculated based on the individual mean exposures
derived from the repeated personal exposure measurements (n=3). The weighing factor
(Bg) was estimated for a fixed number of repeated measurements (J) on each individual
using equation 2.
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Surface mutagenic contamination was calculated by averaging the mutagenic activity
levels of relevant contact surfaces for each subject. In these calculations, surface wipe
samples were weighed equally regardless of the frequency and duration of contact with
the particular surface. Mean ambient TSPM mutagenicity was calculated based on the
pooled TSPM samples according to the work areas the subject was employed in. Cotinine
corrected Sunday and weekday urinary mutagenicity levels were calculated based on the
algorithms found for the relation between urinary cotinine and urinary mutagenicity
levels as described previously 175.
Within- and between-worker components of exposure variance were estimated from the
ln-transformed exposure concentrations employing a one-way nested random-effects
ANOVA model. Comparisons of geometric means of cotinine corrected mutagenicity levels
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between Sunday and weekdays and a-priori defined exposure groups were tested with the
Student’s t-test. Finally, a multivariate regression model was built to identify factors,
which contributed significantly to ln-transformed urinary mutagenicity levels. The
obtained results are presented separately for the Sunday and weekday urine samples.
Possible differences in the regression coefficients (β) of the identified determinants
between the Sunday and weekday urinary mutagenicity levels were studied in a mixed
effect model with the additional inclusion of interaction terms between day (Sunday or
weekday) and the identified determinants. The random effects part of the mixed effect
model was used to allow for the fact that Sunday and weekday urinary mutagenicity
levels were repeated urine samples from the same subject.
Estimation of the effect of the identified determinants on urinary mutagenicity was
calculated based on the used multivariate regression models. In these calculations the
25%- and 75%-percentile of the ln-transformed parameters were used to estimate the
percentage increase in urinary mutagenicity levels. For dichotomous variables the
exponent of the estimated β-coefficient (eβ) was used to estimate the percentage increase
in urinary mutagenicity levels. All statistical analyses were performed using SAS version
6.12 software 79.
Results
Of the 116 selected subjects, 105 subjects (90.5%) had complete data concerning the
ambient exposure estimates, current skin condition, urinary cotinine and urinary
mutagenic activity levels. Subsequently, results presented in this paper are based on
these 105 subjects. For some of the subjects (20%) one of the three repeated personal
inhalable or dermal exposure measurements were missing due to equipment failure or
analytical errors. In these instances the individual mean exposure (zgi) was calculated
based on the two remaining measurements. Subjects were all male with a mean age of
37.9 (sd. 9.0) year.
An overview of the study population and mean mutagenic TSPM and surface
contamination levels for the a-priori defined exposure groups is presented in Table 4.4-1.
The exposure groups HL and HH revealed both statistically significant higher TSPM
mutagenicity levels than exposure group LL (t-test, p<0.0001). Exposure group HH
exhibited statistically significant higher surface mutagenic contamination levels than
exposure groups LL and HL (t-test, p<0.0001). No statistical difference in TSPM
mutagenicity was observed between exposure group HL and HH. These results confirmed
the intended differences in ambient mutagenic exposure profile between the a-priori
defined exposure groups.
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Table 4.4-1 Mean mutagenic activity of total suspended particulate matter
(TSPM) (rev/m3) and mutagenicity of surface contamination
(rev/cm2) levels for the a-priori defined exposure groups.
Exposure group NS / S a TSPM 
GM (GSD) b 
Surface 
GM (GSD) b 
- Low TSPM and low surface 
mutagenic contamination levels (LL) 
 
18 / 18 73 (2.13) 19 (1.02) 
- High TSPM and low surface 
mutagenic contamination levels (HL) 
 
19 / 0 449 (1.73) 20 (1.12) 
- High TSPM and high surface 
mutagenic contamination levels (HH) 
 
20 / 16 514 (1.73) 147 (2.60) 
- Technical engineers (TD) 10 / 4 N.Q c N.Q 
    
 
a) Number of subjects. NS= non-smokers; S= smokers 
b) Geometric mean (gm) and geometric standard deviation (gsd) of mutagenic exposure 
levels 
c) Not quantified 
 
Variability in personal exposure measures was almost equally distributed between and
within subjects (Table 4.4-2). The estimated between- and within variance components
resulted in a James-Stein estimator (Bg) of 0.23, 0.23 and 0.26 for the inhalable
particulate, inhalable CSM and dermal CSM exposure measures, respectively. Mean
individual exposure estimates (Θgi) were therefore largely based on the individual mean
exposure. The observed within- and between-worker variance components were large for
urinary mutagenicity levels. Correction of urinary mutagenicity for urinary cotinine
levels reduced the between-variance component significantly (48%). This indicates that
differences between subjects in urinary mutagenicity are to a large extent explained by
tobacco smoke intake.
Geometric mean of cotinine corrected urinary mutagenicity levels for the a-priori
defined exposure groups are presented in Figure 4.4-1. Non-smokers [A] and smokers [B]
revealed similar patterns in Sunday and weekday urinary mutagenicity for the different
a-priori defined exposure groups with the exception of a borderline significant
difference in cotinine corrected Sunday urinary mutagenicity levels between smokers and
non-smokers within the exposure group HH (t-test, p=0.10). In order to increase the
number of subjects per exposure group smokers and non-smokers were subsequently
pooled [C]. A borderline significant increase in cotinine corrected urinary mutagenicity
between Sunday and weekday urine samples was observed for the total population
(+1605 rev./g creat; t-test, p=0.08) and technical engineers (+4196 rev./g creat; t-test,
p=0.08). The exposure group HH showed also an increase in urinary mutagenicity levels
during the week, however, statistically non-significant (+3206 rev./g creat; t-test,
p=0.12).
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Figure 4.4-1 Geometric mean (GM) and 95% upper confidence limit of cotinine
corrected urinary mutagenicity levels (rev/g creatinine) for the a-priori
defined exposure groups. , Sunday urinary mutagenicity;
, Weekday urinary mutagenicity.
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Table 4.4-2 Total, between- and within-worker variability of several
personal exposure measures and urinary mutagenicity.
 N a S2t  b S2bw  c S2ww d 
Inhalable particulate (mg/m3) 290 0.79 0.42 0.38 
Inhalable CSM  (µg/m3) 284 0.37 0.19 0.18 
Dermal CSM (µg/cm2) 304 1.55 0.74 0.82 
Urinary mutagenicity (rev/ g. creatinine) 210 2.23 1.38 0.86 
Urinary mutagenicity (rev/ g. creatinine) 
(cotinine corrected)  
210 1.62 0.72 0.90 
     
 
a) Number of measurements, number of subjects is 105 
b) Estimated variance component of total distribution 
c) Estimated variance component of the between-worker distribution 
d) Estimated variance component of the within-worker distribution 
Possible relations between exposure measures, skin aberrations and biotransformation
phenotypes were further investigated by means of multivariate regression analyses. These
analyses were allowed for urinary cotinine concentration, skin aberrations and NAT2
phenotype as these factors were statistically significant associated with Sunday and/or
weekday urinary mutagenicity levels (Table 4.4-3). Incidence of minor dermatitis and
skin injuries were associated with increased urinary mutagenicity levels. Major
dermatitis exhibited no relationship with urinary mutagenicity (data not shown).
Consequently, only workers with minor dermatitis and traumata of the skin at time of
the survey were classified as subjects with skin aberrations (n=36). This classification
was subsequently used in all statistical analyses. Age and CYP1A2 biotransformation
phenotype revealed no association with the observed urinary mutagenicity levels and
were therefore not included in the multivariate regression models.
Exposure group HH revealed a significant increase (β=0.62; p=0.01) in weekday urinary
mutagenicity levels relative to the LL exposure group (Table 4.4-3). No statistical
differences between the a-priori defined exposure groups were found in Sunday urinary
mutagenicity levels. The observed associations between the a-priori defined exposure
groups, skin aberrations and urinary cotinine with Sunday and weekday urinary
mutagenicity were not statistically significantly different. For slow acetylation
phenotype a statistical significant different relationship with urinary mutagenicity for
the Sunday and weekday urine sample was present.
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Table 4.4-3 Relationship between urinary cotinine, NAT2-phenotype, skin aberrations and the a-priori
defined exposure groups and Sunday and weekday urinary mutagenicity levels
(rev/g. creatinine) of rubber manufacturing workers (n=105).
 Sunday urinary 
mutagenicity 
Weekday urinary 
mutagenicity 
 β (SE) a p-value β (SE) a p-value 
Intercept 8.24 (0.34) 0.0001 8.59 (0.25) 0.0001 
Urinary cotinine (µg /g. creatinine) 0.27 (0.05) 0.0001 0.26 (0.04) 0.0001 
Slow acetylation (NAT2) b 0.08 (0.28) 0.78 0.45 (0.21) 0.03 
Skin aberrations c 0.52 (0.29) 0.08 0.42 (0.22) 0.06 
High TSPM mutagenicity and low surface mutagenicity  (HL) d 0.05 (0.42) 0.90 -0.20 (0.31) 0.52 
High TSPM mutagenicity and high surface mutagenicity (HH) d 0.39 (0.33) 0.23 0.62 (0.25) 0.01 
Technical service (TD) d -0.51(0.44) 0.25 0.29 (0.33) 0.39 
     
 
a) β-coefficient and standard error of estimate 
b) Relative to fast-acetylation phenotype 
c) Minor dermatitis and/or traumata of the skin 
d) Relative to low TSPM mutagenicity and low surface mutagenicity (LL) exposure group 
 
Further statistical analyses with ambient and personal exposure measures resulted in the
model presented in Table 4.4-4. No relationship was found between TSPM mutagenicity
and urinary mutagenicity levels. Also, personal inhalable CSM and dermal CSM exposure
estimates revealed no statistically significant associations with urinary mutagenicity.
TSPM mass (mg/m3) and personal inhalable particulate exposure, however, showed a
significant association with both Sunday and weekday urinary mutagenicity levels. Both
particulate exposure measures were significantly correlated (r=0.55, p<0.0001) and
therefore only the personal inhalable particulate exposure estimate was used in the
multivariate regression model as this exposure estimate showed statically stronger
associations with urinary mutagenicity than TSPM mass. The observed relationships
between urinary cotinine, skin aberrations and exposure measures were again not
statistically significant different for the weekday and Sunday urinary mutagenicity levels
except for slow acetylation phenotype, which exhibited only a significant relationship
with the weekday urinary mutagenicity levels. The constructed multivariate models
explained 34% and 46% of the variance in Sunday and weekday urinary mutagenicity
levels, respectively. Interestingly the intercept of the models showed a slight increase in
urinary mutagenicity during the week, which was not explained by the determinants
included in the model.
Estimates of the percentage increase in Sunday and weekday urinary mutagenicity for
the models presented in Table 4.4-4 are given in Table 4.4-5. High versus low tobacco
smoke exposure resulted in the largest percentage increase of the studied determinants
in both Sunday and weekday urinary mutagenicity levels, 267% and 289%, respectively.
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Of the exposure measures surface mutagenicity revealed an almost three times stronger
effect on Sunday and weekday urinary mutagenicity than inhalable particulate exposure
(51% and 67% versus 21% and 23%). In addition, skin aberrations resulted in an increase
of 51% and 42% for Sunday and weekday urinary mutagenicity levels, respectively.
Percentage increase in urinary mutagenicity during the workweek as a result of slow-
acetylation phenotype was estimated at 52%.
Table 4.4-4 Relationship between urinary cotinine, NAT2-phenotype, skin aberrations and exposure
measures and Sunday and weekday urinary mutagenicity (rev/g. creatinine) of rubber
manufacturing workers, excluding technical engineers (n=91) a.
Sunday urinary mutagenicity Weekday urinary mutagenicity
β (SE) b p-value β (SE) b p-value
Intercept 7.86 (0.50) 0.0001 7.95 (0.36) 0.0001
Urinary cotinine (µg /g. creatinine) 0.22 (0.05) 0.0001 0.23 (0.04) 0.0001
Slow acetylation (NAT2) c 0.09 (0.28) 0.75 0.42 (0.23) 0.03
Skin aberrations d 0.41 (0.29) 0.17 0.35 (0.24) 0.14
Inhalable particulate dust (mg/m3) 0.42 (0.23) 0.07 0.46 (0.19) 0.02
Surface mutagenicity (rev/cm2) 0.24 (0.12) 0.05 0.30 (0.10) 0.0028
a)
 
Technical engineers were not included in the analyses due to missing ambient mutagenic exposure estimates
b)
 β-coefficient and standard error of estimate
c)
 
Relative to fast-acetylation phenotype
d)
 
Minor dermatitis and/or traumata of the skin
Table 4.4-5 Estimation of the effect (percentage increase) of the identified determinants on Sunday
and weekday urinary mutagenicity levelsa.
 Exposure distribution Sunday urinary 
mutagenicity 
Weekday urinary 
mutagenicity 
 25%-
percentile 
75%-
percentile 
 
%-increase 
 
%-increase 
Urinary cotinine (µg /g. creatinine) 2 693 266.8 289.1 
Slow acetylation b  NA c  9.4 52.2 
Skin aberrations d NA c  50.7 41.9 
Inhalable particulate dust (mg/m3) 0.52 0.82 21.2 23.4 
Surface mutagenicity (rev/cm2) 19 106 50.9 67.2 
     
 
a) Based on the multivariate regression model presented in table 4.4-4 
b) Relative to fast-acetylation phenotype 
c) Not applicable, dichotomous variable 
d) Minor dermatitis and/or traumata of the skin 
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Discussion
We studied mutagens in urine of rubber workers in relation to inhalable and dermal
exposure. In addition, the potential influence of skin aberrations and biotransformation
polymorphisms on urinary mutagenicity levels was addressed. Smoking is almost
invariably the most important contributor to urinary mutagenicity levels. Therefore,
adequate adjustment of daily tobacco smoke exposure is a necessity when using the
urinary mutagenicity assay to evaluate possible genotoxic exposures in the workplace
175. In this study urinary mutagenicity levels were corrected for urinary cotinine
concentrations based on the algorithms described previously 175 or by inclusion of the
urinary cotinine concentrations in the multivariate regression analyses. The observed
relationships between urinary cotinine and urinary mutagenicity in these regression
analyses were similar to the previously published algorithms. After urinary cotinine
correction the patterns in Sunday and weekday urinary mutagenicity levels were
remarkably similar with no indication of a synergistic effect between smoking and
occupational exposure. Therefore, cotinine corrected urinary mutagenicity data of non-
smokers and smokers could be pooled to increase sample size in further statistical
analyses.
Inhalable and dermal exposure assessment was based on ambient and personal exposure
measurements. Ambient measurements were used to assess potential mutagenic exposure
conditions encountered in the rubber manufacturing industry as personal exposure
samples did not result in enough collected material to be tested in the Ames
mutagenicity assay. The collected TSPM and surface contamination samples were tested
for mutagenicity with S. typhimurium YG1041 in the presence of a metabolic activation
system. The strain YG1041, with elevated levels of nitroreductase and O-acetyltransferase
was shown in a previous study to be highly sensitive for detecting mutagenicity in
rubber dust and fume samples 168. Therefore, this strain was used in the current survey to
test mutagenic activity in TSPM, surface wipe samples and in urine of rubber workers
under identical test conditions. Assignment of ambient mutagenic exposure levels to the
individuals was based on the work area the subject was mainly employed in and actual
tasks performed. Mean individual TSPM and surface mutagenicity levels were calculated
independent of duration of contact with a particular surface or residence time in a
particular work area. Therefore, these estimates could have been imprecise. However,
TSPM and surface mutagenic exposure levels are to a large extent determined by
company specific factors and production functions within a company 171. Therefore,
individual estimates of ambient mutagenic TSPM and surface contamination will have
resulted in a justifiable relative ranking of subjects from different companies and
production functions regarding external mutagenic exposure conditions. Personal
exposure estimates of inhalable particulate, inhalable CSM and dermal CSM exposure were
calculated based on a weighted mean of the individual and group mean exposure to
maximize accuracy and precision of the exposure estimates 180. Estimates of exposure
based on individual means may result in attenuation of the exposure-response
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relationship, while grouped estimates may control attenuation bias but may result in a
decrease of the precision 181. Combining individual and group estimates can
simultaneously control both types of error.
The results of this study showed an increase in urinary mutagens of rubber workers
during the workweek relative to Sunday. The increase in urinary mutagenicity was most
pronounced among technical engineers and subjects with potential high TSPM and
surface mutagenic exposure levels. No increase in urinary mutagenicity was found for
subjects with a high TSPM but low surface mutagenic activity. Based on these results it
can be concluded that dermal contact with mutagenic surface contamination is probably
the most likely exposure route. Further statistical analysis using mutagenic activity of
contact surfaces (rev/cm2) as a continuous variable confirmed the relationship between
mutagenicity of possible contact surfaces and Sunday and weekday urinary mutagenicity
levels, while again no association was found between TSPM mutagenic activity levels and
mutagens in urine of rubber workers. However, exposure estimates of both ambient and
personal particulate mass revealed a significant association with urinary mutagenicity
levels. That a relationship with particulate exposure was observed and not with inhalable
CSM or TSPM mutagenic activity suggests significant non-extractable particle bound
mutagenicity. The existence of non-extractable bound bioactive material to the surface
of airborne rubber dust particles was previously demonstrated in a study by Alink et al. 122.
In this study, 83% of the inhibition of the gap-junctional intercellular communication
could be attributed to bio-active material tightly bound to the surface of the particulate
matter that originated from a mixing department of a rubber tire company. As the
highest personal inhalable particulate exposure levels were measured in the mixing
departments of the involved companies the a-priori defined exposure groups might have
had limited value with regard to airborne mutagenic exposure conditions. Interestingly,
personal dermal CSM exposure showed no relationship with urinary mutagenicity levels,
while surface mutagenicity levels did. Presumably, quantification of the personal dermal
CSM exposure levels at the wrist did not result in a more accurate exposure measure for
dermal mutagenic exposure conditions.
Identified associations between occupational exposure estimates and urinary mutagenic-
ity were not statistically different for the pooled weekday urine samples and Sunday
urine samples, though in most instances the observed associations with Sunday urinary
mutagenicity were weaker and statistically less significant. If the biological half-life of
the detected mutagenic compounds is longer than successive exposure intervals, accumu-
lation of these compounds will occur resulting in a steady-state concentration. As
significant occupational related (residual) urinary mutagenic activity was detected in
the Sunday urine samples, these samples cannot be regarded as a ‘clean’ baseline sample.
Therefore, the ratio or absolute difference between Sunday and weekday urinary
mutagenicity levels would have certainly resulted in an underestimation of the
mutagenic effect.
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Subjects with skin aberrations showed statistically significant higher urinary mutagenic-
ity levels than subjects with a normal skin barrier function. This association was stronger
in the regression analyses that included also the technical engineers. Technical engineers
have a high prevalence of minor dermatitis and traumata of the skin, 33% and 22%,
respectively. Exclusion of this production function due to missing ambient mutagenic
exposure estimates, from subsequent regression analyses resulted in the loss of statistical
power and consequently the loss of statistical significance. The observed trend between
skin aberrations and urinary mutagenicity remained, however, the same. Volunteer
studies have shown that even mild skin barrier damage could dramatically increase
percutaneous penetration 172; 182-184. However, the magnitude of the effect depends greatly
on the chemical properties and clinical manifestation of the disease 185. In this study,
increased penetration was observed for subjects with mild dermatitis and traumata of the
skin at time of the survey but not for subjects with major dermatitis. In a previous study
it was shown that rubber workers often do not regard their impaired skin (e.g. minor
dermatitis) as a disease and will therefore not alter their working practice 75. However, in
the case of major dermatitis changes in behavior were found with regard to skin aggra-
vating risk factors 167. The results of this study suggest that subjects with major dermati-
tis consciously minimized direct skin contact with contaminated surfaces and therefore
did not reveal the same positive trend in urinary mutagenicity as subjects with less
severe skin aberrations. More importantly, the observed association between skin
aberrations and urinary mutagenicity is another indication of the importance of the
dermal exposure route in this particular industry.
Slow-acetylators revealed significantly higher weekday urinary mutagenicity levels than
fast-acetylators. NAT2 modulation of urinary mutagenicity has been found in several
studies of subjects exposed to aromatic amines 32; 33; 186. In addition, slow-acetylation
status has been associated with an increase in urinary bladder cancer risk among subjects
with past occupational exposure to aromatic amines 38. NAT2 selectively N-acetylates
arylamines and can also catalyze the O-acetylation of the N-hydroxy-arylamine
metabolites. For urinary mutagenicity N-acetylation of arylamines represents in most
instances a competing pathway for N-oxidation, a necessary metabolic activation step
occurring in the liver 163. However, no indication was found in this study for this
competing pathway as N-oxidation capacity revealed no association with urinary
mutagenicity. However, there is considerable debate whether the urinary metabolite
ratio between paraxanthine and caffeine accurately reflects CYP1A2 activity as
paraxanthine is both a product and a substrate of CYP1A2 and is significantly influenced
by urine-flow 126. Remarkably, NAT2 phenotype only influenced the urinary mutagenicity
levels during the workweek, while the other determinants significantly affected both
weekday and Sunday urinary mutagenicity levels. The observed relationship between
urinary mutagenicity and the exposure estimates were therefore probably not modulated
by NAT2-dependent enzyme activities. This point towards other NAT2 modulated (occupa-
tional) exposures that were not quantified as such with the used sampling and/or analyti-
cal techniques. Also, the observed slight increase in intercepts of the applied
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multivariate regression models for weekday urinary mutagenicity compared to Sunday
urinary mutagenicity levels suggest unmeasured exposure routes for mutagenic
substances, like the gaseous phase or oral exposure route.
In conclusion, the dermal exposure route seemed to contribute more to urinary
mutagens of rubber workers than the inhalable route, especially when taken into
account that subjects with skin aberrations revealed an additional increase in urinary
mutagenicity of about 40%. In addition, levels of mutagens in urine were partly
modulated by NAT2-dependent enzyme activity with slow acetylators having higher
levels of mutagens in their urine. Prevalence rates of these unfavorable skin and
biotransformation conditions are, however, high, 40% and 60%, respectively. Therefore
the increase in urinary mutagenicity due to these factors is of real importance.
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Section 4.5
Urothelial cell DNA adducts among rubber
manufacturing workers
Workers employed in the rubber manufacturing industry appear to have a
significant excess cancer risk in a variety of sites, including cancer of the
urinary bladder. In this cross-sectional study, we investigated the
occurrence of DNA adducts in exfoliated bladder cells of currently
exposed, non-smoking rubber workers (n=52) and their relationship with
occupational exposure estimates and biotransformation phenotypes (NAT2
and CYP1A2). Four DNA adducts were identified with the proportion of
positive samples ranging from 3.8% to 79%. The highest proportion of
positive samples and the highest relative adduct labeling (RAL) levels
were in workers involved in the production functions ‘mixing’ and ‘curing’,
areas with potential for substantial exposure to a wide range of
compounds used in rubber manufacturing (p < 0.05 for adducts #2 and/or
#3, compared to all other departments). However, no statistically
significant relationships were found between identified DNA adducts and
non-specific personal inhalable and dermal CSM exposure estimates or
urinary mutagenicity. Interestingly, subjects with a fast NAT2 acetylation
phenotype tended to have higher levels of DNA adducts. Aryldiamines,
common in mixing and curing, might represent a potential exposure
consistent with these data. This study suggests that workers in mixing and
curing may be exposed to compounds that can adduct DNA in urothelial
cells. Larger studies among rubber workers should be conducted to study
in more detail the potential carcinogenicity of exposures encountered in
these work areas.
Submitted for publication
Introduction
Epidemiological studies of workers employed in the rubber manufacturing industry have
indicated a significant excess cancer risk in a variety of sites (e.g. lung and urinary
bladder cancer and leukemia) 7; 8. Urinary bladder cancer, in this industry has been
attributed traditionally to exposure to antioxidants such as Nonox ‘S’ that contained free
β−naphthylamine as a contaminant 2. The use of this antioxidant and similar compounds
contaminated with β-naphthylamine was subsequently discontinued in the 1950’s.
However, several recent epidemiological studies have found a moderate excess risk of
urinary bladder cancer among workers with supposedly no concomitant exposure to
β−naphthylamine 9; 187. These observations placed in doubt the exclusive link between
β−naphthylamine exposure and urinary bladder cancer in the rubber manufacturing
industry. Interestingly, an excess of urinary bladder cancer was also reported in two
recent cohort studies of workers manufacturing chemicals for the rubber manufacturing
industry; these workers were exposed to neither benzidine nor β-naphthylamine 188; 189.
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Workers in the rubber manufacturing industry are exposed to a wide range of potentially
carcinogenic compounds 7; 188. The chemical composition and toxic properties of the
complex exposure mixture is, to a large extent, unknown. Non-chemical specific
exposure- and biomarkers are often applied in these exposure conditions 20; 188. Examples
of such markers are the S. typhimurium mutagenicity assay and 32P-postlabelling method
for bulky carcinogen-DNA adducts. In several studies in the rubber manufacturing
industry, exposure to mutagenic compounds was established with the S. typhimurium
mutagenicity assay either by measuring mutagenicity of airborne particulates and fumes
or by measuring the mutagenicity in urine of workers 14; 17; 19; 25; 26; 168; 188. Although, the
32P-postlabeling method has been used in a large number of studies on occupational
exposures to detect carcinogen-DNA adducts 190, it has to our knowledge so far not been
applied in the rubber manufacturing industry.
Biotransformation polymorphisms may play an important role in the individual variabil-
ity in carcinogen metabolism. N-acetyltransferase capacity plays a significant role in the
biotransformation of arylamines, of which some are known bladder carcinogens 163; 164 .
Slow NAT2 acetylation status has been associated with increased urinary mutagenicity 31;
31; 32; 149; 188; 188, DNA adducts 34-37; 149; 188 and a modest increase in urinary bladder 38 and
several other cancers 39. Fast acetylators have been suggested to be at higher risk of
developing cancer of the colon 40. Although the increase in biomarkers or cancer risk due
to specific biotransformation polymorphisms in most cases is small, the polymorphisms
are widespread in the general population and may be of importance for individuals with
a particular exposure 191.
We studied the relationship between inhalable and dermal exposure and urinary muta-
genicity and urothelial cell DNA adduct levels in a population of rubber manufacturing
workers, which were selected from a large cross-industry survey in The Netherlands 166; 167.
Subjects were selected based on smoking status (non-smokers) and ambient mutagenic
exposure profile. Ambient mutagenic exposure levels were measured with strain
S. typhimurium YG1041 in the presence of a metabolic active rat liver S9-fraction. In
addition the influence of NAT2 and CYP1A2 biotransformation phenotype on DNA adduct
levels was investigated.
Materials & methods
Cross-sectional study
The field phase of this study was conducted from January 1997 through July 1997,
among subjects working in the rubber manufacturing industry in the Netherlands.
Subjects (n=225) were employed in 9 companies (3 rubber tire, 5 general rubber goods
and 1 retreading company) and were randomly selected based on their production
function (e.g. compounding and mixing, pre-treating, moulding, curing, finishing,
shipping, engineering service and laboratory) 166; 167. Fieldwork was carried out within
Genotoxic exposure and biological effects in the rubber manufacturing industry
112
one week per company and comprised a medical survey, ambient and personal exposure
measurements and collection of biological samples. Informed consent was obtained after
the study was explained to the subjects.
After completion of the field phase of the survey and preliminary analysis, subjects were
selected from the original population based on their ambient mutagenic exposure
profile. The study population was divided into 4 a-priori exposure groups using median
levels of total suspended particulate matter (TSPM) mutagenicity and surface mutagenic
contamination levels. The exposure groups are characterized as follows:
[a] low TSPM mutagenicity and low surface mutagenic exposure levels (LL);
[b] high TSPM mutagenicity and low surface mutagenic exposure levels (HL);
[c] low TSPM mutagenicity and high surface mutagenic exposure levels (LH);
[d] high TSPM mutagenicity and high surface mutagenic exposure levels (HH).
No subjects matched the a-priori categorization of low TSPM mutagenicity and high
surface mutagenic exposure levels (LH) leaving three exposure groups (LL, HL, HH).
Twenty non-smokers were randomly selected from the three remaining exposure groups
resulting in a study population of 60 subjects of which 56 subjects (93.3%) had
retrievable 24h-urine samples.
All subjects were male and were administered a questionnaire, as part of the initial
survey to collect information regarding age, medical history, alcohol and roasted meat
consumption and use of open fire place. Environmental tobacco smoke (ETS) intake was
evaluated by assessing urinary cotinine levels by high performance liquid
chromatography according to the method of Barlow et al. 141 with modifications by
Parviainen et al. 142. Urinary cotinine levels were expressed as µg/g creatinine.
Occupational exposure measures
Ambient exposure measurements were collected as described previously 165; 168. Briefly,
TSPM exposure was measured on random selected days (Tue. – Thurs.) using a high-
volume sampler 94. On average 1.8 samples were collected per department within a
company; samples within a department were subsequently pooled for mutagenicity
analysis. Surface contamination was estimated by obtaining wipe samples of potential
contact surfaces. Samples were taken by a modification of the OSHA wipe sampling
procedure 116. Personal inhalable particulate exposure was measured on three consecutive
days (Tue. – Thurs.) by means of a PAS6 sampling head mounted near the breathing zone
of the worker 94; 95. Personal dermal exposure to cyclohexane soluble matter (CSM) was
measured by means of a dermal pad sampler worn at the lower part of the wrist of the
hand of preference on the same days as the personal inhalable exposure measurements
were taken 10; 76. CSM contents of inhalable and dermal exposure samples were determined
by means of the NIOSH PCAM 217 method 77; 95. In short, samples were placed in
cyclohexane (Merck, Darmstadt, Germany) and sonificated for 20 minutes. The suspension
was filtered through a glassintertube G4 (Schott, Germany) and collected in a pre-
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weighed 10 ml-vial. After evaporation of cyclohexane under nitrogen and subsequent
drying for 2h at 40°C the residue was weighed by means of a microbalance 166. No
chemical analysis of the extract was performed.
Mutagenicity assays
TSPM and surface contamination samples were extracted consecutively with cyclohexane
(Merck), dichloromethane (Merck) and methanol (Merck) as described previously 168.
After evaporation of organic solvents under nitrogen at 40°C, the residue was dissolved
in 2.5 ml of dimethylsulfoxide (DMSO) (Merck) 19. Spot urine samples were collected on
Wednesday and Thursday after work had ended (± 4 PM). Volumes, corresponding with
0.5 mmol of creatinine of the Wednesday and Thursday urine samples were pooled for
each subject prior to mutagenicity analysis. Pooled urine samples were neutralized to
pH 7.0 and extracted with XAD-2 resin (6-cm3 bed volume) and eluted with 10 ml of
acetone. After evaporation of acetone under nitrogen at 40°C, the residue was dissolved
in 2.5 ml of DMSO 19.
TSPM, surface contamination and urine extracts were assayed for mutagenic activity with
S. typhimurium strain YG1041 with S9-mix of aroclor 1254 induced rat liver 21; 143.
Mutagenic activity was calculated based on the dose-response curve acquired at different
dose levels. The slope of the linear component was used as an estimate of the mutagenic
potency 144. Mutagenicity of TSPM and surface contamination was expressed as
revertants/m3 and as revertants/cm2, respectively. Urinary mutagenic activity was
expressed as revertants/g creatinine.
Urothelial cell DNA adduct analysis
Twenty-four hour urine samples were collected from Monday (after first morning void) to
Tuesday (including first morning void). Samples were kept cold (± 4°C) during collection
and made 20% glycerol (v/v) to minimize cell loss due to lysis after freezing.
Consequently, samples were stored at –20°C until analysis.
Frozen samples were thawed, mixed and urinary pH was assessed. A 500 ml aliquot of the
urine samples was filtered through sequential 500 and 250 µm sieves, then exfoliated
urothelial cells were isolated by vacuum filtration using 5 µm nylon filters (Osmonics,
USA). Cells were washed of the filters with a phosphate buffered saline solution (PBS, pH 7.4)
and washed several times by re-suspension in the same buffer followed by centrifugation
at 800 RPM for 15 minutes in a refrigerated centrifuge. DNA was isolated from the cell
pellets by a solvent extraction technique and quantitated by normal nucleotide analysis
with the 32P-postlabeling method as described by Talaska et al. 192. 32P-postlabeling of the
exfoliated urothelial DNA samples was performed under conditions of radiolabelled
adenosine 5’-triphosphate (ATP) excess 193. Necessary excess of ATP was provided by the
addition of 150 µCi to each sample. Carcinogen-DNA adduct levels were calculated by
determining the relative adduct labeling (RAL), which was defined as: counts per minute
(c.p.m.) in adduct spots / c.p.m. in normal nucleotides.
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32P-postlabeling analyses were performed with blind-coded samples and each sample was
analyzed in duplicate, at least. Samples that had insufficient amounts of DNA (arbitrary
cut-off point 20x106 nucleotides) were reanalyzed by increasing the amount of DNA-
sample to be tested or by re-isolation of larger volumes (>500 ml) of the same 24h urine
sample (n=19).
NAT2 and CYP1A2 biotransformation phenotype
An aliquot of the Wednesday urine spot sample was taken and analyzed for caffeine and
metabolites according to the procedure described by Grant et al.176. Designation of the
acetylator (NAT2) phenotype was based on the ratio between 5-acetylamino-6-
formylamino-3-methyluracil (AFMU) and 1-methylxanthine (1X). Results showed a clear
bimodality of N-acetylation capacity with a ratio cut point of 1.7. N-oxidation
phenotype (CYP1A2) was determined by the ratio of urinary paraxanthine (17X) and
caffeine (137X) as described by Lang and Kadlubar 177. As the ratio was symmetrically
distributed, the median (5.5) was used as cut point to assign slow and fast N-oxidation
phenotypes.
Calculations and statistical analysis
Surface mutagenic contamination was calculated by averaging the mutagenic activity
levels of relevant contact surfaces for each subject. In these calculations, surface wipe
samples were weighed equally regardless of the frequency and duration of contact with
the particular surface. Mean ambient TSPM mutagenicity was calculated based on the
pooled TSPM samples according to the work areas the subject was employed in. Cotinine
corrected pooled weekday urinary mutagenicity levels were calculated based on the
algorithms found for the relation between urinary cotinine and urinary mutagenicity
levels as described previously 175.
Mean personal inhalable particulate, inhalable CSM and dermal CSM exposure was
estimated using the James-Stein estimator (Bg) 
178; 179 to maximize accuracy and precision
of the exposure estimates 180. In this computation a weighted mean of the individual and
group mean exposure is calculated, based on the between- and within-worker exposure
variability. Subjects were grouped by production function (n=8) and subsequently group
means were calculated based on the individual mean exposures derived from the repeated
personal exposure measurements (n=3).
RAL levels were not normally distributed. Therefore, two-tailed non-parametric tests
were used throughout the study. Spearman correlation coefficients were used to
investigate the relationship between identified DNA adducts and several exposure indices.
Differences in DNA adduct levels between exposure groups were tested with the Wilcoxon
rank sum test. Trends in proportion of positive samples by phenotype or production
function were investigated using the Cochran-Armitage test for trend. Because of the
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small numbers in most analyses exact p-values were calculated for the analyses with the
proportion of positive DNA adduct samples 82. All statistical analyses were performed
using SAS version 6.12 software 79.
Results
An overview of the study population and ambient mutagenic exposure levels of the a-
priori defined exposure groups is presented in Table 4.5-1. Sufficient DNA (> 20x106
nucleotides) for 32P-postlabeling analysis was obtained from 52 of 56 available 24h-urine
samples (93%). There was a wide range in the quantity of radiolabeled nucleotides
(20x106 – 256x106), as would be expected since the number of DNA in each sample was
not known prior to the analysis. An excess of radiolabel was seen in the normal
nucleotide maps for each sample, indicating that sufficient [32P]ATP was available to
label all nucleotides in the samples.
Table 4.5-1 Mean mutagenic activity of total suspended particulate matter
(TSPM) (rev/m3) and mutagenicity of surface contamination
(rev/cm2) levels for the a-priori defined exposure groups.
Exposure group N (n) a TSPM 
GM (GSD) b 
Surface 
GM (GSD) b 
- Low TSPM and low surface 
mutagenic contamination levels 
(LL) 
19 (18) 
 
73 (2.13) 19 (1.02) 
- High TSPM and low surface 
mutagenic contamination levels 
(HL) 
20 (18) 
 
449 (1.73) 20 (1.12) 
- High TSPM and high surface 
mutagenic contamination levels 
(HH) 
17 (16) 
 
514 (1.73) 147 (2.60) 
 
a) Number of subjects selected. Between parenthesis number of subjects of whom 
sufficient amounts of DNA were retrieved 
b) Geometric mean (GM) and geometric standard deviation (GSD) of mutagenic 
exposure levels 
 
During the analyses, eleven different possible DNA adducts were observed (numbering in
temporal order of detection). Adducts 5, 7 and 8 were later identified as un-adducted
deoxyguanosine nucleotides. Adducts 4 (number of positive samples=1), 6 (n=2), 9 (n=5)
and 10 (n=2) were detected in samples that had DNA amounts lower than the a-priori
minimum level of 20x106 normal nucleotides. Repeated analysis of the same samples,
however, with increased DNA concentrations did not show the previously mentioned
adducts and these DNA adducts were therefore not included. In Table 4.5-2, Spearman
correlation coefficients for the four remaining adducts (1,2,3, and 11) and mean relative
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adduct labeling levels (RAL x 107) are shown. Mean RAL levels were inversely related to
the proportion of positive samples. Significant correlation coefficients were observed
between adducts 1 and 3 (r=0.52, p=0.0001) and adducts 2 and 11 (r=0.32, p=0.02).
Table 4.5-2 Spearman correlation coefficients (and p-values) between
identified DNA adducts and mean relative adduct labeling
(RAL x 107) among rubber manufacturing workers (n=52).
Adduct No. 1 2 3 11 
2 0.23 (0.11)    
3 0.52 (0.0001) a 0.25 (0.08)   
11 0.08 (0.55) 0.32 (0.02) a 0.14 (0.33)  
N b 41 13 29 2 
Mean (sd) c 2.85 (2.99) 5.77 (5.17) 3.68 (3.42) 12.55 (5.30) 
     
 
a) Correlation coefficient significant at the 0.05 level 
b) Number of subjects tested positive for a particular DNA adduct 
c) Mean RAL and standard deviation of the positive DNA samples for a 
particular DNA adduct 
 
In Table 4.5-3, median and mean RAL levels and proportion of positive samples for DNA
adducts by the a-priori defined exposure groups are presented. No significant differences
in RAL or the proportion of positive samples were observed between the three a-priori
defined exposure groups.
Table 4.5-3 Median and mean relative adduct labeling levels (RAL x 107) and proportion of positive samples
stratified by the a-priori defined exposure groups.
 Adduct 1 (n=41) Adduct 2 (n=13) Adduct 3 (n=29) Adduct 11 (n=2) Exposure 
group a 
N Median Mean % b Median Mean % b Median Mean % b Median Mean % b 
LL  18 1.15 2.58 83.3 0.00 0.26 22.2 0.40 2.15 55.6 0.00 0.49 5.6 
HL 18 1.38 1.32 72.2 0.00 0.74 27.8 0.08 1.42 50.0 - - 0.0 
HH 16 1.98 2.19 81.3 0.00 2.49 25.0 1.15 1.57 62.5 0.00 1.02 6.3 
              
 
a) A-priori defined exposure groups: [LL] potential low TSPM mutagenicity and low surface mutagenic exposure levels; [HL] 
potential high TSPM mutagenicity and low surface mutagenic exposure levels; [HH] potential high TSPM mutagenicity and 
high surface mutagenic exposure levels. 
b) Percentage of positive samples of DNA from exfoliated bladder cells 
 
Possible influence of potential confounders or effect-modifiers on RAL levels or the
proportion of positive samples was studied by linear and logistic regression,
respectively. Age, alcohol- and roasted meat consumption, urinary-pH and -cotinine
concentration and levels of normal nucleotides were not associated with the observed
RAL levels or frequency of the four major adducts. A consistent, moderate increase in the
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proportion of positive samples for all four identified DNA adducts was observed for
subjects with a fast N-acetylation status (Figure 4.5-1). The observed difference was
statistically significant for adduct 1 (p=0.04) but non-significant for the other adducts,
presumably due to the limited number of positive samples. CYP1A2 activity was not
related to the proportion of positive samples or RAL levels of DNA adducts. Several
quantitative external and internal exposure indices, which were independent of the
initial grouping scheme were consequently studied in relation with the observed RAL
levels (Table 4.5-4). Personal inhalable particulate, inhalable CSM and dermal CSM
exposure indices were not related with the observed DNA adducts, except for inhalable
CSM exposure and adduct 3 (r=0.31, p=0.03). No consistent patterns could be discerned.
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Figure 4.5-1 Proportion of positive samples of DNA from exfoliated urothelial cells by
N-acetyltransferase activity. , slow N-acetylation phenotype (n=32);
, fast N-acetylation phenotype (n=20). Fisher exact p-values given for the
difference in proportion of positive samples between slow and fast acetylators.
Table 4.5-4 Spearman correlation coefficients (and p-values) for several exposure
indices and urothelial DNA adducts among rubber manufacturing workers
(n=52).
Adduct 
No. 
Inhalable dust Inhalable CSM Dermal CSM Urinary mutagenicity 
     
1 0.02 
(0.91) 
 
0.06 
(0.69) 
0.17 
(0.23) 
0.06 
(0.65) 
2 0.16 
(0.25) 
 
0.21 
(0.13) 
0.08 
(0.58) 
0.17  
(0.25)  
3 0.14 
(0.32) 
 
0.31 a 
(0.03) 
0.06 
(0.67) 
0.04 
(0.80) 
11 -0.02 
(0.91) 
0.23 
(0.11) 
0.09 
(0.55) 
0.04 
(0.78) 
 
a) Correlation coefficient significant at the 0.05 level 
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Figure 4.5-2 shows the distribution of the proportion of positive DNA samples by
production function. Samples from workers involved in ‘mixing’ had the highest
proportion of positive samples for DNA adducts followed by the production function
‘curing’ and ‘miscellaneous’. The production functions ‘mixing’ and ‘curing’ were
investigated further as these production functions differ substantially from each other
and the remaining production functions regarding chemical nature of and level of
exposure.
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Figure 4.5-2 Proportion of positive samples of DNA from exfoliated urothelial cells by production
function.  The number of samples obtained from each function are: mixing, n=5;
Moulding, n=10; Pre-treating, n=14; Curing, n=15; Miscellaneous, n=8.
Table 4.5-5 Median and mean relative adduct labeling levels (RAL x 107) and proportion of positive
samples stratified by production functions ‘mixing’ and ‘curing’. # p<0.10; * p<0.05.
 Adduct 1 (n=41) Adduct 2 (n=13) Adduct 3 (n=29) Production 
function 
N Median Mean % a Median Mean % Median Mean % 
Mixing 5 1.4 2.3 100 1.4 * b 5.0 60.0 # c 4.1 * b 3.8 100 * c 
Curing 15 2.6 2.0 73.3 0 1.4 33.3 1.9 * b 2.4 73.3 # c 
Other 32 1.1 2.0 81.3 0 0.4 15.6 0 1.1 40.6 
           
 
a) Percentage of positive samples of DNA from exfoliated bladder cells 
b) Relative adduct labeling levels in the production functions ‘mixing’ and ‘curing’ versus the ‘other’ 
production functions were evaluated by the Wilcoxon rank sum test  
c) Fisher exact p-values for difference in proportion of positive samples between the production functions 
‘mixing’ and ‘curing’ versus the ‘other’ production functions 
At least, estimated mean personal inhalable dust levels were significantly higher in
‘mixing’ than in the other production functions (Wilcoxon, p=0.035) and rubber fume
exposure quantified as CSM exposure was significantly higher in ‘curing’ than in the other
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production functions (Wilcoxon, p=0.0006). DNA adduct 11 was not included in these
analyses as the number of positive samples (n=2) was too small to enable any further
statistical analyses. Stratified analysis by production function showed a significant
difference in RAL levels and proportion of positive samples between the ‘mixing’ and
‘other’ production functions for both adduct 2 (p=0.03 and p=0.06, respectively) and
adduct 3 (p=0.01 and p=0.02, respectively) (Table 4.5-5). For the production function
‘curing’ a statistical significant difference in RAL level and proportion of positive samples
was only found for adduct 3 (p=0.03 and p=0.06, respectively). Further stratification by
both production function and NAT2 phenotype produced statistically significant trends
both in the proportion of positive samples and median RAL for adducts 2 and 3 within
‘mixing’ and ‘curing’ (Table 4.5-6).
Table 4.5-6 Trends in median and mean relative adduct labeling levels (RAL x 107) and proportion of positive
samples stratified by production functions ‘mixing’ and ‘curing’ and N-acetylation status (NAT2).
 Adduct 1 (n=41) Adduct 2 (n=13) Adduct 3 (n=29) NAT2 Production 
function 
N Median Mean % a Median Mean % Median Mean % 
Fast  Mixing 1 1.0 1.0 100 5.6 5.6 100 4.1 4.1 100 
Slow Mixing 4 2.8 2.7 100 0.7 4.8 50.0 3.6 3.7 100 
Fast  Other b 13 1.7 1.9 92.3 0 0.6 23.1 0.2 2.4 53.8 
Slow Other b 19 0.8 2.1 68.4 0 0.2 10.5 0 0.2 31.6 
   
 P=0.062 d  P=0.020  P=0.009 
Fast  Curing 6 2.9 3.2 100 1.4 1.8 50.0 3.3 3.9 100 
Slow Curing 9 0.6 1.2 55.6 0 1.3 22.2 1.1 1.3 55.6 
Fast  Other c 13 1.7 1.9 92.3 0 0.6 23.1 0.2 2.4 53.9 
Slow Other c 19 0.8 2.1 68.4 0 0.2 10.5 0 0.2 31.6 
    P=0.520  P=0.066  P=0.008 
         
 
a) Proportion of positive samples 
b) Excluding subjects employed in the production function ‘curing’ 
c) Excluding subjects employed in the production function ‘mixing’ 
d) Exact p-value for trend (Cochran-Armitage test for trend) for percentage of positive samples 
Overall, production functions ‘mixing’ and ‘curing’ (i.e. occupational exposure) seemed to
be more important than NAT2 phenotype. Stratified analysis within the production
function ‘curing’ revealed a moderate, but non-significant correlation between dermal
CSM exposure and adducts 1 and 3 (r=0.45;p=0.09 and r=0.42;p=0.11). In contrast, for
adduct 2 a moderate, but again non-significant correlation with inhalable CSM exposure
was noted (r=0.43;p=0.11). Unfortunately, the number of subjects employed within the
production function, ‘mixing’, were too small to explore possible relationships between
quantitative external occupational exposure estimates and the detected DNA adducts.
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Discussion
Excess risk of cancer of the urinary bladder in the rubber industry has been reported
since the 1950’s with SMR’s ranging from 250 to 2000 in studies published until 1965 2; 194.
The majority of the excess of urinary bladder cancer appeared attributable to antioxi-
dants that contained a contamination of free naphthylamines, including
β-naphthylamine, a known bladder carcinogen. These antioxidants were removed from
the manufacturing process around 1950 2. However, several more recent epidemiological
studies among workers with no recorded exposure to β-naphthylamine found a moderate
excess risk of urinary bladder cancer with SMR’s ranging from 159 to 214 8; 9. These
results placed in doubt the exclusive link between β-naphthylamine exposure and
urinary bladder cancer in the rubber manufacturing industry.
We studied urothelial carcinogen-DNA adducts levels in a population of non-smoking
occupationally exposed rubber workers. Subjects were selected from a large cross-
industry survey based on ambient mutagenic total suspended particulate matter and
mutagenic surface contamination and history of non-smoking. The rationale for this
selection was to increase contrast in both inhalable and dermal mutagenic exposure
conditions, to evaluate specific exposure routes. In addition, the exposure group with
low TSPM mutagenicity and low surface mutagenic exposure levels was intended to be
used as an internal comparison group. Usually, an internal control group is desirable as
long as there is a wide range of clearly identifiable exposures of interest within a work
place, since selection bias and confounding are likely to be less of a problem than could
be encountered when using an external comparison group 83. However, external
mutagenicity turned out not to be related to the observed DNA adducts. Therefore, the
a-priori grouping scheme based on total dose measures and the internal comparison
group were probably of limited value.
Four DNA adducts (adduct 1,2,3 and 11) were detected with prevalence rates of 79%,
25%, 56% and 3.8%, respectively. Relative adduct labeling levels were, however, low. As
adduct 1 and 3 and adduct 2 and 11 were moderately correlated, the correlated adducts
might reflect metabolites of the same compound or of compounds of similar exposure
paths. Identified DNA adducts were not associated with the a-priori defined exposure
groups or quantitative personal exposure estimates except for a significant correlation
between inhalable CSM exposure and adduct 3, which probably can be attributed to
chance. Only stratification by production function showed statistically significant
different RAL levels and proportion of positive samples, with the production functions
‘mixing’ and ‘curing’ showing the highest DNA adduct levels. This trend was most
pronounced for adducts 2, 3 and 11. The relationship between mixing and curing and
adduct 1 was less clear and it can be argued that this particular DNA adduct might not
be occupationally related although it was significantly correlated with adduct 3. The
high prevalence of adduct 2 and 3 (25 and 56%, respectively) and the observation that
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the adducts were found for all production functions suggested that the responsible
exposures may be common and widespread in the rubber manufacturing industry, but
occur more frequently and at higher levels in the mixing and curing departments.
Occupational exposure to chemical compounds in the rubber manufacturing industry
essentially arises by handling of bulk raw materials and chemical additives and due to
the generation of rubber fumes and gases because of high process temperatures during
activities like curing. Highest exposure levels to specific chemicals are likely to occur in
the mixing department where most handling, weighing and mixing of raw materials
takes place and the curing department where the highest process temperatures are
reached (e.g. generation of rubber fumes and gases). Indeed, significant higher inhalable
dust levels were detected in the mixing department and for curing significant higher
inhalable CSM exposure concentrations were observed. However, these exposure measures
are non-specific and do not necessarily reflect variability in chemical-specific exposure
levels. When these non-specific exposure measures are used across production functions
and companies, misclassification due to differences in chemical composition of the
complex mixture will obscure relations with DNA adducts. The numbers of workers in a
production function in a company were too small to study the relation between external
exposure measures and the observed DNA adducts for each department separately.
Stratified analysis for the production function curing (across 7 companies) revealed
nevertheless a moderate, but non-significant correlation between dermal CSM exposure
and adducts 1 and 3 and likewise for adduct 2 with inhalable CSM exposure.
As no real unexposed control group was present in this study and no strong
unambiguous associations were found with occupational exposure estimates, the
observed increase in DNA adduct levels for the production functions ‘mixing’ and ‘curing’
have to be interpreted with caution. Although exposure to non-occupational
(concomitant) genotoxic compounds cannot be ruled out it seems unlikely that these
would have resulted in the consistent DNA adduct patterns observed for the several
production functions, particularly in a group of non-smokers. Interestingly, the observed
differences in DNA adduct levels by production functions were comparable to the
distribution of the urinary bladder cancer risk in the past. Urinary bladder cancer risk
was then observed in various work areas but mostly in the compounding and mixing
department 3; 195, which might suggest that the observed DNA adducts in this study are
related to exposure to one or more raw rubber chemicals or unknown contaminants.
Observed DNA adducts levels tended to be moderately increased for subjects with a fast
N-acetylation phenotype. In a previous study we showed that both Sunday and weekday
urinary mutagenicity levels were related to both dermal and inhalable exposure
conditions. Furthermore, subjects with skin aberrations such as minor dermatitis and
skin injuries like cuts and burns revealed higher levels of urinary mutagenicity,
substantiating the importance of the dermal exposure route in this industry. Adduct
levels were not correlated with urinary mutagenicity, but these two biomarkers integrate
exposure over different periods; urinary mutagenicity being more responsive to daily
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exposure variations and adduct levels integrating exposure over urothelial cell lifespan.
In addition, levels of mutagens in urine were modulated by NAT2-dependent enzyme
activity differently than were adduct levels, with slow acetylators having higher levels of
mutagens in their urine 196. The different modulation by N-acetylation activity and
absence of a relationship between urinary mutagenicity and urothelial cell DNA adducts
suggest that urinary mutagenicity may be due to, at least for a significant part, by
different compounds or metabolites than the bulky DNA adducts detected with the
32P-postlabeling method.
Fast-acetylation was marginally associated with an increased risk of urinary bladder
cancer in workers exposed only to benzidine 197. N-acetylation is normally considered as
a detoxification step in arylamine biotransformation. However, benzidine is an aryldiamine
and N-acetylation is required to produce the active N-hydroxy, N’-acetylbenzidine
metabolite 198; 199. Although, the participating rubber companies did not use benzidine,
several other aryldiamines were widely used as antidegradants like for example, several
derivates of p-phenylenediamine. These aryldiamines are generally considered to be non-
mutagenic which could explain the discrepancy between urinary mutagenicity and
observed DNA adduct levels 159.
In conclusion, this study showed low, but significantly increased levels of urothelial DNA
adducts in certain groups of rubber workers. The study was too small to explore in depth
possible relationships between external occupational exposure estimates and detected
DNA-adducts within the identified high risk production functions ‘mixing’ and ‘curing’.
The potential ambiguous role of N-acetylation activity in relation to urinary
mutagenicity and urothelial DNA adduct levels needs more clarification, however. Larger
studies among rubber workers employed in these production functions with inclusion of
an unexposed control group should be conducted to study in more detail the potential
carcinogenicity of the exposures encountered in these work areas.
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Chapter 5
General discussion
In this chapter the main findings of this thesis are
evaluated and methodological problems interfering with
the interpretation of the results are considered. Finally,
implications of the presented results for the rubber
manufacturing industry and future (epidemiological)
research are addressed.
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General discussion
Introduction
The main objective of this study was to investigate the relevance of the dermal exposure
route for genotoxic exposure and biological effects among rubber manufacturing
workers. To this end, an industry-wide exposure survey comprising 225 subjects from 9
different rubber manufacturing companies was initiated.
Workers in the rubber manufacturing industry are exposed to a complex mixture of
chemical compounds. The chemical complexity and unknown toxic properties of these
exposures precludes selection and detailed chemical analysis of individual genotoxic
components. A stepwise approach for the assessment of the potential carcinogenic risk of
complex mixtures was used as an outline for this study 20. In this approach non-chemical
specific exposure estimates are used to characterize the exposure conditions. Four tiers
were discerned in this study. In the first tier, personal exposure to inhalable particulates,
inhalable cyclohexane soluble matter (CSM) and dermal CSM contamination was
investigated. In the second tier, mutagenicity of ambient exposure measurements was
used to estimate the genotoxic exposures encountered in the rubber manufacturing
industry. The first two tiers were used to characterize the pattern and level of external
exposure to the complex mixture. In the third tier, urinary mutagenicity was assessed to
estimate the internal genotoxic dose. In the fourth and last tier DNA adduct levels in
exfoliated urothelial bladder cells were studied as an early biological effect marker.
Based on the results obtained in the third and fourth tier the relevance of the dermal
exposure route was assessed.
In this chapter key findings of the study are critically discussed and will encompass
choice of study design, selection of the study population and exposure assessment
methods, which may have influenced the results of this study. Implications and
recommendations for the rubber manufacturing industry and future epidemiological
research are presented in the last part of this chapter.
Choice of study design
Selection of companies and production functions
For the purpose of this study, an industry wide exposure survey in 9 different rubber
manufacturing companies was initiated. The selected companies formed a representative
cross-section of the rubber manufacturing industry in The Netherlands (3 rubber tire, 5
general rubber goods and 1 retreading company) (For an overview see Table 2.2-1). All
production functions (basic manufacturing operations), which can be distinguished in
any rubber company, were included in the survey. These production functions were
Genotoxic exposure and biological effects in the rubber manufactoring industry
126
Compounding and mixing, Moulding, Pre-treating, Curing, Finishing, Engineering service,
Laboratory and Shipping. The inclusion of different rubber companies and all eight
production functions enabled a complete overview of all production processes and
related exposures that could be encountered in the present-day rubber manufacturing
industry in the industrialized world.
Selection of the study population
In total 1,355 workers were employed in the selected companies at time of the survey,
which comprised about 35% of the workers directly involved in the production process
in the rubber manufacturing industry in The Netherlands in 1997. A random sample of
the total workforce was selected (n=224), stratified by production function. For these
subjects personal exposure to inhalable particulates, inhalable CSM and dermal CSM
exposure was assessed. As only 15% of the total worker population in these companies
participated in the survey there is a potential for selection bias. Although it cannot be
ruled out, there were no indications during the fieldwork that this has occurred.
Furthermore, for most small and medium-sized companies (n=5), a significant part of the
workforce (>35%) was included in the survey, which will have limited the possibility of
selection bias.
Based on the measured ambient mutagenic exposure conditions a-priori defined exposure
groups were constructed and a selection of urine samples of smoking and non-smoking
rubber workers (n=116) was analyzed for urinary mutagens. The rationale for this
selection was to increase contrast in both inhalation and dermal mutagenic exposures in
order to facilitate the disentangling of the inhalation and dermal exposure route. In
addition, the exposure group with low total suspended particulate matter (TSPM)
mutagenicity and low surface mutagenic exposure levels was intended to be used as an
internal comparison group. The validity of the a-priori defined exposure groups and
subsequently the selection of subjects will be discussed later. Of the 116 subjects who
were selected in the third tier, 24h-urine samples of 60 non-smokers were selected in the
fourth tier to study the possible presence of DNA adducts in exfoliated urothelial bladder
cells. Non-smoking rubber workers were selected as main stream tobacco smoke exposure
has been shown to induce DNA adducts in exfoliated bladder cells which migrate along
the diagonal radioactive zone on the thin-layer chromatography (TLC) plates 200. This
strong diagonal zone of DNA adducts (background) would have made the identification
of the relatively low levels of DNA adducts expected in this study extremely difficult. By
a-priori exclusion of smokers a synergistic or additional effect of cigarette smoking on
detected DNA adduct levels could not be investigated. However, in the literature no
synergistic effects of smoking and occupational exposures on adduct formation in
lymphocytes or exfoliated bladder cells have been described. Synergistic effects of
smoking and occupational exposure on urinary mutagenicity, however, has been
observed for several exposures 155; 201 and in several industries 202; 203 among which the
rubber industry 17; 159. A synergistic effect of smoking and occupational exposure on
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urinary mutagenicity might be due to induction of enzymes involved in the mutagenic
bioactivation or due to oral absorption of mutagens by a finger-shunt effect 155. The
results of our study, however, did not show any synergistic effect of smoking on the
observed urinary mutagenicity levels. Adjustment of urinary mutagenicity for tobacco
smoke intake based on urinary cotinine levels may, however, have controlled for the
effect of induced enzyme systems and oral absorption of mutagenic compounds, masking
a possible synergistic effect.
Exposure assessment methods
Selection of appropriate biomarker(s), as an index of exposure to carcinogens is difficult
as complex mixtures frequently contain more than one carcinogen and in addition the
concentration of the marker in the mixture often varies within workplaces and time. In
most instances, the exact individual components of the complex mixture are unknown.
In such exposure situations non-specific exposure parameters have to be used, which
give an estimate of the integrated carcinogenic potency of the exposure. In this study
the Salmonella microsome assay for detection of mutagens 204 and the 32P-postlabeling
method for detection of DNA adducts 205 were used. These markers integrate exposure to
a variety of genotoxic agents into a single measurement.
Genotoxic exposures
Many carcinogens are genotoxic and mutations are likely to be involved in the initiation
of carcinogenesis. Epigenetic carcinogens, which raise the incidence of cancer by action
through non-genotoxic mechanisms on cell populations, which have been previously
exposed to initiating doses of other carcinogens were outside the scope of this
investigation. Mutagenic activity was assessed with the Ames Salmonella microsome assay
204. Although various limitations might be encountered in detecting mutagens with the
Ames assay it is generally considered a valuable tool in testing the genotoxic potency of
complex mixtures 132. Such limitations include interaction of extraction solvents with
test compounds 206, toxicity of substances to bacteria and liver homogenates,
competition of indirect mutagens for enzyme sites and inadequacy of the activation
system to reflect the in-vivo situation 207; 208. Despite these shortcomings, a high
correlation between mutagenicity and carcinogenicity within chemical groups such as
aromatic amines and polycyclic aromatic hydrocarbons (PAH) has been observed 209.
These chemical groups are also of main interest in the rubber manufacturing industry 8; 14; 15
and therefore the S. typhimurium mutagenicity test was deemed appropriate for the
evaluation of genotoxic exposures in this industry.
Predominantly, low levels of mutagenic activity in rubber dust and fume samples were
detected with S. typhimurium TA98 in the pilot study (Section 4.2). Use of more
sensitive derivatives of TA98 revealed a high mutagenic activity in S. typhimurium strain
YG1024, which has elevated levels of O-acetyltransferase activity while no mutagenic
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activity could be detected in S. typhimurium strain YG1021, which has elevated levels of
nitroreductase activity. These results were indicative for the presence of mutagenic
aromatic amines in rubber dust and fume samples. However, as this observation was
based on samples originating from the mixing and curing department of only one rubber
tire company use of YG1024 throughout the study could have resulted in biased results
towards aromatic amines. Therefore, S. typhimurium strain YG1041, which has elevated
levels of both enzymes was used as screening strain in this study.
Biological effects
Chemical carcinogens or their metabolites can interact with macromolecules such as DNA,
forming adducts 210. Unless repaired, such DNA lesions may result in mutations at critical
genomic sites during DNA replication, ultimately leading to cancer through the
multistage process of carcinogenesis. Measurement of DNA adducts formed from a
genotoxic agent is a measure of its initiating potential. The used 32P-postlabeling assay
has been shown to be a very sensitive method to detect DNA adducts induced by
structurally diverse carcinogens, particularly bulky aromatics 211.
As described above the two non-selective methods that were used in this study, are able
to detect a wide range of genotoxic compounds. However, both methods are less suitable
for measuring the genotoxicity of N-nitrosamines 212; 213, which have been shown to be
generated during and after curing of rubber products 214. Estimates of genotoxic
exposure and biological effects in this study have therefore limited significance for the
possible genotoxic risk exerted by volatile N-nitrosamines in the rubber industry.
Exposure grouping
In the third tier of the study 116 subjects were selected based on ambient mutagenic
TSPM and mutagenic surface contamination and smoking habits. The rationale for this
selection was to increase contrast in both inhalation and dermal mutagenic exposure in
order to facilitate the disentangling of the inhalation and dermal exposure route. In
addition, the exposure group with low TSPM mutagenicity and low surface mutagenic
exposure levels was intended to be used as an internal comparison group. Usually, it is
desirable to select internal comparison groups because comparisons of exposed to non-
exposed workers tend to be less influenced by selection bias and confounding than when
an external comparison group is used 83.
The three a-priori defined exposure groups exhibited a significant difference in TSPM
mutagenicity and mutagenic surface contamination (Table 4.4-1). The highest exposed
subjects also revealed the largest increase in urinary mutagenicity during the working
week, which was attributed to the mutagenic surface contamination levels (Figure 4.4-1).
No relation was found between TSPM mutagenicity and urinary mutagenicity. However,
further statistical analyses revealed a significant relation between urinary mutagenicity
and both ambient and personal inhalable particulate mass. This suggested substantial
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particle bound mutagenic activity that was not detected in extracts of TSPM samples on
which the a-priori exposure categorization was based. Therefore, the a-priori defined
exposure groups might have had limited value with regard to airborne mutagenic
exposure conditions.
Frequency and timing of sampling
Knowledge of toxicokinetics is important for determining the frequency and timing of
biological sampling, and for selection of fluids most appropriate for study 215. Due to the
unknown chemical composition of the exposure, the toxicokinetics involved were
unknown. Therefore spot urine samples collected at the end of the workshift on
Wednesday and Thursday were pooled in order to collect a sample that would reflect
occupational exposures with a range of half-lives. As a consequence ambient external
exposure samples were pooled before analyses and personal exposure estimates were
averaged to derive mean exposure estimates, which were intended to be used to explain
the change in urinary mutagenicity during the working week relative to Sunday. In this
study design, subjects function as their own reference without the need to control for
factors like smoking and dietary habits. Underlying assumption in this approach is that
behavioral patterns with regard to these confounding factors are similar during the
weekend and weekdays. This was shown not to be the case for main stream and
environmental tobacco smoke intake, which was clearly higher during the weekend than
during the working week (Figure 4.1-1). Therefore, urinary mutagenicity levels were
corrected for tobacco smoke intake based on urinary cotinine concentrations. After this
correction, urinary mutagenicity levels were comparable between smokers and non-
smokers and an almost similar increase in urinary mutagenicity of respectively 39% and
34% was observed for smokers and non-smokers respectively in relation to occupational
genotoxic exposures (Table 4.1-3).
Dermal exposure
Dermal exposure was assessed with a single pad sampler on the hand of preference. In a
small study we showed that the use of more pad samplers on different areas of the body
would not have resulted in another exposure classification than based on the one pad
sampler on the hand of preference (Table 3.2-4). However, if significant differences in
permeability of the skin exist between anatomical regions then CSM contamination at the
lower wrist does not necessarily reflect total dermal uptake 125. Surrogate skin
techniques (e.g. placing a chemical collection medium against the skin supposedly
mimicking the properties of the skin) like a pad sampler measures potential dermal
exposure, which is by definition an overestimation of the actual dermal uptake 102; 113.
Use of other dermal exposure techniques (e.g. hand washing) or surrogate skin
techniques with a larger surface area (e.g. gloves) would, however, have interfered with
the dermal absorption of skin contaminants making simultaneous unbiased assessment of
the internal dose impossible.
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Evaluation of main findings
Genotoxic exposures
The presence of genotoxic compounds in the air and on possible contact surfaces, like
machines and rubber products, which a worker would most likely touch during normal
work practice, was demonstrated by the detection of substantial mutagenic activity in
TSPM and in surface wipe samples (Section 4.3). Also, elevated levels of mutagens were
detected in urine samples of rubber workers (Section 4.4). These elevated levels of
urinary mutagenicity were related to the mutagenicity found on contaminated surfaces
and to the airborne particulate mass. No relation was found between TSPM mutagenicity
and urinary mutagenicity.
The mutagenic potency of the TSPM, surface wipe and urine samples are difficult to
compare with those found in other studies because no other published study in the
rubber industry used the Salmonella strain YG1041. In section 4.2 it was estimated that
the strain YG1041 was about 5 to 30 times more sensitive in the detection of mutagenic
activity in the collected TSPM samples than the conventional strain TA98. However, this
observation was based on only 2 samples in which mutagenic activity could be detected
with TA98. As these samples originated from only one production function of one
company, the derived estimates of increased sensitivity have limited validity for other
companies and other production functions. Hagiwara et al. 143 have shown that the
increase in sensitivity of the YG1041 strain could vary from 1 to 1700 times for various
mutagenic chemicals relative to TA98.
Biological effects
Four specific DNA adducts were identified in exfoliated urothelial bladder cells among
non-smoking rubber manufacturing workers. The identified DNA adducts were prevalent
and were observed in workers from all production functions but predominantly in
workers in the production functions ‘mixing’ and ‘curing’. No relations were observed
between inhalable particulate, dermal CSM exposure, ambient- and urinary mutagenicity
and the identified DNA adducts. Because no relations were found, it can be argued that
genotoxic exposures through other exposure routes (e.g. gaseous phase or oral route)
may have contributed to the identified DNA adducts. Yet, inhalable particulate, dermal
CSM exposure and ambient and urinary mutagenicity are all non-chemical specific
exposure estimates. Although the 32P-postlabeling method as such is non-selective, the
detected DNA adducts are in principle an addition product of a single agent and thus
chemical specific. The absence of a relation between the non-chemical specific exposure
estimates and DNA adducts might therefore not be surprising. However, as no really
unexposed control group was included in the survey and no dose-response relationship
was found between one or more exposure estimates and DNA adducts, it cannot be
excluded that the observed DNA adducts are non-occupationally related. However, as this
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is the first study to show DNA adducts in bladder cells of rubber workers, the results are
not without significance. The DNA adducts were present at the highest levels in the
mixing and curing departments suggesting that workers in these areas may be currently
exposed to bladder carcinogens.
Studies in other occupational settings have shown that adducts are quantitatively related
to genotoxic exposures. These studies were performed in occupational settings with
known unique chemical exposures and previously identified DNA adducts, mostly PAH
related 216. However, even in these situations correlations between exposure estimates
and DNA adducts are often weak 217. Only, among benzidine exposed workers in India a
significant correlation (r=0.59) between urinary mutagenicity and urothelial DNA
adducts has been found 24. However, these workers had extensive dermal and respiratory
contact with excessive amounts of benzidine or benzidine-dyes. Therefore, the majority
of urinary mutagens were benzidine related, which was demonstrated by the high
correlation between benzidine metabolites and urinary mutagenicity (r=0.88). Genotoxic
exposure levels in the rubber manufacturing industry are much lower and most likely
due to their complex nature less dominated by a single compound. The absence of a
relation between urinary mutagenicity and DNA adducts in exfoliated bladder cells might
therefore not be surprising.
Relevance of the dermal route
The relevance of the dermal route for genotoxic exposure and biological effects among
rubber manufacturing workers was estimated based on the relations found between
inhalation and dermal exposure route estimates and the two end-points urinary
mutagenicity and DNA adducts.
As no relations were observed between inhalable particulate, dermal CSM exposure and
ambient mutagenicity levels on the one hand and the four identified DNA adducts on the
other the relevance of the dermal exposure route for the observed biological effect could
not be deduced. Although, animal experiments have shown that topical application of
used gasoline engine oils containing PAH related carcinogens could lead to the formation
of DNA adducts in critical internal organs 218; 219.
Mutagen levels in urine of rubber workers were clearly associated with mutagenicity of
contaminated surfaces and the mass of airborne particulate exposure levels. The two
exposure estimates were not interrelated (r= -0.13; p=0.21) and therefore evidently
reflect different exposure routes. Estimation of the contribution of the two exposure
routes showed that mutagenicity of contaminated surfaces contributed more to the
observed urinary mutagenicity levels than the mass of the airborne particulate exposure
levels, approximately by a factor of three. The importance of the dermal exposure route
was underlined by the observation that subjects with an impaired skin barrier function
revealed almost two times higher levels of urinary mutagens than subjects with an intact
skin. Prevalence rates of these unfavorable skin conditions were high in this population
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with 44% of the subjects diagnosed with major or minor hand dermatitis and/or trau-
mata of the skin at time of the survey. Increase in urinary mutagenicity due to an
impaired skin is therefore relevant for a large group of rubber workers.
The relation between urinary mutagenicity and contaminated surfaces is remarkable, as
this exposure measure is a very indirect measure for dermal exposure. Actual personally
measured dermal CSM exposure levels on the other hand did not reveal a significant
association with urinary mutagenicity. The existence of mutagenic compounds on
surfaces is probably more discriminatory than personally measured dermal CSM exposure
in relation to urinary mutagenicity. Furthermore, due to the high day-to-day variability
in personally measured dermal CSM exposure the dermal CSM exposure estimates might
have led to attenuation of the exposure-response relation.
Already in the early eighties dermal absorption of genotoxic compounds in this
particular industry was suggested by Falck et al. 17, Kilpikari et al. 18 and a few years
later by Bos et al. 19. In section 3.1 it was shown that personal dermal exposure levels
have dropped in the same rate as the personal inhalable particulate exposure levels over
the last decade (approximately 6-7% per year). Therefore, the suggestion that because of
declining airborne exposure levels, the dermal exposure route is becoming increasingly
more important 102; 103 does not hold true for the 7 longitudinally studied rubber
manufacturing companies in this survey. As this is the only longitudinal dermal exposure
survey to date, it is unknown whether this observation is relevant for other companies or
industries as well. However, reducing the overall environmental contamination by
control or elimination of the source of the contaminant is likely to result in a decrease
in exposure through inhalation and dermal uptake 109; 220. Although the downward trend
in inhalable particulate and dermal contamination was similar, inhalable particulate and
dermal CSM exposure levels were only moderately correlated (r=0.22; p<0.001) (Section 3.2).
The low correlation between the inhalation and dermal exposure estimates has also large
implications for previously conducted epidemiological research, which has focussed
primarily on the inhalation route. Estimates of exposure through inhalation do not
necessarily reflect the dermal exposure route, which could result in potentially severe
misclassification of total exposure.
Influence of biotransformation polymorphisms
The observed levels of urinary mutagenicity and DNA adducts were both moderately
modulated by NAT2-dependent enzyme activity. Slow acetylators revealed significantly
higher levels of urinary mutagenicity, but in contrast borderline significantly lower
levels of DNA adducts. The possible different modulation by N-acetylation activity and
absence of a relationship between urinary mutagenicity and urothelial DNA adducts
suggest that urinary mutagenicity was caused, at least for a significant part, by different
chemical compounds or metabolites than the identified DNA adducts. Increased levels of
urinary mutagenicity among slow-acetylators has been observed in several studies among
workers exposed to aromatic amines 32; 33; 186. The existence of mutagenic aromatic amine
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exposure in the rubber manufacturing industry was also suggested in section 4.2 as
mutagenic activity was exclusively observed in S. typhimurium strains with elevated
levels of O-acetyltransferase activity (strain YG1041 and YG1024), which are highly
sensitive to mutagenic aromatic amines 143. Fast-acetylators revealed higher levels of DNA
adducts in exfoliated urothelial bladder cells. So far increased levels of DNA adducts have
been predominantly associated with slow-acetylation status 34-37, which in turn has been
shown to be associated with an increased risk of urinary bladder cancer 38. However, for
exposure to some specific chemicals exceptions to this observation exist. For example,
for workers exposed to benzidine fast-acetylation status has been shown to be associated
with an increased risk of urinary bladder cancer 197. Benzidine is a biphenyldiamine and
although benzidine exposure in this industry can be excluded, several other aryldiamines
are widely used as antidegradants in the rubber manufacturing industry like for example,
several derivatives of p-phenylenediamines.
Conclusions and recommendations
Based on the results described in this thesis it was concluded that workers in the rubber
manufacturing industry in The Netherlands are currently exposed to genotoxic
compounds and that the dermal exposure route is of major importance for the uptake of
these compounds. Whether this holds true for DNA adduct formation in the urinary
bladder remains unclear. Exposure to arylamines is being suggested as of particular
importance in this industry. Implications and recommendations based on the obtained
results for the rubber manufacturing industry and future epidemiological research are
described below.
The rubber manufacturing industry
Since 1982 the rubber industry has been listed by IARC as ‘an exposure circumstance that
entails exposures that are carcinogenic to humans’ 7. After this date, workplace
improvements have been implemented to improve the working circumstances in the
rubber industry. These improvements have resulted in a significant decrease in both the
inhalable particulate 74; 156 and dermal CSM exposure levels over the last decades 74.
Whether the observed decline in exposure levels has also reduced the observed cancer
risk in this particular industry is unknown. Nevertheless, because genotoxic compounds
and biological effects are still being detected in the present-day rubber manufacturing
industry 14; 168; 171; 196 additional reductions in exposure levels are a necessity to limit the
potential cancer risks in the rubber industry. When reducing external exposure levels
special attention must be given to the dermal exposure route as this route has been
shown of particular importance, especially for workers with an impaired skin. The
prevalence rate of an impaired skin barrier function as a result of major or minor
dermatitis and/or skin injuries are high in this population, 7%, 28% and 17%,
respectively. The most frequent occurring skin problem ‘minor dermatitis’ was found to
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be strongly associated with moderate and frequent hand washing especially with indus-
trial surfactants containing scrubbing particles. The awareness of skin problems and the
importance of the dermal exposure route has to be disseminated also to the rubber
workers, as it was shown that skin problems were often not recognized by the workers as
an adverse health effect (Section 2.1). Furthermore, sensible hand washing practices have
to be introduced, which minimize irritant and mechanical insults to the skin but still
can be frequently used to minimize the residence time of the genotoxic contamination
on the skin.
Future research
Epidemiological research in the rubber manufacturing industry has always been ham-
pered by the absence of detailed exposure assessment 8. In only two case-control studies
and in two cohort studies exposure measures other than job categories or work areas
were used 195; 221-223. In a case-control study of lymphatic and haematopoietic cancers
seventy job groupings were categorized independently by industrial hygienists as to
estimated solvent exposure 222. Exposure to polycyclic hydrocarbons, N-nitrosamines,
carbon black and talc were independently categorized for the individual jobs in a case
control study of stomach cancer 221. In a cancer mortality study in the British rubber
industry occupational exposure was estimated by the cumulative duration of employment
in jobs associated principally with exposure to either dust, fumes and/or solvents 195. In
a recent cohort study among German rubber workers crude semi-quantitative exposure
estimates for N-nitrosamines were used to study the relationship between this exposure
and cancer mortality 223. Still, none of these exposure estimates used in these studies
were based on actual quantitative measurement data.
The study presented in this thesis identified elevated exposure to mutagenic compounds
and elevated levels of DNA adducts in the present-day rubber industry. Indicators of the
variability in these exposure estimates between companies and production functions
were derived. However, exposure assessment in the rubber industry would benefit most if
specific chemicals or groups of chemicals, which are related to the observed cancer risks
would be identified. The selective response in the used S. typhimurium strains and the
NAT2 modulation of urinary mutagenicity and DNA-adducts pointed at the possible
importance of arylamine exposure in the present-day rubber industry. Future
toxicological and occupational hygiene research should therefore focus on the further
chemical identification of the mutagenic compounds and observed DNA adducts.
Subsequently, these specific chemical exposures will have to be measured and their
exposure affecting factors assessed. Based on the occurrence of these identified factors
historical exposure estimates could be derived and incorporated in new epidemiological
research. These estimates should comprise both the inhalation and dermal exposure
route. In addition, inclusion of skin quality and biotransformation polymorphisms like
NAT2 status is of particular importance.
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The recently observed cancer risks in the rubber industry are moderate to low 8. As both
the inhalation and dermal exposure levels have decreased significantly in the last decade,
the observed cancer risks probably have, at least to a certain extent, as well. Therefore
new epidemiological studies should preferably rely on cancer incidence rather than on
mortality statistics to increase the number of cases and therefore the statistical power of
the study. Two prospective cohort studies among rubber workers have recently been
initiated in the United Kingdom 187 and Germany 224. These studies are an excellent
opportunity to incorporate more biologically relevant exposure measures and genetic
susceptibility markers to determine the role of specific exposures and polymorphisms in
the aetiology of cancer in this industry.
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Summary
Epidemiological studies among workers employed in the rubber manufacturing industry
have indicated a significant excess cancer risk in a variety of sites. Although, several
associations between exposures and observed cancer risks have been hypothesized, it has
in general not been possible to identify specific agents for the majority of observed
cancer risks. In several studies, however, the importance of the dermal route has been
advocated. The main objective of the study described in this thesis was to investigate the
relevance of the dermal exposure route for genotoxic exposure and biological effects
among rubber manufacturing workers. To this end, an industry-wide exposure survey
comprising 225 subjects from 9 different rubber manufacturing companies was initiated.
Workers in the rubber manufacturing industry are exposed to a complex mixture of
chemical compounds. In chapter 1, basic concepts in the evaluation of exposure to
complex mixtures of potentially carcinogenic chemicals are introduced. As the chemical
composition and toxic properties of the complex mixture in the rubber industry is
largely unknown non-specific exposure estimates were used in this survey. In the
evaluation of potentially carcinogenic chemicals these estimates are usually derived from
techniques that make use of the notion that one step in carcinogenesis is damage to or
mutation in DNA.
The study described in this thesis can be divided according to the three major research
questions formulated in chapter 1. Namely:
♦ to evaluate current inhalable particulate and dermal exposure levels in the rubber
manufacturing industry in The Netherlands (Sections 3.1 & 3.2);
♦ to characterize external mutagenic exposure conditions in the rubber
manufacturing industry in The Netherlands (Sections 4.2 & 4.3);
♦ to study the relation between inhalable particulate matter, dermal exposure levels,
urinary mutagenicity and DNA adducts in exfoliated urothelial bladder cells
(Sections 4.4 & 4.5).
Based on these research questions the relevance of the dermal exposure route for
genotoxic exposure and biological effects was eventually estimated. As a decrease in the
barrier function of the skin could lead to an increase in dermal uptake, adverse skin
conditions and possible workplace related and personal factors were studied as well. In
Section 2.1, we evaluated the applicability of a previously validated symptom-based
questionnaire on hand dermatitis. The assessment of skin complaints based on the
questionnaire was compared to a medical evaluation performed by a dermatologist. The 2
different diagnostic tools used for assessing hand dermatitis resulted in dissimilar
estimates of the prevalence of active dermatitis, ranging from 6.9% to 38.1% of all
workers (n=202). Using the medical evaluation as ‘gold standard’ we observed a moderate
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sensitivity (71.4%) and specificity (76.1%), for the classification based on the self-
administered questionnaire. Based on these results it was concluded that the use of a
symptom-based questionnaire to assess skin complaints in a population of rubber
workers was questionable. As a consequence, only the diagnosis of skin complaints made
by the dermatologist was used in subsequent analyses. Prevalence of ‘major’ hand
dermatitis (7%) among rubber workers was comparable with that in the general
population, ‘minor’ signs of dermatitis, however, were more common among the surveyed
population (28%) as were traumata’s of the skin (17%) (Section 2.2). Dermal exposure to
cyclohexane soluble matter (CSM) during work was related to the occurrence of ‘major’
hand dermatitis, but not to the occurrence of ‘minor’ hand dermatitis. Moderate and
frequent hand washing especially with industrial surfactants containing scrubbing
particles were found to be strongly associated with the occurrence of ‘minor’ dermatitis
(OR=4.27; 95% C.I. 0.90 – 20.27 and OR=6.38; 95% C.I. 1.33 – 30.17, respectively).
Seven out of the nine companies, involved in the present study were previously surveyed
in 1988. In both surveys sampling and analytical methodologies were kept identical
which enabled the identification of exposure trends in both inhalable and dermal
exposures (Section 3.1). In addition, changes in working organization and control
measures taken after 1988 were identified and their effectiveness in reducing personal
exposure levels were evaluated. Comparison of the exposure levels between 1988 and
1997 revealed a reduction rate of 5.7% and 6.7% per year for inhalable particulate and
dermal exposure, respectively. Companies and production functions with the highest
exposure levels in 1988 and workers with seniority (more experience) showed a steeper
decline in exposure levels. Fifty-seven control measures, mostly designed to control the
levels of inhalable exposure were identified. Using this information 80% of the historical
decline in mean inhalable dust concentrations was explained. For dermal exposure, only
30% of the decline was explained by these factors. Elimination of the source was proven
to be the most effective control measure for both inhalation and dermal exposures,
reducing them by 67% and 66%, respectively. Control measures designed to control the
levels of contaminants were somewhat less effective, but still were associated with
statistically significant exposure reductions of 34% and 49%, respectively. Surprisingly,
measures aimed at reduction of emission did not appear to contribute in general to a
decrease in exposure levels. The results indicated that efforts taken to improve work
conditions in the rubber manufacturing industry in The Netherlands between 1988 and
1997 had successfully reduced both inhalable particulate and dermal contamination.
In section 3.2, we applied a conceptual model for dermal exposure (see appendix) to
identify compartments and mass transport processes relevant for dermal exposure in the
rubber manufacturing industry. Identification of the spatial distribution of the dermal
contamination among ten rubber workers showed high CSM surface concentrations for
the upper body. Moreover, because of the high correlation between dermal exposure at
the wrist and calculated total body exposure (r=0.89, p<0.01) an exposure assessment
strategy based on only one pad sampler was subsequently employed to estimate CSM
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surface concentrations in the skin contaminant layer of the total population of rubber
workers. Qualitative and quantitative evaluation of the relevant compartments and
related mass transport processes demonstrated the importance of deposition of air-
borne contaminants and direct transfer of contaminants from sources and surfaces to
the skin contaminant layer. Interestingly, the importance of the different exposure
pathways varied considerably between production functions.
Lifestyle factors such as smoking have been shown to influence urinary mutagenicity.
Therefore, these factors have to be carefully considered when evaluating occupational
genotoxic exposures. In section 4.1, we investigated day-to-day variability in active
and passive tobacco smoke intake by studying urinary cotinine levels and determined
their influence on observed urinary mutagenicity. Urinary cotinine was assessed for a
sub-population of smoking and non-smoking rubber workers (n=105) on Sunday,
Wednesday and Thursday. A sharp decrease in urinary cotinine concentration was
observed during the week compared to Sunday for smokers (39%, p<0.01) and non-
smokers (23%). Regression-coefficients for urinary cotinine and urinary mutagenicity,
measured by the S. typhimurium strain YG1041 with metabolic activation, were similar
for the Sunday and pooled weekday urine samples (Wed. and Thurs.). The derived
estimates were subsequently used to adjust urinary mutagenicity for tobacco smoke
intake. Cotinine adjusted urinary mutagenicity levels were comparable between
smokers and non-smokers and a similar increase in urinary mutagenicity of
respectively 39% and 34% was observed for both smokers and non-smokers due to
occupational mutagenic exposures or other changes in lifestyle factors. The results
indicated that adequate adjustment for daily tobacco smoke exposure is a necessity
when using the urinary mutagenicity assay to evaluate possible mutagenic exposures in
the workplace.
In section 4.2 mutagenic activity of ambient rubber dust and fume exposure in the
mixing and curing department of two rubber tire companies situated in The
Netherlands and Sweden were investigated. S. typhimurium strains YG1021, YG1024 and
YG1041 were used to study the possible presence of mutagenic nitroarenes and
aromatic amines. A large difference in mutagenic activity was found between the two
companies. While the rubber tire company situated in The Netherlands revealed overall
high mutagenic activity of rubber dust and fumes in the mixing and curing
departments, respectively 430 and 279 rev/m3 (YG1041), the Swedish company showed
almost no mutagenic activity, respectively 18 and 54 rev/m3 (YG1041). Further
identification of the mutagenic profile showed that mutagenic activity was exclusively
observed in S. typhimurium strains with elevated levels of O-acetyltransferase activity
(YG1041 and YG1024) in the presence of a metabolic active liver S9 fraction, possibly
indicating the presence of indirect mutagenic aromatic amines.
In section 4.3 mutagenic exposure conditions in eight production functions of several
general rubber goods (n=5), rubber tire (n=3) and retreading companies (n=1) in The
Netherlands were studied. Large differences in median mutagenicity of total suspended
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particulate matter (TSPM) samples were observed between companies (range 49-1056
rev/m3) and to a lesser extent between production functions (range 129 - 402 rev/m3).
The production function curing revealed overall the highest TSPM mutagenicity levels.
Forty-one percent of the surface wipe samples revealed mutagenic activity ranging from
26 – 665 rev/cm2. Mixing had the largest proportion of positive samples resulting in a
median surface mutagenic contamination of 39 rev/cm2. Surface mutagenic
contamination, averaged per department/company combination, showed only a weak
correlation with TSPM mutagenicity (r=0.28, p=0.05). Company, production function and
total soluble matter exposure explained 79% and 81% of the variability in mutagenicity
of TSPM and surface contamination levels, respectively. ‘Company’ was identified as the
most important exposure determinant for mutagenic activity in TSPM and surface wipe
samples. This indicated the importance of company specific determinants like production
volume and rubber chemicals used for the encountered mutagenic exposure conditions.
Detection of substantial mutagenic activity on possible skin contact surfaces supported
the potential importance of the dermal route in the uptake of genotoxic compounds of
workers in the rubber manufacturing industry.
In section 4.4, the relation between airborne particulate and dermal mutagenic exposure
levels and mutagens in urine of rubber workers (n=105) were studied to determine the
relevance of the inhalable and dermal exposure route. In addition, the potential
influence of skin aberrations and biotransformation polymorphisms (NAT2 and CYP1A2)
on urinary mutagenicity levels was addressed. A significant increase of 1605 rev./g.
creat. in urinary mutagenicity during the working week relative to Sunday was observed
for the total population (t-test, p=0.08). The increase in urinary mutagenicity was most
pronounced among technical engineers (+4196 rev./g. creat.; t-test, p=0.08) and
subjects with potential high TSPM and surface mutagenic exposure levels (+3206 rev./g.
creat. ;t-test, p=0.12). Subsequent multivariate regression analyses revealed statistically
significant associations between the mutagenic activity of potential contact surfaces,
inhalable particulate exposure, skin aberrations and slow acetylation phenotype and
weekday urinary mutagenicity. Similar trends were observed with Sunday urinary
mutagenicity levels except for slow-acetylation phenotype that only resulted in
increased weekday urinary mutagenicity levels. Surface mutagenic exposure levels were
estimated to increase weekday urinary mutagenicity with about 67%, while inhalable
particulate exposure resulted in an increment in weekday urinary mutagenicity levels of
about 23%. These results suggested that the dermal exposure route contributed more to
urinary mutagens of rubber workers than the inhalable route. Especially since subjects
with skin aberrations revealed an additional increase in weekday urinary mutagenicity of
about 40%.
In section 4.5, we investigated the occurrence of DNA adducts in exfoliated urothelial
bladder cells of currently exposed, non-smoking rubber workers (n=52) and their
relationship with occupational exposure estimates and biotransformation phenotypes.
Four DNA adducts were identified with the proportion of positive samples ranging from
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3.8% to 79%. The highest proportion of positive samples and the highest relative adduct
labeling (RAL) levels were in workers involved in the production functions ‘mixing’ and
‘curing’, areas with potential for substantial exposure to a wide range of compounds used
in rubber manufacturing (p < 0.05 for adducts #2 and/or #3, compared to all other
departments). However, no significant relationships were found between identified DNA
adducts and non-specific personal inhalable and dermal CSM exposure estimates or
urinary mutagenicity. Interestingly, subjects with a fast NAT2 acetylation phenotype
tended to have higher levels of DNA adducts. Aryldiamines, common in mixing and
curing, might represent a potential exposure consistent with these data. This study
suggested that workers in mixing and curing are exposed to compounds that can adduct
DNA in urothelial cells.
In conclusion, results of this study provided evidence of genotoxic exposures in the
rubber manufacturing industry and biological effects among rubber workers. Four
possibly, work-related DNA adducts were identified in exfoliated urothelial bladder cells
in certain groups of non-smoking rubber manufacturing workers. The identified DNA
adducts were prevalent and were observed for all production functions but occurred
predominantly in the production functions ‘mixing’ and ‘curing’. The presence of
genotoxic compounds in the air and on contact surfaces was demonstrated by the
detection of substantial mutagenic activity in TSPM and in surface wipe samples.
Subsequently, elevated levels of mutagens were detected in urine samples of rubber
workers. These elevated levels of urinary mutagenicity were related to the mutagenicity
of skin contact surfaces and airborne particulate exposure levels. In addition, increased
levels of urinary mutagens were observed for rubber workers with an impaired skin
barrier function and slow-acetylation status. Prevalence rates of these unfavorable skin
and biotransformation conditions are high in this population, 40% and 60%,
respectively. Therefore increase in urinary mutagenicity levels due to these factors are of
real significance for a large group of rubber workers. The potential ambiguous role of
N-acetylation activity in relation to urinary mutagenicity and urothelial DNA adduct
levels, however, needs more clarification.
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Samenvatting
De Nederlandse samenvatting is geschreven voor een ieder die geïnteresseerd is in
het onderzoek beschreven in dit proefschrift.
In buitenlands epidemiologisch onderzoek onder werknemers in de rubberverwerkende
industrie is meerdere malen een oversterfte geconstateerd aan diverse vormen van
kanker. Welke stoffen in deze bedrijfstak verantwoordelijk zijn voor het verhoogde risico
op kanker van onder andere de blaas en longen is niet met zekerheid te zeggen. De IARC
gaat vooralsnog (veiligheidshalve) dan ook niet verder dan de gehele bedrijfstak als
kankerverwekkend te kwalificeren.
Opname van chemische stoffen gebeurt in het algemeen via de ademhalingswegen,
ingestie en door de huid. Het is tot nu toe onbekend of de opname via de huid (dermale
route) van mogelijke kankerverwekkende stoffen een werkelijke risicofactor is voor
werknemers in de rubberverwerkende industrie. In het onderzoek beschreven in dit
proefschrift is gekeken naar de relatieve bijdrage van de dermale route voor de opname
van genotoxische stoffen en mogelijk biologische effecten. Genotoxische stoffen zijn
stoffen die in staat zijn mutaties in het erfelijk materiaal (DNA) te veroorzaken. Om dit te
kunnen bestuderen is in 1995 begonnen met een vooronderzoek in twee
rubberbandenfabrieken waarna in 1997 een grootschalig onderzoek is gestart onder 225
mensen werkzaam in 9 verschillende Nederlandse rubberverwerkende bedrijven.
Werknemers in de rubberverwerkende industrie worden blootgesteld aan een complex
mengsel van bekende en onbekende chemische stoffen. Bij het onderzoek naar
blootstelling aan een complex mengsel van chemische stoffen, waaronder mogelijke
kankerverwekkende stoffen wordt vaak gebruik gemaakt van zogenaamde niet-selectieve
bepalingen. Met behulp van deze bepalingen tracht men een schatting te maken van de
blootstelling aan of opname van een groep van chemische stoffen met overeenkomstige
eigenschappen. Voor de niet-selectieve bepalingen, die in dit onderzoek gehanteerd zijn,
is gebruik gemaakt van het feit dat één van de stappen in de ontwikkeling van kanker
beschadiging van of mutatie in het DNA-materiaal is. Mutagene stoffen dienen om die
reden dan ook als mogelijk genotoxisch te worden beschouwd. Als een vroegtijdig
biologische effect is gezocht naar stoffen die binden aan lichaamseigen moleculen
(adduct-vorming). Uitkomsten van dergelijke metingen geven niet alleen inzicht in de
hoeveelheid stof die in het lichaam aanwezig is, maar ook in de effecten die ze teweeg
brengen.
Het onderzoek in dit proefschrift kan beschreven worden aan de hand van drie primaire
onderzoeksdoelen:
♦ het bepalen van de huidige inhaleerbaarstof en dermale blootstellingsconcentraties
in de Nederlandse rubberverwerkende industrie (Sectie 3.1 & 3.2);
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♦ het in kaart brengen van de mutagene blootstellingsconcentraties in de
Nederlandse rubberverwerkende industrie (Sectie 4.2 & 4.3);
♦ Het bestuderen van de relatie tussen de inhaleerbaarstof, dermale
blootstellingsconcentraties en mutagene stoffen in de urine enerzijds en
bindingsproducten met DNA-moleculen (DNA-adducten) in blaascellen anderzijds
(Sectie 4.4 & 4.5).
Op basis van deze drie onderzoeksdoelen is uiteindelijk de relatieve bijdrage van de
dermale route voor de opname van genotoxische stoffen en biologische effecten afgeleid.
Aangezien een verminderde barrièrefunctie van de huid mogelijk tot een verhoogde
opname van chemische stoffen kan leiden is tevens gekeken naar het voorkomen van
huidaandoeningen in de geselecteerde onderzoekspopulatie.
Bij het stellen van de diagnose ‘handeczeem’ kan gebruik gemaakt worden van
verschillende onderzoeksmethodieken. In sectie 2.1 is de diagnose ‘handeczeem’
gebaseerd op een gestandaardiseerde vragenlijst vergeleken met de diagnose zoals die is
gesteld door een dermatoloog. Helaas bleek de diagnose op basis van de vragenlijst
slechts een beperkte validiteit te hebben (sensitiviteit 71.4% en specificiteit 76.1%). In
het vervolg van het onderzoek is daarom alleen gebruik gemaakt van de diagnose zoals
die is gesteld door de dermatoloog. Bij 7% van de werknemers in de rubberverwerkende
industrie is ten tijde van de studie handeczeem (‘major’ dermatitis) geconstateerd.
Schattingen van de prevalentie van handeczeem in de algemene bevolking variëren van 2
tot 10%. Dit is vergelijkbaar met het percentage werknemers met handeczeem in de
rubberindustrie. Geringe huidaandoeningen (‘minor’ dermatitis), die beschouwd kunnen
worden als een voorstadium van eczeem, en verwondingen, meestal van geringe omvang,
zijn regelmatig bij de onderzochte populatie geconstateerd, respectievelijk bij 28 en
17% van de onderzoekspopulatie (n=202) (Sectie 2.2). Het voorkomen van deze geringe
huidaandoeningen is sterk gerelateerd aan het regelmatig of frequent wassen van de
handen. Dit wordt versterkt als men hierbij gebruik maakt van zogenaamde schuurzepen.
Deze zepen bevatten naast zeepbestanddelen harde stukjes om een extra schurende
‘schoonmakende’ werking te krijgen.
Van de 9 bedrijven die aan het onderzoek deelnamen hadden 7 bedrijven al in een eerder
onderzoek (eind jaren tachtig) naar verbeteringen van arbeidsomstandigheden in de
Nederlandse rubberverwerkende industrie geparticipeerd. Op basis van deze twee
onderzoeken is een schatting gemaakt van de historische blootstellingsdaling in deze 7
bedrijven. Inhaleerbaarstof- en dermale blootstellingsconcentraties zijn in de 9
tussenliggende jaren met ongeveer de helft teruggebracht (Sectie 3.1). Opmerkelijk is
dat bedrijven en productiefuncties met de hoogste blootstellingsconcentraties in 1988
en werknemers met meer werkervaring een nog sterkere daling in de
blootstellingsconcentraties vertonen. Doordat ook veranderingen in het productieproces
en de getroffen beheersmaatregelen bekend zijn, is het mogelijk om de effectiviteit van
deze maatregelen (in het totaal 57 beheersmaatregelen) te bestuderen. Op basis van deze
informatie is 80% van de historische daling in inhaleerbaarstof concentraties verklaard.
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Voor de huidblootstelling kon echter slechts 30% van de daling op basis van de getroffen
beheersmaatregelen worden verklaard. Verwijderen van de blootstellingsbron is de meest
effectieve manier om zowel de inhaleerbaarstof en dermale blootstelling te verlagen,
respectievelijk met 67 en 66%. Beheersmaatregelen gericht op het controleren van reeds
ontstane emissies zijn minder effectief, maar nog steeds gerelateerd aan een significante
daling in zowel de inhaleerbaarstof - als de dermale blootstellingsconcentraties
(respectievelijk 34 en 49%). Op basis van de gevonden trends en de relaties met de
getroffen beheersmaatregelen kan geconcludeerd worden dat pogingen om de
blootstelling aan chemische stoffen in de Nederlandse rubberindustrie te reduceren
geresulteerd hebben in een verlaging van zowel de inhaleerbaarstof als dermale
blootstellingconcentraties.
Huidblootstelling kan het gevolg zijn van verschillende processen zoals bijvoorbeeld
direct contact met chemicaliën of door depositie van stoffen op de huid. In sectie 3.2 is
op basis van een conceptueel model (zie bijlage) geprobeerd inzicht te krijgen in de
bijdrage van de verschillende massatransportprocessen (depositie, direct contact etc.)
aan de huidblootstelling in de rubberverwerkende industrie. Aangezien de blootstelling
op de huid vaak niet gelijkmatig is verdeeld over het gehele lichaam is tevens gekeken
naar de verdeling van deze blootstelling over het lichaamsoppervlak. De hoogste
huidblootstellingsconcentraties zijn gevonden op meerdere delen van het bovenlichaam.
Bovendien blijkt de huidblootstelling aan de onderarm sterk gerelateerd te zijn aan de
geschatte totale huidblootstelling. Hierdoor is het mogelijk om voor deze
blootstellingssituatie op basis van slechts één meting aan de pols een inschatting van de
totale huidblootstelling te maken. De kwalitatieve en kwantitatieve evaluatie van de
relevante massatransportprocessen onderstrepen het belang van zowel depositie van
deeltjesvormige blootstellingen op de huid als het belang van direct of indirect
huidcontact met de bron of besmette oppervlakken. De bijdrage en relevantie van de
massatransportprocessen verschillen echter aanzienlijk tussen de onderzochte
productiefuncties.
Persoonlijke leefgewoonten, zoals bijvoorbeeld roken, dragen bij aan de aanwezigheid
van mutagene stoffen in de urine. Daarom moet bij het kwantificeren van de
beroepsmatige bijdrage aan mutagene stoffen in urine rekening worden gehouden met
verschillen in persoonlijke leefgewoonten en met mogelijke veranderingen van deze
leefgewoonten in de tijd. In sectie 4.1 is de dag-tot-dag variantie in actieve en passieve
rookgewoonten bestudeerd door het bepalen van de cotinineconcentraties in zowel
zondag- als woensdag- en donderdagurine (verzameld na werktijd) van 105 werknemers.
Cotinine is een van de belangrijkste afbraakproducten van nicotine, een bestandsdeel van
sigarettenrook. Een sterke daling in cotinineconcentraties gedurende de werkweek ten
opzichte van de zondag is waar te nemen voor zowel rokers (-39%) als niet-rokers (-23%).
Tevens is een duidelijk relatie gevonden tussen de cotinineconcentraties van zowel de
zondag- als het samengevoegde weekmonster (Wo. en Do.) en de mutageniteit van deze
urinemonsters. Op basis van deze statistische relatie is vervolgens de mutageniteit van de
urine gecorrigeerd voor de blootstelling aan sigarettenrook. Gecorrigeerde concentraties
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aan mutagene stoffen in urine zijn vergelijkbaar voor rokers en niet-rokers. Tevens is een
vergelijkbare stijging in de concentratie aan mutagene stoffen in de urine van de
werkweek ten opzichte van de zondagurine gevonden voor zowel rokers als niet-rokers
(respectievelijk +39 en +34%). Deze stijging in mutageniteit van de urine is
waarschijnlijk het gevolg van beroepsmatige blootstelling aan mutagene stoffen op de
werkplek.
Mutageniteit van rubberstof en dampblootstelling in de mengerij en vulkanisatieafdeling
van twee rubberbandenfabrieken, één in Nederland en één in Zweden, staat beschreven in
sectie 4.2. Bij het bepalen van de mutageniteit is gebruik gemaakt van verschillende
bacteriestammen in de Salmonella/microsome test (‘Ames’ test), namelijk S. typhimurium
YG1021, YG1024 en YG1041. Door gebruik te maken van bacteriestammen met een
specifieke gevoeligheid voor een bepaalde groep mutagene stoffen kan een inschatting
gemaakt worden van het soort mutagene stoffen waaraan werknemers mogelijk zijn
blootgesteld. De bacteriestammen, die in deze studie gebruikt zijn hebben een specifieke
gevoeligheid voor mutagene nitroarenen en/of aromatische amines. Een duidelijk
verschil in mutageniteit van de blootstelling, gemeten met S. typhimurium YG1041, is
zichtbaar tussen de Nederlandse en Zweedse fabriek voor zowel de mengerij (430 rev/m3
versus 18 rev/m3) als voor de vulkanisatieafdeling (279 rev/m3 versus 54 rev/m3).
Mutagene stoffen in rubberstof en dampmonsters zijn alleen gedetecteerd met behulp van
de S. typhimurium-stammen met een verhoogde activiteit van het enzym
O-acetyltransferase (YG1041 en YG1024) in de aanwezigheid van een metabolisch
activeringssysteem (S9-fractie). Deze resultaten wijzen op de aanwezigheid van
aromatische amines met een indirecte mutagene werking in de gemeten rubberstof en
dampblootstelling in deze twee rubberbandenfabrieken.
De aanwezigheid van mutagene stoffen in de lucht en op oppervlakken waarmee
werknemers direct in aanraking komen tijdens normale werkzaamheden, is vervolgens
onderzocht voor alle productiefuncties (n=8) in de negen deelnemende bedrijven van het
hoofdonderzoek (Sectie 4.3). Een grote spreiding in de mutageniteit van het rubberstof
en damp is gevonden tussen de verschillende bedrijven (spreiding 49 – 1056 rev/m3) en
in mindere mate tussen de verschillende afdelingen (spreiding 129 – 402 rev/m3).
Mutageniteit van de verschillende bemeten contactoppervlakken laten eveneens een grote
spreiding zien (spreiding 26 – 665 rev/cm2). De mutageniteitsconcentraties in de lucht
en op oppervlakken, gemiddeld per afdeling per fabriek zijn slechts zwak aan elkaar
gerelateerd (r=0.28, p=0.05). Bedrijf, productiefunctie en blootstelling aan de totaal
oplosbare fractie verklaren respectievelijk 79 en 81% van de variabiliteit in de
concentratie aan mutagene stoffen in de lucht en op mogelijke contact oppervlakken.
Hierbij is vooral het bedrijf waarvan de monsters afkomstig zijn de meest bepalende
factor. Dit duidt op het belang van bedrijfsspecifieke determinanten zoals
productievolume en het gebruik van specifieke rubberchemicaliën voor de mutageniteit
in de lucht en op mogelijke contact oppervlakken. Het detecteren van mutagene stoffen
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op oppervlakken, waarmee de werknemers direct of indirect met de huid in contact
komen, versterkt tevens het vermoeden dat de dermale blootstellingsroute van belang is
in de rubberverwerkende industrie.
In sectie 4.4 is de mogelijke relatie tussen de blootstellingen aan mutagene stoffen en de
aanwezigheid van deze stoffen in de urine van werknemers (n=105) in de rubberindustrie
bestudeerd. Daarnaast is de mogelijke invloed van een verminderde huidkwaliteit en een
snelle of langzame enzymatische omzettingscapaciteit (acetylering en N-oxidatie
capaciteit) op de aanwezigheid van mutagene stoffen in de urine bekeken. Gemiddeld is
voor alle werknemers een toename in de concentratie aan mutagene stoffen in de urine
gevonden gedurende de werkweek ten opzichte van zondag (+1605 rev/g. creat.). Deze
toename is het sterkst voor werknemers van de technische dienst (+4196 rev/g. creat.)
en voor werknemers die blootgesteld zijn aan hoge concentraties aan mutagene stoffen
in de lucht en op mogelijke contact oppervlakken (+3206 rev/g. creat.). Mutageniteit
van de weekurine is sterk gerelateerd aan de mutageniteit van contactoppervlakken,
inhaleerbaar-stofblootstelling, het hebben van huidaandoeningen en een langzame
acetyleringscapaciteit. Voor de mutageniteit van de zondagurine zijn vergelijkbare
relaties gevonden, alleen minder sterk dan voor de mutageniteit van de weekurine.
Vermoedelijk worden de opgenomen stoffen slechts langzaam via de urine uitgescheiden.
Dit is belangrijk aangezien gifstoffen meer schade kunnen aanrichten naarmate ze langer
in het lichaam verblijven. Direct contact met mutagene stoffen resulteert in een toename
van 67% in mutageniteit van de urine. Blootstelling aan mutagene stofdeeltjes resulteert
in een toename van 23% in mutageniteit van de urine. Hieruit is afgeleid dat de dermale
route waarschijnlijk de meest belangrijke blootstellingsroute is. Dit vermoeden wordt
nog eens versterkt doordat werknemers met een slechtere huidkwaliteit een additionele
toename in de mutageniteit van de urine van 40% vertonen.
In sectie 4.5 is de aanwezigheid van bindingsproducten met DNA (DNA-adducten) in
blaascellen, die in de urine worden uitgescheiden onderzocht voor 52 niet-rokende
werknemers. Vier DNA-bindingsproducten konden worden geïdentificeerd. Het hoogste
percentages werknemers met DNA-adducten in blaascellen en de hoogste adductniveaus
zijn gevonden voor de productiefuncties ‘mengen’ en ‘vulkanisatie’. Er zijn echter geen
relaties gevonden tussen het voorkomen van deze DNA-adducten en persoonlijke
inhalatoire en dermale blootstellingen. De hoge prevalentie aan DNA-adducten, variërend
van 3.8 tot 79% voor de verschillende DNA-adducten, is een aanwijzing dat de
blootstelling algemeen voorkomt in de rubberverwerkende industrie, maar dat deze
adducten zich voornamelijk manifesteren in de mengerij en vulkanisatieafdeling.
Opmerkelijk is dat werknemers met een snelle acetyleringscapaciteit vaker hogere DNA-
adductniveaus hebben dan werknemers met een langzame acetyleringscapaciteit.
Op basis van de resultaten van het totale onderzoek kan geconcludeerd worden dat
werknemers in de rubberverwerkende industrie in Nederland blootgesteld zijn aan
genotoxische stoffen. Ten eerste is de aanwezigheid van genotoxische stoffen in de
werkomgeving aangetoond door de detectie van mutagene stoffen in rubberstof en damp
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en op mogelijke contactoppervlakken. Daarenboven zijn verhoogde niveaus aan mutagene
stoffen in de urine van werknemers gevonden. Ten tweede zijn vier mogelijk
werkgerelateerde DNA-adducten geïdentificeerd in blaascellen van werknemers uit de
rubberverwerkende industrie.
De relatieve bijdrage van de dermale route voor de opname van genotoxische stoffen en
biologische effecten is afgeleid aan de hand van relaties die gevonden zijn met de
mutageniteit in de urine. De verhoogde mutageniteitsniveaus in urine zijn gerelateerd
aan de mutageniteit van contactoppervlakken en inhaleerbaarstofconcentraties.
Gebaseerd op de gevonden relaties is geschat dat huidcontact met mutagene stoffen
resulteert in een 3 maal hogere bijdrage aan de mutageniteit in urine dan blootstelling
aan inhaleerbaarstof. Bovendien blijken werknemers met een verminderde huidkwaliteit
een additionele toename van de mutageniteit in de urine te vertonen. Deze laatste
bevinding is een extra aanwijzing voor het belang van opname van genotoxische stoffen
via de huid in de rubberverwerkende industrie.
Genotoxic exposure and biological effects in the rubber manufacturing industry
162
List of abbreviations
137X caffeine
17X paraxanthine
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r correlation coefficient
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RPM rounds per minute
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Epilogue
The study described in this thesis is the result of 5 years of research in the rubber
manufacturing industry in The Netherlands. Many persons have contributed to the
project and without their valuable input the whole project would certainly have been
less thriving.
First of all I would like to thank Hans Kromhout for giving me the opportunity to
embark on this interesting research topic. Hans, you have been not only the best and
most inspiring supervisor I could have wished for but next to that a good friend.
Together we have had to take the necessary administrative hurdles that due to several
reorganizations came on our path. In spite these difficulties we have managed to keep
the project alive and made it to what it is. Next, I would like to thank Rob Bos for his
enthusiasm and scientific advice during all this time and for giving me the opportunity
to develop my interest in occupational toxicology. Bert Brunekreef is greatly
acknowledged for his valuable comments on the various parts of this thesis.
During the fieldwork and consequently numerous analytical and toxicological analyses
many persons have been of invaluable help. Without Jeroen de Hartog, the fieldwork of
the ‘rubber tour’ would have been less successful and certainly much less enjoyable. Derk
Bruynzeel and Edith de Boer enabled the dermatological survey within the rubber study
for which much gratitude. Paul Swuste is recognized for his knowledgeable input on the
technical aspects of control measures. Paul Heeres, Hillion Wegh, Fred Hoek, Wim Braun,
Siegfried de Wind, Jacques Spithoven, Hanneke Kruize, Daan Bouwman, Wobbe van de
Meulen, Mirjam Knape, Claudia Hiemstra, Roberto d’Onofrio, Pieter Westers, Hinkelien van
Drooge, Jeanne Pertijs, Jack Theuws, Peter Voshol, Jantine Heideman, Arjan Mom and Tim
de Groot are recognized for their technical and analytical support and hard work during
different parts of the project. Without the support of Nathaniel Rothman and Patricia
Stewart of the Occupational Epidemiology Branch, National Cancer Institute, Bethesda,
the exfoliated urothelial cell study would never have surfaced. Glenn Talaska and Brenda
Schumann are thanked for introducing me to 32P-postlabeling and for the hospitality
during my stay at the University of Cincinnati.
I am furthermore greatly indebted to the employers and employees of the rubber
companies for their close co-operation in this study. I hope the results of this study will
help to further improve working circumstances in the rubber manufacturing industry in
The Netherlands in order to prevent possible negative health effects in the near future.
As mentioned before, this study was potentially threatened by several reorganizations
during the course of the project. Starting of as a collaborative project of the Department
of Air Quality at the Wageningen Agricultural University and the Department of
Toxicology, Faculty of medical sciences at the University of Nijmegen, it ended as a
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concerted project of the Environmental and Occupational Health Group, Institute of Risk
Assessment Sciences, Utrecht University and the Department of Pharmacology &
Toxicology, UMC St. Radboud, University of Nijmegen. This process included three
reorganizations and the loss of two of the initial supervisors. It has become harshly
apparent in the last few years that even within academia the process of continuous
reorganization has found its way. Often these reorganizational decisions are made on a
purely ‘political’ basis and not on scientific merits or social importance. Although, more
flexibility within academia itself is to be welcomed, the influence of such administrative
political decisions has to be critically watched.
Finally, I would like to thank Wieteke, my parents, Gert-Jan and Laura, friends and
colleagues for their support during these years but more importantly for all the things
but work.
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Appendix
Conceptual model for assessment of dermal exposure
Dermal exposure, primarily to pesticides, has been measured for almost
half a century. Compared with exposure by inhalation, limited progress
has been made towards standardization of methods of measurement and
development of biologically relevant exposure measures. It is suggested
that the absence of a consistent terminology and a theoretical model has
been an important cause of this lack of progress.
Therefore, a consistent terminology based on a multicompartment
model for assessment of dermal exposure is proposed that describes the
transport of contaminant mass from the source of the hazardous
substance to the surface of the skin. Six compartments and two barriers
together with eight mass transport processes are described. With the
model structure, examples are given of what some existing methods
actually measure and where there are limited, or no, methods for
measuring mass in a compartment or transport of mass. The importance
of measuring the concentration of contaminant and not mass per area in
the skin contaminant layer is stressed, as it is the concentration
difference between the skin contamination layer and the perfused tissue
that drives uptake. Methods for measuring uptake are currently not
available.
Measurement of mass, concentration and transport processes must be
based on a theoretical model. Standardization of methods for dermal
exposure measurement is strongly recommended.
Occupational & Environmental Medicine, 1999, 56, 765-773
Introduction
Exposure to hazardous substances most commonly occurs either by inhalation, ingestion,
dermal contact, or some combination of these routes. Occupational hygiene has
traditionally focused on exposure by inhalation because it was almost invariably
considered to be the most important pathway. Many methods have been developed to
measure exposure levels from inhalation and there is a clear understanding of how such
levels should be interpreted to help reduce risk. The situation is less clear for the dermal
route of exposure. Practical methods of measurement have been developed to assess
dermal exposure 1 and proposals have been made to develop dermal exposure limits in an
analogous way to those for inhalation exposure 2; 3. However, there has been criticism of
the existing methods of measurement of dermal exposure because they determine the
mass of contaminant either depositing on the skin or retained on the skin at the end of
the exposure period 1; 4.
Hazardous substances on the dermal surface will be taken up continuously into the body
through the stratum corneum and the epidermis towards the dermis where they or their
dermal metabolites will be removed by the blood flow. The transport process is driven by
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the concentration gradient between the dermal surface and the perfused tissue. The risk
arising from dermal exposure is thus firstly related to the time dependent concentration
of a substance on the dermal surface rather than the mass of material on that surface at
any given time. Mass is nevertheless important when there is a little material available
for uptake.
Contamination of the skin may arise in many different ways. It is possible for hazardous
substances to land on or be adsorbed into the skin directly from the air. They may be
transferred to the skin from contact with contaminated surfaces or by submersion of part
of the body into the substance. Also, the contaminant may be lost from the skin either
by evaporation or some other mechanisms such as washing or abrasion, without being
taken up into the body. Finally, the presence of clothing or protective garments may
modify the rate at which hazardous substances come into contact with the skin. All of
these processes are important to consider when making an assessment of dermal
exposure and a complete understanding of these complex processes will help in
developing an appropriate control strategy.
In this paper we have attempted to produce a consistent terminology for assessment of
dermal exposure. The terminology is based on a conceptual model of the processes
leading to exposure (from the source of a hazardous substance to the surface of the
skin). We have also defined several terms related to exposure, which provide a valid basis
for investigating the risks posed by dermal exposure. It has not been our intention to
consider the process of uptake into the body or the derivation of dose estimates from
dermal exposure, although others have developed models that could be used in such
contexts 5; 6.
Conceptual model of dermal exposure
A consistent terminology has to be based on a coherent and systematic description of
dermal exposure scenarios. A multicompartment model is an appropriate basis for a
terminology as it comprises distinct physical objects or compartments connected by
mass transport processes. Models of this type are concerned with what happens - for
example, where fingers get contaminated by touching a surface and not why it happens
– for example, particle adhesion.
Compartments
All compartments are assumed to be well and instantaneously mixed. As a result the
concentration in a compartment is described by the amount of mass and distribution
volume of the compartment. Six principle compartments are being distinguished in the
model (Figure A-1):
Source (S) - Processes or activities, from which a mass is being introduced into any of
the compartments, will be considered as sources.
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Figure A-1 Overview of the conceptual model, compartments and rate constants.
(E=emission (  ), Dp=deposition (       ), L=resuspension or evaporation ( ), 
T=transfer (          ), R=removal (            ), Rd=redistribution (            ),  
D=decontamination (           ), P=penetration and permeation (          )   
RdAir
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Air - The air compartment contains vapors and dispersed particles, which are assumed to
be homogeneously distributed in the compartment. The total mass of a given substance
in the air compartment is well defined and can, in principle, be measured. The compart-
ment volume is given by the size of room or other boundaries, either physical or virtual.
Surface contaminant layer (Su) - Contaminants on a surface form a layer, which deline-
ates the compartment called surface contaminant layer. The compartment is assumed to
be homogeneous. In principle, all substances belonging to the surface contaminant layer
can be identified and thus mass in this compartment can be assessed. The compartment
volume is given by the three dimensional volume of this layer. For many practical
purposes, a two dimensional representation of this layer will suffice.
Outer and inner clothing contaminant layer (CloOut, CloIn) - Solid or liquid contaminants
at the boundary between outside and the surface of the outer clothing are modeled as
the compartment called outer clothing contaminant layer. The fabric separates this
compartment from the inner clothing contaminant layer. For simplicity of the model the
fabric is described as a barrier (mass transfer rate limiting) having the property to retain
mass (MReservoir). If the mass of the hazardous substance in the outer clothing contaminant
compartment is MCloOut then some of this material will be transported through the cloth-
ing to the compartment called inner clothing contaminant layer. The mass in the inner
clothing compartment is MCloIn = MCloOut – MReservoir. For many practical purposes a two
dimensional representation of these compartments will suffice.
Skin contaminant layer (Sk) - On the skin, contaminants, sweat, skin oil, and barrier
cream (if applied) form a layer. This layer constitutes the skin contaminant layer. The
compartment is assumed to be homogeneous. In principle, all substances belonging to
the skin contaminant layer can be identified and thus the mass in this compartment can
be identified and measured. The compartment volume is given by the three dimensional
volume of this layer. The conventional two dimensional representation of this layer is an
oversimplification, which has contributed to the confusion about the principles involved
in the choice of measurement principles for and interpretation of dermal contamination
in terms of dermal uptake.
Mass transport processes
The mass transport from the source to the compartments and sinks in the system is
shown in Figure A-1. Below the horizontal dotted line in the figure a person’s movement
begins to influence the transport processes. Two units are used to measure transport of
mass; g.s-1 and g.event-1. For processes called events, it is important to describe the
number of events within a reference time period, typically 8 hours. The mass transport
can be divided into eight distinct processes as described later and in Table A-2.
Emission (E) - Emission (E) is the transport of substances into the air, onto surfaces,
outer clothing, and the skin contaminant layer from all primary sources. Evaporation of
liquids or emission of droplets or particles into the air gives rise to emission of contami-
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nant mass to the air. For aerosols we restrict this emission pathway to those with
aerodynamic diameter <100 µm so that sedimentation is relatively unimportant.
Emission to the different surfaces in the model can arise from splashing, spilling,
immersion and impaction of large particles. Splashing is the emission of large droplets
the trajectory of which towards the surfaces is unaffected by air movement, whereas
spilling is the event by which a liquid or powder is spilled on a surface. Immersion is an
event whereby a part of the body is submerged into a liquid or a powder. Impaction is
the process by which large particles are generated at the source and ejected from that
source to impact onto surfaces. The emission rate is given as either g.s-1 or as g.event-1.
Deposition (Dp) - Deposition (Dp) is the transport of substances from the air to surfaces,
outer clothing, and the skin contaminant layer. Deposition can be of mass as either solid,
liquid, or vapor. The time dependent mass deposition rate Dp(t), in units of g.s-1, can be
represented by the deposition velocity v(t) in units of cm.s-1 as follows:
XAtCtvtDp ⋅⋅= )()()(  (1)
where C(t) is concentration in air outside the boundary layer and AX is the area of the
two-dimensional representation of the compartment, where X is either Su for surface, Clo
for clothing or Sk for skin).
Resuspension or evaporation (L) - Resuspension or evaporation (L) is the transport of
substances from surfaces, outer clothing, and the skin contaminant layer to the air, as
particulate (resuspension), vapors or both. Evaporation is a continuous process driven by
diffusion. Mechanical forces cause resuspension. If resuspension is caused by a single
mechanical impact then the transport of mass is conveniently modeled as a transfer of
mass per single event. If resuspension is caused by a sudden flow of air along a surface,
there is a short initial peak of resuspended mass followed by a decay of resuspended
mass per time 7. Thus resuspension can, in general, be measured as a transport of mass
per single event.
Transfer (T) - Transfer (T) is the transport of substances by direct contact between
surface, skin, and outer and inner clothing contaminant layers in a direction towards the
worker. Transfer from the surface to the skin contaminant layer is event based and takes
place from a small area of actual contact. That area could be considerably smaller than
the surface area of the body part involved in the contact. The actual surface area of the
skin that will be contaminated, as well as the efficiency of mass transfer, will depend on
the actual contact, - for example, single pressure, or movements of the skin along the
surface.
Removal (R) - Removal (R) is the transport of substances by direct contact between skin,
inner and outer clothing, and surface contaminant layer in a direction away from a
worker. Removal thus is defined as an event based transport in the opposite direction of
transfer.
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Redistribution (Rd) - If contaminants in the air, on the surface, clothing, or skin are not
homogeneously distributed, or different parts of the body such as palm, neck, and trunk
need to be distinguished, the compartments can be subdivided initially into
subcompartments. Redistribution then is the transport of substances from a
subcompartment to another subcompartment of the same type. Redistribution of
contaminants from one part of the skin contaminant layer to another can occur as a result
of touching the face with contaminated fingers. Also, fabric wetting can redistribute liquid
contaminants.
Decontamination (D) - Decontamination (D) is the deliberate transport of contamination
from the system – for example, ventilation of room air, cleaning of room surfaces and
outer clothing or washing material off the skin. The air compartment is decontaminated by
the combined effect of natural and mechanical ventilation. Cleaning of contaminated
surfaces, changing of clothing, and cleaning of skin all result in permanent loss of mass
from the system and thus are decontamination processes. By contrast, brushing dust off
clothing transports particulate mass to the room air and thus is resuspension, not
decontamination.
Penetration and permeation (P) - Penetration and permeation (P) both involve transport of
substances through a rate limiting barrier - such as clothing or the stratum corneum.
Penetration is transport caused by external pressure, capillary penetration, and
evaporation-condensation. Permeation always involves diffusion.
Transport of contaminants through permeable clothing occurs by aerosol penetration and
liquid transport. External air pressure can be considered to be the driving forces for
penetration of aerosols through fabric 8, whereas the mechanisms of liquid transport are
capillary penetration, pressure penetration, impact penetration, and evaporation-
condensation 9. Mass transport through non-permeable clothing is a diffusion process
driven by concentration. The rate of mass transport through the stratum corneum PSk(t)
can be represented by a permeability coefficient K(t), the concentration difference over
the stratum corneum CSk(t) and skin contaminant layer area A(t) as:
)()()()( tAtCtKtP SkSk ⋅⋅= (2)
The area of the skin contaminant layer can be time dependent, which for example is the
case for a drop that dries while on the skin. Roed et al. 10 have shown that very small
particles may penetrate into the stratum corneum but their fate is not known.
Concentration
The model describes transport of mass of a given substance, which is a conserved quantity
provided we neglect chemical reactions. However, several transport processes are driven by
the compartment concentration. For the air compartment concentration is readily obtained
from mass because an air compartment can be defined such that it has a constant volume.
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For the surface and skin contaminant layers, volume is defined by the total amount of
material present (Table A-1). If the skin contaminant layer compartment only contains
liquids the concentration CSk of a hazardous substance of mass MSk is given by the ratio
otherSkSk
Sk
Sk MM
MC
,
+
= (3)
where MSk, other is the mass of all other liquid substances. This concentration can be
readily transformed into the molar concentration, which is more relevant for the skin
contaminant layer. As a first approximation and for substances of low volatility CSk can
be considered to be the concentration in the bulk liquid.
The concept of concentration is more complicated for particles as they are discrete
entities and solid substances must dissolve to diffuse through the stratum corneum. For
soluble or leachable substances it is the concentration in the wet layer around the
individual particle that has to be used for CSk in equation 2. This may mean that uptake
will be limited by the rate of dissolution rather than diffusion through the stratum
corneum. Furthermore, if uniform deposition takes place a monolayer of particles may be
built up until the entire surface is covered. As a multilayer forms, the additional mass
will have less and less influence on uptake and may be likely to dislodge and fall off. For
this reason the mass of particles in the skin contaminant layer may only have limited
relevance to uptake.
Measurement methods of skin and surface contamination
Depending on the perspective from which the exposure scenario is investigated a range
of measurement approaches have been developed from the 1950’s onwards 11. In Table A-3
methods in common use for skin and surface contamination are listed. Several of these
methods are used to assess both compartment mass – for example, total mass in surface
layer and mass transport processes – for example, dislodgeable mass. A clear distinction
is not always made and this can create confusion about determination and interpretation
of sampling efficiencies. As an example, measurement methods should aim to have 100%
sampling efficiency where they intend to assess compartment mass. On the other hand, a
100% sampling efficiency for a wipe test to measure the transfer to skin upon contact
with a surface is not necessarily desirable 1. The amount that can be transported from
surfaces to the skin or outer clothing contaminant compartments depends on the type of
surface, the contaminant, and on the forces acting on the contaminant layer, rather than
how much mass is present in the compartment. Measurement of transport must therefore
be based on a model. Several routes may be followed. The transport process from surfaces
could be simulated with, for example, using a standardized instrumental sampling
method or standardized events. Transport can also be measured during actual field
conditions for an exposed population, with the result summarized in the form of a
distribution of mass transport. Such reported distributions have been used for risk
assessment, - for example, transfer from soil giving the results as soil to skin adherence 12.
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Deposition from air is more predictable and Schneider and Stokholm 13 have proposed a
theoretical model dependent on particle size for the transport of airborne dust onto the
ocular surface in terms of relative deposition velocities. This could be called the ocular
deposition fraction, by analogy with the inhalable fraction. Roed, and others 10 have
given experimental data for mean deposition velocities on arms and other body parts for
people seated in a test room, which likewise could form a basis for defining other dermal
deposition fractions.
There is a close analogy to requirements for sampling inhalable airborne particles.
Historically, fractions with biologically relevant particle size have been based on
experimental data that reflect mean deposition efficiencies in the airways. An alternative
approach has been to define the fraction as that obtained by a given sampling
instrument. Initially there were different proposals for the size fractions, and samplers
were not available which could measure according to these criteria. However, better
experimental data on deposition efficiencies has resulted in the adoption of an
international standard for the definition of the respirable, thoracic, and inhalable
fractions 14. Recent development has resulted in samplers, which have aspiration
efficiencies that match the definition of the fractions 15.
In the following section some strategies for measuring with the model compartment mass
and mass transport processes will be discussed, highlighting several problems in
conventional approaches to measurement and possible routes forward.
Compartments
The mass in a compartment at a given time can in principle be measured by sampling all
of the contaminant present at that time in the compartment. A strategy often used in
monitoring is to estimate the entire compartment mass by sampling a small proportion
of the whole 16; 17.
Air - Methods for measurement of concentration of hazardous substances in the air
compartment are well established relative to estimation of inhalation risk. For aerosols
specifications are available for sampling fractions of biologically relevant inhalable size
14, but methods for determining the concentration of non-inhalable particles, which are
relevant for estimating surface deposition, have not yet been developed.
Surface contaminant layer - For surfaces, several in situ methods are available, but they
can only measure a limited range of substances, and never total mass. Portable x-ray
fluorescence analysis is one example of this type of analysis 18. Methods based on
removal - such as adhesive tape sampling - can have a high sampling efficiency. The
efficiency in field use is usually estimated with consecutive sampling of the same area.
However, this is based on a circular argument, as only the contaminant that the tape can
actually remove will ever be sampled 19.
Clothing contaminant layers - In the model clothing was divided into an outer and inner
contaminant layer, with a buffer to represent the mass residing inside the clothing which
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does not come into contact with surfaces or skin, respectively. Measurement of the entire
mass in the clothing would in principle be no problem and if this were done for non-
permeable fabrics theoretically the outer contaminant layer would be measured. To our
knowledge a method which measures the inner contaminant layer for permeable layers is
not available.
Skin contaminant layer - The skin rinse method 20 has been used to assess the mass in the
skin contaminant layer compartment. The method typically recovers 40%-90% of
contaminants spiked onto the skin. Recoveries can be determined experimentally.
However, spiking experiments have inherent problems as it is unclear whether this result
should be interpreted as a 40%-90% sampling efficiency for the skin contaminant layer
or if it reflects partitioning between this compartment and the stratum corneum or
perfused tissue. Measurement methods based on UV fluorescence of tracer compounds
mixed with the contaminant at source 21-25 indirectly measure the mass of the contami-
nant in the skin contaminant layer. However, fluorescent tracers have the ability to bind
with the cell proteins in the stratum corneum and the method is not able to differentiate
between the skin contaminant layer and the stratum corneum.
Mass transport processes
Transport can in principle be measured with a mass balance calculation for the change in
mass in all relevant compartments per event or per time. Transport can more directly be
determined by methods, which standardize a set of external factors considered to be
important determinants of the transport process (Table A-3).
Deposition - Adhesive tape can measure the particle deposition unaffected by loss. This
has been done for particle deposition onto the face 26, but the method does not work for
parts of the body that get into contact with other surfaces. Charcoal cloth has been used
to measure skin deposition of volatile compounds. A problem is that the method does
not differentiate between vapors from air and liquid splashes 27; 28.
Resuspension or evaporation - Resuspension is usually best described as a series of single
events. If events are repeated, say at a frequency n, and the ratio n/T tends to infinity,
where T is a suitable reference time interval, resuspension can be treated as a continuous
process. In this case it is customary to define a resuspension rate R by the equation
where the mass of substance lost from the surface per unit time (L) (Table A-2) is:
)()()( 11 gMsRsgL Su⋅= −− (4)
This definition assumes that R is independent of MSu (see also discussion for transfer). An
approach to assess resuspension based on events would be to collect all dust resuspended
as the result of a standardized mechanical impact 29 have developed the surface total
emission potential of particles (STEPP) tester, which simulates resuspension caused by a
walking person from a carpet. Resuspension caused by air movements is simulated in the
SMAIR tester 30. In this instrument a well defined air jet is directed at a surface contami-
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nant layer and the resuspended particles collected on a filter. Vacuuming techniques
could be used to simulate resuspension caused by strong air velocities, provided the
nozzle does not touch the surface. Evaporation is driven by diffusion and thus it is
simpler to specify external factors. Wolkoff 31 has developed a field and laboratory
emission cell (FLEC), which in principle is a small air compartment that is placed on a
surface. A well defined flow of conditioned air is passed through the compartment and
the exhaust air is analyzed for evaporated substances. The diffusive transport of water
vapor from the skin (Transepidermal water loss) can be measured with simply instru-
ments 32. A similar principle could be used for other vapors lost from the skin.
Transfer - The increase in mass over time in the skin contaminant layer measures is the
measured net balance between transport to and from the compartment and thus is
affected by deposition, resuspension or evaporation, removal, and uptake. Surrogate skin
methods such as pads, gloves, and coveralls are based on the assumption that they are
estimates of the transport of mass to the skin contaminant layer from surfaces. However,
the materials used do not have the roughness, stickiness and other properties of human
skin and so may not meet this assumption. Dislodgeable foliar residue (DFR), a procedure
first described by Iwata et al. 33, determines the pesticide remaining on foliage after
spraying. It involves destructive sampling of foliage by punching or removing leaves to
provide a sample leaf area of about 100 cm2 and subsequent, partly mechanical partly
chemical, removal of pesticide residue by shaking the leaves in water with some drops of
surfactant. This process is intended to mimic transfer to skin. Then pesticide is extracted
from the water and analyzed chemically. Sometimes an organic solvent is used in the
first step, but this then measures the mass in the compartment rather than the DFR. Both
methods, however, have been used to indicate the strength to transfer by direct contact
from the source, which may be relevant to predict exposure by contact. A more general
form of DFR is transferable residue (TR). If TR is measured simultaneously with increase
per event of mass per area MSk/ASk in the skin contamination layer, a dermal transfer
coefficient, DTC, can be defined as (see also Fenske 1 and Zweig et al. 34):
)(
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Sk (5)
For this equation to be useful it has to be assumed that TR is independent of MSk/ASk.
However, Brouwer et al. 35 have shown that TR depends non-linearly on the mass per area
in the surface contaminant layer, MSu/ASu. A better approximation would be to assume a
functional relationship:
TR=TR(MSu/ASu) (6)
determined by non-linear regression. In reality a stochastic relation must be expected,
and thus for given MSu/ASu , TR has a given distribution with variables (mean and vari-
ance) being functions of MSu/ASu. It is to be expected that liquid contaminants can be
assessed with the simple relation, grease or other paste-like contaminants an intermediate
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Table A-2 Mass transport process descriptions.
Process Definition Symbola Units 
• Mass of hazardous substance emitted into air from primary 
sources per unit time 
EAir g.s -1 
• Mass of hazardous substance emitted to surface 
contaminant layer  by splashing, spilling and ejection of 
particles from primary sources per unit time per event 
ESu g.s-1 
g.event-1 
• Mass of hazardous substance emitted to the outer clothing 
contaminant layer for a particular worker by splashing, 
spilling and ejection of particles from primary sources per 
unit time per event 
ECloOut g.s-1 
g.event-1 
Emission 
• Mass of hazardous substance emitted to skin contaminant 
layer for a particular worker by splashing, spilling and 
ejection of particles from primary sources per unit time per 
event 
ESk g.s-1 
g.event-1 
• Mass of hazardous substance deposited from air 
compartment to the surfaces per unit time 
DpSu g.s-1 
• Mass of hazardous substance deposited from the air 
compartment to the outer clothing contaminant layer for a 
particular worker per unit time 
DpCloOut g.s-1 
Deposition 
• Mass of hazardous substance deposited from the air 
compartment to the skin contaminant layer for a particular 
worker per unit time 
DpSk g.s-1 
• Mass of hazardous substance lost from the surface 
contaminant layer to the air compartment by evaporation 
per unit time or by resuspension/evaporation per event 
LSu g.s-1 
g.event-1 
• Mass of hazardous substance lost from the outer clothing 
contaminant layer of a particular worker to the air 
compartment by or evaporation per unit time or by 
resuspension/evaporation per event 
LCloOut g.s-1 
g.event-1 
Resuspension or 
Evaporation 
• Mass of hazardous substance lost from the skin 
contaminant layer of a particular worker to the air 
compartment by evaporation per unit time or by 
resuspension/evaporation per event 
LSk g.s-1 
g event-1 
• Mass of hazardous substance transferred from the surface 
contaminant layer to the skin contaminant layer for a 
particular worker by direct contact per event 
TSu, Sk g.event-1 
• Mass of hazardous substance transferred from the surface 
contaminant layer to the outer clothing contaminant layer 
for a particular worker by direct contact per event 
TSu, CloOut g.event-1 
• Mass of hazardous substance transferred from the inner 
clothing contaminant layer to the skin contaminant layer 
for a particular worker by direct contact per event 
TCloIn,Sk g.event-1 
Transfer 
• Mass of hazardous substance transferred from the outer 
clothing contaminant layer to the skin contaminant layer 
for a particular worker by direct contact per event 
TCloOut,Sk g.event-1 
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Table A-2 (Continued)
Process Definition Symbola Units 
• Mass of hazardous substance removed from the skin 
contaminant layer of a particular worker and transferred to 
the surface contaminant layer by direct contact per event 
RSk,Su g.event-1 
• Mass of hazardous substance removed from the skin 
contaminant layer and transferred to the inner clothing 
contaminant layer of a particular worker by direct contact 
per event 
RSk,CloIn g.event-1 
• Mass of hazardous substance removed from the skin 
contaminant layer and transferred to the outer clothing 
contaminant layer of a particular worker by direct contact 
per event 
RSk,CloOut g.event-1 
Removal 
• Mass of hazardous substance removed from the outer 
clothing contaminant layer of a particular worker and 
transferred to the surface contaminant layer by direct 
contact per event 
RCloOut,Su g.event-1 
• Mass of hazardous substance transferred from one part of 
air compartment to other part per event 
RdAir g.event-1 
• Mass of hazardous substance transferred from one part of 
contaminant layer to other part per event 
RdSu g.event-1 
• Mass of hazardous substance transferred from one part of 
inner clothing contaminant layer to other part  per event 
RdcloIn g.event-1 
• Mass of hazardous substance transferred from one part of 
outer clothing contaminant layer to other part  per event 
RdcloOut g.event-1 
Redistribution 
• Mass of hazardous substance transferred from one part of 
skin contaminant layer to other part  per event 
RdSk g.event-1 
• Mass of hazardous substance removed from the air 
compartment by ventilation per unit of time 
DAir g.s-1 
• Mass of hazardous substance removed from the surface 
contaminant layer  by deliberate decontamination per event 
DSu g.event-1 
• Mass of hazardous substance removed from the outer 
clothing contaminant layer by deliberate decontamination 
per event 
DCloOut g.event-1 
• Mass of hazardous substance removed from the inner 
clothing contaminant layer by deliberate decontamination 
per event 
DCloIn g.event-1 
Decontamination 
• Mass of hazardous substance removed from the skin 
contaminant layer by deliberate decontamination per event 
DSk g.event-1 
• Mass of hazardous substance transported through stratum 
corneum 
PSk g.s-1 
• Mass of hazardous substance transported from the outer 
clothing contaminant layer to the inner clothing 
contaminant layer per unit time 
PCloIn, 
PCloOut 
g.s-1 
Penetration and  
permeation 
• Mass of hazardous substance transported from the inner 
clothing contaminant layer to the outer clothing 
contaminant layer per unit time 
PCloOut, 
PCloIn 
g.s-1 
a) Air= air compartment, Su= surface contaminant layer, Sk= skin contaminant layer, CloOut= outer clothing 
contaminant layer, CloIn= inner clothing contaminant layer  
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relation, and particulate contaminants with the most complex relation. Transfer of
particles will depend on contaminant properties - such as particle size distribution,
shape, and humidity or cohesion. In all cases it must be remembered that TR will depend
on the method used for its measurement. There are several versions of samplers designed
to exert a constant force on a defined area in a wiping action. These methods have
potential for simulating the transfer of mass and are non-destructive. One such monitor
is a fixed pressure dislodgeable residue sampler such as a polyurethane foam roller 36.
Ross, and others 37 used standardized movements (aerobic dance routines following an
instructor and music) to measure transfer of pesticides from fogged carpets onto the
skin. Transfer from the inner clothing contaminant layer to the skin contaminant layer is
usually estimated with patches or underwear. No other method seems to have been
developed specifically for measuring this transfer.
Removal - Dissipation of contaminants from the clothing compartment has been subject
of many studies, however, the studies were focussed on the transport of mass from the
clothing compartment to the skin compartment – that is, the opposite direction to
removal. Yang and Li 38 reported a frictional transport of pesticides of 1% to 5 % from
contaminated clothing to underwear. As mechanical or frictional transport may be an
important mechanism of removal, these data indicate the range of mass transport from
clothing in the opposite direction. Removal from skin to surface has been studied by
Brouwer et al. 35. They reported a mean removal efficiency of 38 % during a single
pressure contact of a contaminated hand with an uncontaminated flat surface.
Redistribution - Information on the area exposed and the redistribution of contaminant
could be obtained by observation. However, the method of choice is the fluorescent
tracer technique with a quantitative image analysis system 21-25. These methods have high
spatial resolution.
Decontamination - Decontamination of the air compartment is the removal of mass from
the air compartment by either local or general ventilation. Methods to assess the
efficiency of ventilation in reducing the concentration of gaseous and particulate
contaminants are well developed 39. Decontamination of surfaces can be assessed by
measuring the mass removed – for example, the quantity of dust in a vacuum cleaner
filter bag - or by the decrease in mass of the surface contaminant layer. A measurement
strategy for decontamination of surface dust in offices has been described by Schneider
et al. 40 and a  standard procedure to assess the efficiency of hand washing has been
developed by Fenske and Lu 41.
Penetration and permeation - Penetration and permeation stand for transport of mass
through either the clothing barrier or the stratum corneum. These mass transport
pathways have been studied in great detail relative to the effectiveness of protective
clothing 42 and percutaneous penetration 43. In both cases a test cell design is used to
measure permeation. However, several different methods are used in the assessment of
percutaneuos penetration ranging from in vitro models with static diffusion cells and
flow through diffusion cells with animal or human skin (viable and non-viable).
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General discussion and conclusions
In this paper we propose a conceptual model of both the important pathways leading to
dermal exposure and the intermediate compartments where the hazardous substances
may reside. This model has allowed us to define a consistent terminology, which should
form the basis for improved comparability between studies of dermal exposure or surface
contamination. Consistent use of the model will ensure that most appropriate variables
are measured in any situation. The model has been constructed at a conceptual level and
omits much of the detail, which is evident in real situations. It is possible to extend the
model as a series of interlinked compartments for the skin, surfaces, etc. In this way
compartments for hands, arms, torso etc., could represent the skin surface; or if greater
resolution is required fingers, palms, etc, could represent the skin surface. In this way
the existing model encompasses sufficient detail to enable terminology to be developed,
it could be generalized for any particular need.
The model can cope with special exposure scenarios, such as immersion of body parts in
liquid or powder. In this case the liquid or powder constitutes the skin contaminant
layer compartment and has infinite volume. For interpretation of contaminated sub-
stances derived from soil and paste-like substances in the skin contaminant layer a
refinement of the model is necessary. The skin contaminant layer could be subdivided
into an outer layer and an inner layer in intimate contact with the stratum corneum. The
possibility exists that it is the supply of hazardous substance from the outer layer to
inner layer, which limits the rate of uptake. This identifies a need to refine existing
methods of measuring mass in the skin contamination layer compartment.
We have not considered the stratum corneum in much detail, as it is generally not
available for surface sampling methods. Skin stripping with adhesive tape is a possible
exception. Consecutive stripping allows semi-quantitative depth profiling, but if the skin
contaminant layer compartment is not empty, the mass in this compartment and in the
stratum corneum will be partially mixed up. The finite thickness of the stratum corneum
constitutes a buffer capacity and introduces a lag time for the transport process to reach
equilibrium after a step change in concentration 44. The lag time may vary from a few
minutes up to days and its significance for risk assessment would be determined by
duration of exposure as compared with lag time.
The inventory of existing methods for skin and surface contamination measurement
(Table A-3) is only illustrative. Compilation of an exhaustive inventory and discussion
relative to the model is beyond the scope of the present paper. However, with the model
structure, limited or non-existing methods for measuring relevant compartment mass or
transport processes have been identified:
♦ The model stresses the importance of measuring concentration in the skin
contaminant layer but methods relevant for uptake are lacking;
♦ The mass of particles in the skin contaminant layer may only have limited rel-
evance for uptake. Particles are less likely to result in uptake than liquids and
Appendix: Conceptual model for assessment of dermal exposure
185
M
et
ho
d
Pr
in
ci
pl
e 
o
f S
am
pl
in
g
Sa
m
pl
in
g 
ar
e
a 
de
fin
iti
o
n
M
ea
su
re
d
co
m
pa
rt
m
en
t m
as
s 
a
M
ea
su
re
d 
tr
an
sp
o
rt
pr
o
ce
s
s 
b
R
ef
.
U
V
 
flu
o
re
sc
en
ce
In
 
sit
u
0.
1-
2 
m
2
M
Sk
,
 
M
Su
,
 
M
Cl
o
O
u
t, 
M
Cl
o
In
A
ll 
pr
o
ce
ss
es
21
-2
5
Po
rt
ab
le
 
X
-
ra
y 
flu
o
re
sc
en
ce
 m
o
n
ito
r
In
 
sit
u
In
st
ru
m
en
t d
ef
in
ed
M
Su
A
ll 
pr
o
ce
ss
es
 
re
la
te
d 
to
th
e 
su
rfa
ce
 
co
n
ta
m
in
an
t
la
ye
r
18
W
et
 w
ip
e
M
an
u
al
 
w
ip
in
g
N
on
e 
o
r 
te
m
pl
at
e
M
Su
,
 
M
Sk
T S
u,
Sk
,
 
T S
u,
Cl
o
O
ut
,
 
R
Sk
,
Su
,
R
Sk
,
Cl
o
In
,
 
R
Sk
,
Cl
o
O
u
t
46
W
et
 w
ip
e
M
ec
ha
n
iz
ed
 
w
ip
in
g
In
st
ru
m
en
t d
ef
in
ed
M
Su
T S
u,
Sk
,
 
T S
u,
Cl
o
O
ut
19
G
el
at
in
e 
fo
il
Su
rfa
ce
 d
u
st
 
lif
tin
g
1:
1 
tr
an
sf
er
 
o
f d
u
st
 
la
ye
r
M
Su
T S
u,
Sk
,
 
T S
u,
Cl
o
O
ut
40
Fi
x
ed
 p
re
ss
u
re
 
di
slo
dg
ea
bl
e 
re
sid
ue
 
sa
m
pl
er
M
ec
ha
n
ic
al
 
tr
an
sf
er
 
in
sit
u
10
-2
0c
m
 
x
 
le
n
gt
h 
sa
m
pl
ed
M
Su
T S
u,
Sk
,
 
T S
u,
Cl
o
O
ut
36
D
isl
o
dg
ea
bl
e 
fo
lia
r 
re
sid
u
e 
sa
m
pl
in
g
Su
rfa
ce
 r
em
o
v
al
Pu
n
ch
es
 
0.
1-
2.
5 
cm
2 ,
 
to
ta
l 1
00
cm
2
M
Su
T S
u,
Sk
,
 
T S
u,
Cl
o
O
ut
33
A
dh
es
iv
e 
ta
pe
Sk
in
 st
rip
pi
ng
1:
1 
tra
n
sf
er
 
o
f d
us
t l
ay
er
M
Sk
D
p S
k,
 
R
Sk
,
Su
,
 
R
Sk
,
Cl
o
In
,
R
Sk
,
Cl
o
O
u
t
44
H
an
d 
w
as
h
W
as
h 
w
ith
 
w
at
er
 
o
r
al
co
ho
l
To
ta
l h
an
d 
su
rfa
ce
M
Sk
R
Sk
,
Su
,
 
R
Sk
,
Cl
o
In
,
R
Sk
,
Cl
o
O
u
t,
 
D
Sk
20
Pa
tc
h
Pa
ss
iv
e
Sa
m
pl
er
 
de
fin
ed
M
Sk
T S
u,
Sk
,
 
T C
lo
In
,
Sk
,
 
T c
lo
O
u
t,S
k,
D
p S
k
16
W
ho
le
 
bo
dy
Pa
ss
iv
e
B
o
dy
 
pa
rt
s
M
Sk
T S
u,
Sk
,
 
T C
lo
In
,
Sk
,
 
T c
lo
O
u
t,S
k,
D
p S
k
16
SM
A
IR
R
es
u
sp
en
sio
n 
by
 
ai
r 
jet
In
st
ru
m
en
t d
ef
in
ed
-
-
-
L S
u
30
ST
EP
P
R
es
u
sp
en
sio
n
 b
y 
im
pa
ct
In
st
ru
m
en
t d
ef
in
ed
-
-
-
L S
u
29
M
ic
ro
v
ac
u
u
m
in
g
R
es
u
sp
en
sio
n 
by
 
su
ct
io
n
In
st
ru
m
en
t d
ef
in
ed
M
Su
L S
u
47
FL
EC
Ev
ap
or
at
io
n 
by
 
ai
rfl
ow
In
st
ru
m
en
t d
ef
in
ed
-
-
-
L S
u
31
TE
W
L
Ev
ap
or
at
io
n
In
st
ru
m
en
t d
ef
in
ed
-
-
-
L S
k
32
a)  
D
ef
in
iti
o
n
 
o
f s
ym
bo
l s
ee
 
Ta
bl
e 
A
1
b)  
M
as
s 
tr
an
sp
or
t p
ro
ce
ss
 
de
sc
rip
tio
ns
 
se
e 
Ta
bl
e 
A
2
Ta
bl
e 
A-
3
M
ea
su
re
m
en
t 
m
et
ho
ds
 (
fo
r 
a 
re
vi
ew
 s
ee
 C
ar
so
n 
et
 a
l. 
45
).
Genotoxic exposure and biological effects in the rubber manufacturing industry
186
solubility of particles is an important qualifier which should be specified along
with results of measurements of the mass and composition of skin contaminant
layer;
♦ A clear distinction must be made between mass in compartment and transport of
mass. Direct measurement of mass transport must be based on an appropriate
theoretical model.
We envision that our paper will stimulate discussions and help in the development of
more appropriate methodologies for the assessment and control of dermal exposure.
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